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SUMMARY
The work in this thesis developed three separate models 
of acute graft-versus-host reaction in irradiated adult 
and oire day old neonatal (CBA x BALB/c)F1 mice and 
(C57B1/10 x DBA/2)F1 mice given C57Bl/lO cells. All these 
models were associated with weight loss and mortality as 
well as an enteropathy characterised by villus atrophy. 
Furthermore? these different hosts consistently developed 
a very similar biphasic pattern of systemic and intestinal 
Gvhr. An initial proliferative phase was characterised by 
the development of splenomegaly which coincided with an 
increase in intraepithelial lymphocytes and crypt cell 
production rate? in the small intestine? as well as a 
transient increase in splenic NK cell activity. These 
early changes were similar to those described previously 
in unirradiated? adult (CBA x BAJLB/c)F^ mice with Gvhr? 
but mice with acute Gvhr subsequently developed weight loss 
and villus atrophy? which were accompanied by specific CTL 
activity? features not observed in previous work on un­
irradiated (CBA x BALB/c)F^ hosts.
The evolution of acute Gvhr was shown most clearly in 
irradiated (CBA x BALB/c)F-^ hosts where the proliferative 
disease rapidly transformed into a lethal disorder with 
severe villus atrophy and ultimately mucosal necrosis.
This was also accompanied by a reduction in the CCPR and 
the number of IEL. The systemic and intestinal consequences 
of a Gvhr in neonatal (CBA x BALB/c)F1 mice depended upon 
the age of the host? with one day old hosts developing an
acute Gvhr, whereas seven day old animals merely showed 
a proliferative disorder with no weight loss, CTL activity 
or villus atrophy. Five day old mice were intermediate 
hosts,-where some animals developed a lethal Gvhr while 
others developed a proliferative form of the disease. However 
even in those mice which developed villus atrophy, no 
evidence of specific CTL was found. These differences were 
not influenced by the number of donor cells used but it was 
found that spleen cells from one day old mice were defective 
at inducing allospecific delayed-type hypersensitivity and 
no anti-host DTH response developed during a Gvhr in one 
day old mice. Furthermore, one day old mice appeared to 
have a T-cell defect as shown by an inability of their 
lymphoid cells to induce a local Gvhr. In contrast to these 
findings spleen cells from 7 day old mice induced similar 
levels of allospecific DTH and developed an anti-host DTH 
response during Gvhr which was similar to that found in 
adult mice of the same strain.
An acute destructive Gvhr also occurred in adult 
(C57B1/10 x DBA/2)F^ mice given BIO spleen cells, whereas 
BDF-^ mice given DBA/2 cells had very little evidence of 
systemic or intestinal Gvhr, apart from some splenomegaly.
In parallel, specific CTL were only found in hosts given 
BIO spleen cells and these mice also had evidence of active 
immunosuppression. The more potent ability of BIO donor 
cells to induce Gvhr was consistent with the observation 
that BIO cells responded better in vitro to both adult and
neonatal BDF1 stimulators. Both BIO and DBA/2 donor 
cells could induce an acute Gvhr in one day old BDF^ mice, 
while 5 day old hosts showed a similar pattern to adult 
mice. These results suggest that DBA/2 cells are merely 
defective at inducing Gvhr and do not induce a qualitatively 
different disorder.
Villus atrophy was also found in a fourth model of 
Gvhr which occurred in adult athymic (CBA x BALB/c)F^ mice 
given CBA donor cells. Compared with euthymic hosts of 
the same strain these mice developed more intense splenomegaly 
and crypt hyperplasia while only athymic hosts had villus 
atrophy, CTL activity and reduced NK activity. These findings 
suggested that one reason for the more severe Gvhr found 
in irradiated and neonatal (CBA x BALB/c)F^ mice was an 
absence of host T-cells which normally regulate the severity 
of the Gvhr in intact hosts.
The immunopathogenesis of the different forms of 
intestinal Gvhr was investigated by examining the nature 
of the donor T-cells and the region of the MHC necessary 
for the induction of Gvhr. Both Lyt 2+ and L3T^+ T-cells 
were required for the development of full splenomegaly 
and intestinal alterations in unirradiated adult (CBA x 
BALB/c)F^ mice with Gvhr. Similar results were found in 
irradiated (CBA x BALB/c)F1 hosts, although Lyt 2 cells 
alone were capable of inducing a lethal Gvhr in this case.
In contrast, L3T4” cells were able to induce an acute 
lethal Gvhr in one day old (CBA x BALB/c)F1 hosts and
these mice also developed some splenomegaly, crypt lengthening 
and villus atrophy. Lyt 2 cells produced no clinical Gvhr 
in these hosts and neither L3T4” nor Lyt 2” cells produced 
any systemic or intestinal changes in 3 day old F^ hosts.
An interesting and consistent observation was that compared 
with unseparated donor cells both L3T4” and Lyt 2~ donor 
cell populations produced more enhancement of NK cell 
activity during a Gvhr.
Although these results using sub-populations of donor 
T-cells were inconclusive induction of a Gvhr across a 
Class II MHC incompatibility in (ATH x ATL)F^ mice produced 
an acute Gvhr with weight loss, splenomegaly and crypt 
hyperplasia. These alterations developed in the absence 
of specific CTL and NK activity and the onset of clinical 
Gvhr occurred about a week later than normally found using 
a full major histocompatibility difference. No systemic 
disease was found in a Gvhr induced across an H-2D or H-2K 
Class I MHC incompatibility and although transient NK cell 
activation and crypt lengthening occurred across an H—2K 
disparity, this was minor and was not found during an H-2D 
disparate Gvhr.
NK cell activation was a consistent feature of most 
models of Gvhr and the role of NK cells in systemic and 
intestinal Gvhr was examined in adult (CBA x BALB/c)F^ mice 
treated with anti-asialo G antibody. This depleted host 
NK cell activity and also reduced the density of IEL in 
control animals. In addition, anti-asialo treated mice
vi -
with. Gvhr had less splenomegaly than normal Gvhr mice and 
did not develop any intestinal alterations of Gvhr. These 
findings were complimented by experiments in which neonatal 
(CBA x BALB/cjFj^ mice were treated with polyinosinic: 
polycytidylic acid. Poly I:C augmented NK activity in these 
mice, and this was associated with more severe weight loss; 
crypt hyperplasia and villus atrophy during Gvhr. These 
results indicate that NK cells may act as non-specific 
effector cells in both the proliferative and destructive 
phases of a Gvhr and do not protect the host animal, as 
others have suggested.
Active immunosuppression occurred in several models 
of acute, destructive Gvhr and the final experiments examined 
the role of suppressor T-cells in acute Gvhr. Host mice 
were depleted of Ts by treatment with 2-deoxyguanosine 
which significantly reduced the mortality due to Gvhr in 
adult BDF^ mice given BIO spleen cells and delayed the 
development of villus atrophy in these mice. dGuo treatment 
of neonatal (CBA x BALB/c)F^ with acute Gvhr had less 
effects on systemic Gvhr but, it prevented the development 
of villus atrophy and produced more intense crypt hyperplasia. 
The role of Ts was also investigated by inducing a Gvhr 
across an incompatibility at the I-J locus in (B10.A3R x 
B10.A5R)F1 mice. Although these mice do not develop any 
systemic Gvhr and had no immunological alterations, transient 
villus atrophy was found. However, this was associated 
with crypt shortening and an absence of local lymphoid cells,
rather than the hypertrophy and inflammation normally 
found in Gvhr.
The overall conclusion from this thesis is that intestinal 
Gvhr provides an excellent means of studying enteropathy 
which is associated with a local T-cell mediated immune 
response. Both proliferative and destructive forms of 
enteropathy can be induced and it appears that the destruction 
represents a continuation of an earlier, proliferative phase. 
Although CTL were often associated with destructive Gvhr, 
this was not always the case and therefore other mechanisms 
such as NK cells or Ts may also be involved. The onset of 
acute Gvhr may represent progression of the DTH response 
thought to be responsible for proliferative enteropathy.
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Cell mediated immunity and the small intestine
The small intestine is constantly bombarded with foreign 
particles or antigens and it is not surprising that this 
important tissue has developed a complex immune system to 
protect itself against potential pathogens. However) 
activation of potent effector mechanisms during initially 
protective responses may also be associated with intestinal 
damage (Mowat> 1984).
One important group of diseases caused by a local immune 
response are the enteropathies associated with active 
hypersensitivity to dietary proteins. These disorders are 
common causes of infantile morbidity and may reflect a 
breakdown in the immune tolerance which normally occurs 
after feeding proteins to naive animals (Mowat
1984). The commonest form of food sensitive enteropathy 
is coeliac disease) which is due to an intolerance to the 
wheat protein given> but similar conditions are associated 
with hypersensitivity to soya) fish) rice) chicken and milk 
(Ament _et al. , 1972; Kuitunen e_fc al. > 1975; Vitoria jet al. f
1982). These food sensitive enteropathies are characterised 
by diarrhoea) malabsorption and a failure to thrive) normally 
within the first 2 years of life. The pathological changes 
are restricted mainly to the upper jejunum and duodenum 
and consist of villus atrophy and crypt hyperplasia (Mike 
& Asquith) 1987). These alterations in mucosal architecture 
are accompanied by a chronic inflammatory cell infiltrate 
(Rubin _et al. , i960), which includes increased numbers of 
plasma cells and mucosal mast cells (Strobel et al. > 1983;
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Mowat, 1987a) in the lamina propria as well as an increased 
density of IEL (Ferguson & Murray, 1971; Holmes e_fc al., 1974). 
In coeliac disease, many IEL have an activated morphology 
and have an increased mitotic rate, as well as showing 
evidence of increased movement in and out of the epithelium 
(Marsh, 1987)• A similar pattern of villus atrophy, crypt 
hyperplasia and increased lymphocytic infiltration of 
the epithelium is also found in several parasitic infections 
of the small intestine, as well as tropical sprue and the 
active lesions of Crohn's disease (Cooke & Holmes, 1984; 
Miller, 1987)* Therefore it seems likely that this group 
of disorders share a common pathogenesis and it would be 
important to elucidate the mechanisms involved.
There is considerable circumstantial evidence from 
clinical studies that FSE is associated with local and 
systemic immunity to dietary antigens (Mowat, 1984; Mike & 
Asquith, 1987)* Furthermore, coeliac disease shows a close 
genetic linkage with certain genes coded by the class II 
region of the human MHC, including HLADW3> DR7 and DQW2 
(Keuning et al. , 1976; BeU-tel et al. , 1980). Together 
with the chronic inflammatory cell infiltrate, these features 
suggest that this group of enteropathies are due to a local 
immune response with the intestine. Nevertheless, many 
different types of immunity to food proteins have been 
detected in patients with FSE and the immunopathogenesis 
of the intestinal damage remains unclear. As it is difficult 
to investigate these issues in diseased patients under 
clinical conditions, animal models have been sought which
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will reproduce the appropriate intestinal pathology in 
association with defined immune responses.
Experimental models of food sensitive enteropathy
1. Naturally occurring disease
There are no naturally occurring models of FSE in 
inbred laboratory animals. Nevertheless, post weaning 
diarrhoea in piglets is characterised by villus atrophy 
crypt hyperplasia and an increased rate of crypt cell 
proliferation (Kenworthy & Allen, 1966(a)(b); Kenworthy, 1970) 
and recent evidence suggests that this is associated with 
a DTH response to antigens present in the weaning diet 
(Stokes, 1984). However, the experimental use of this 
model is limited by the outbred nature and availability 
of the host animal and by claims that enteropathogenic 
E.coli are primarily responsible for the intestinal damage 
(Kenworthy, 1970).
2. Local CMI responses to fed protein antigens
Induction of an active immune response to fed proteins 
would be the most appropriate experimental model of clinical 
FSE. Although antibodies to food proteins causing the 
enteropathy are present in a majority of patients, they are 
probably not important, as antibodies are also present in 
normal children (Ferguson & Carswell, 1972; Savilahti, 1973? 
Eastham & Walker, 1977) and in patients with intestinal 
damage due to diseases not associated with food hypersensitivity 
(Ferguson, 1976). Furthermore, the induction of antibodies
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which, react with the small intestine does not produce the 
appropriate histologic changes (Rabin & Rogers, 1976). 
Finally, although mucosal mast cell numbers are increased 
in coeliac disease, there are no alterations in mucosal IgE, 
plasma cell numbers and local anaphylactic reactions do 
not produce crypt hyperplasia (Strobel _et al. , I983).
This direct approach of inducing immunity to dietary antigens 
has also proved very difficult, because the usual result of 
feeding soluble antigens to naive animals is the induction 
of profound systemic tolerance (Mowat, 1987b). If this 
induction of oral tolerance can be prevented after feeding 
mice ovalbumin, subsequent oral challenge with antigen will 
produce a CMI response in the intestinal mucosa and lymphoid 
tissues (Mowat, 1987b). This local hypersensitivity reaction 
is associated with crypt hyperplasia and increased IEL 
counts (Mowat & Ferguson, 1981a; Mowat, 1986) and so has 
some similarities to the natural disorders.
In addition recent studies indicate that immune 
responsiveness to dietary ova may be controlled in part by 
MHC genes (Lamont e_t al. , 1988 ; Mowat _et al_. , 1987 ) • 
Together, these studies suggest that clinical FSE may reflect 
a local CMI response which occurs due to a genetic defect 
in the induction of oral tolerance to dietary antigens. 
However, this experimental model of food hypersensitivity is 
limited by the fact that the intestinal damage is generally 
mild and, thus far, it has proved impossible to induce 
villus atrophy. Therefore, it seems likely that the study 
of immune responses to dietary antigens in mice will provide
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information on the induction phase of FSE and it will be 
necessary to examine the pathogenic effector mechanisms 
in other models.
3• Experimental parasitic infections
The mucosal lesions seen during FSE are reproduced by 
certain experimental parasitic infections including 
Nippostrongylus brasiliensis? Trichinella spiralis and 
Giardia muris (Miller? 1987; Roberts-Thomson? 1987)* The 
intestinal damage caused by N. brasiliensis is preceded by 
an influx of T-lymphoblasts into the mucosa and does not 
occur in thymus-deprived? B rats (Ferguson & Jarrett? 1975)* 
Furthermore? both the mucosal pathology and associated 
hyperplasia of mucosal mast cells can be adoptively trans­
ferred by immune T-cells (Manson-Smith e_fc al.? 1979)* The 
enteropathy found in mice with T. spiralis infection is 
also preceded by increased localization of T-lymphoblasts 
in the small intestine (Manson-Smith ej; al_. ? 1979) and 
immune T-cells are required for the expulsion of the parasite 
from the intestine (Wakelin & Wilson? 1979)*
T-cell immunity has also been implicated in murine 
giardiasis (Roberts-Thomson? 1987)> which is accompanied 
by villus atrophy? crypt hyperplasia and an increase in IEL 
(MacDonald & Ferguson, 1978; Ferguson e_fc al., 198I).
Although these studies suggest that activated T-cells 
are responsible for the intestinal pathology in parasite 
infections? others have shown that although nude mice had 
a delayed clearance of T. spiralis ? these mice still developed
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a full range of pathology (Ruitenberg et al., 1977). 
Furthermore? it has also been suggested that antibody 
mediated immunity may be of most importance in giardiasis 
(Ridley & Ridley? 1976). In general? the complexity of 
parasite infections limits their usefulness as models of 
specific immune-mediated tissue damage.
4. Rejection of intestinal allografts
Several years ago? it was shown that rejecting allografts 
of canine jejunum developed villus shortening and crypt 
hyperplasia followed by crypt necrosis (Holmes ejfc al.? 1971)* 
Later studies in mice by Ferguson & Parrott (1972? 1973) 
showed that rejection of allografts of foetal intestine 
implanted under the kidney capsule was associated with villus 
atrophy and crypt hyperplasia. These features were thymus- 
dependent and did not correlate with the development of 
the humoral immune response (Elves & Ferguson? 1975)*
More detailed analysis of mucosal architecture and 
epithelial cell kinetics in this model showed that the earliest 
sign of rejection was an increased IEL count? and that villus 
atrophy was preceded by an increased CCPR (MacDonald &
Ferguson? 1976). These studies were the first clear 
demonstration that a local T-cell response could produce 
this pattern of intestinal damage. In addition? they 
established sensitive methods which could be used to measure 
intestinal immune responses of this kind.
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5• Intestinal phase of Graft-versus-host reaction
Another form of alloreactivity in vivo is graft-versus- 
host reaction and it has long been known that Gvhr in man 
and experimental animals is associated with damage to the 
small intestine (Billingham, 1967; Glucksberg et al. , 1974; 
Woodruff ejfc al•, 1976; Slavin & Santos, 1973; Bril &
Benner, 1985). As will be described below, the intestinal 
features include villus atrophy, crypt hyperplasia as well 
as increased lymphocytic infiltration of the epithelium 
and so mimic closely those of naturally occurring enteropathies 
(MacDonald & Ferguson, 1977; Mowat & Ferguson, 1981b, 1982).
One further advantage of Gvhr as an experimental model is 
that the pathological consequences can be manipulated, 
depending on the donor-host combination used and many workers 
have found the Gvhr to be a flexible means of studying T-cell 
mediated immunopathology (G1eichmannetal, 1984; Bril &
Benner, 1985). The aim of this thesis was to investigate 
further whether murine Gvhr provided a suitable means of 
elucidating the pathogenesis of FSE.
Graft-versus host reactions
Gvhr is the syndrome which occurs after the transfer 
of immunocompetent lymphocytes into genetically incompatible, 
immunoincompetent hosts (Billingham, 1967). The first 
formal description of Graft-versus-host disease was applied 
by Billingham, Brent & Medawar (1935) to the runting disease 
which occurred in some neonatal mice after the induction 
of tolerance to allogeneic cells.
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Around the same time, Simonsen (1957) reported that 
newly hatched chicks given allogeneic lymphoid cells developed 
hepatosplenomegaly, as well as haemolytic anaemia. Spleno­
megaly also occurred in newborn mice inoculated with spleen 
cells from homologous adult donors (Simonsen, 1962) and, 
subsequently Gowans (1962) demonstrated that the small 
lymphocyte was important in evoking what were termed MGvhM 
reactions. Later studies showed that T-lymphocytes were 
responsible for the induction of Gvhr (Argyris, 1974; Grebe & 
Streinlein, 1976; Vallera e_fc al. , 1981) and since then 
Gvhr has received considerable attention from both clinicians 
and experimental immunologists.
Pathological features of Gvhr
Gvh disease remains one of the most important complications 
of human bone marrow transplantation although it is now less 
common due to the use of T-cell depleted donor bone marrow 
(Waldman _et al. , 1984; Prentice et al. , 1984). Although 
pathological changes may occur in a wide variety of different 
tissues, the principal target organs are usually the small 
intestine, skin and liver (Elkins, 1971; Bril & Benner, 1985). 
The skin normally shows the first signs of damage, with an 
erythematous rash which may progress to formation of bullae 
and desquamation. Histological examination reveals 
degeneration of the epidermis or mononuclear cell inflammatory 
infiltration and necrosis (Woodruff ejfc al., 1976; Bril &
Benner, 1985). Intestinal involvement occurs shortly after 
the skin lesions and presents as diarrhoea and vomiting.
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Macroscopic examination shows ulcerative lesions in the 
small intestine (Elkins, 1971) and, as the disease progresses, 
histological sections exhibit degeneration of the mucosa 
with vacuolated crypts, flattened villi and a mononuclear 
cell infiltrate (Bril & Benner, 1985). These features may 
be complicated by infection (Santos e_t al_. , 1985) and are 
less marked, in patients treated with barrier nursing. The 
liver damage which occurs varies according to the form of 
Gvhd (Bernuau et al., 1980; Bril & Benner, 1985)* but commonly 
involves lymphoid infiltration at sinusoids and portal tracts, 
destruction of the bile ducts followed by hepatocellular 
necrosis (Suitters & Lampert, 1984). In all these tissues, 
induction of Class II MHC antigens on tissue cells is a 
prominent feature of Gvhd, but its relationship to the 
pathological damage is unknown.
Two forms of human Gvhd have been described; acute 
and chronic (Tsoi, 1982; Santos e_fc al_. , 1985; Gale _eti al. , 
1985). Acute Gvhd normally begins within 30 days post­
transplant and may be accompanied by an early enhancement 
of antibody production and DTH (Santos _et al. , 1985). 
Thereafter non-specific suppressor T-cells may appear (Hess 
et al. , 1982; Witherspoon e_fc al. , 1984) and these probably 
account for the high incidence of bacterial and viral 
infections in these patients (Witherspoon et_ al. , 1984).
Acute Gvhd is also associated with epithelial cell damage 
in many tissues (de Gast et al. , 1987) and in the gut this 
results in necrosis of individual enterocytes, followed by 
degeneration and loss of crypts (Sloane & Dilly, 1988).
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Chronic Gvhd begins >100 days after BMT and may develop 
after acute Gvhd or can occur de novo. It has many 
characteristics of collagen vascular disorders? autoimmune 
diseases? such as SLE and scleroderma (Tsoi et al • ? 1978;
Graze and Gale? 1979? Shulman e_t al. ? I98O; Santos _et al. ?
1985). Severe immunodeficiency is a further feature of 
chronic Gvhd and this may lead to recurrent and sometimes 
fatal infections. Infection is predisposed by the profound 
immunosuppression which is a characteristic feature of most 
patients with chronic Gvhd. This may be due to reduced 
activity of helper T-cells? B cells or antigen presenting 
cells? while elevated levels of non-specific suppressor T- 
cell activity may also be present (Tsoi _et al. ? 1982). In 
contrast? long term stable chimeras? without Gvhd are 
specifically tolerant of host antigens? but lack anti-host 
cellular responses and do not have non-specific Ts or abnormal 
B and T helper cell activities. The maintenance of long term 
chimerism appears to be dependent upon specific suppressor 
cells (Tsoi e_t al. ? I98I).
Many studies of Gvhr in animals have also found evidence 
of immune suppression which may affect both cellular (Lapp 
et al.? 1974; Shand? 1976) and humoral immunity (Pickel & 
Hoffman? 1977). Although? later work showed that this 
immunosuppression may be attributed to suppressor T-cells 
(ishikawa et_ al. ? 1982) as in man? several different mechanisms 
have been implicated in this phenomenon. These include 
defects in the function of T cells? B cells and macrophages 
(Seddik _et al. ? 1984? 1985* 1986a? b).Interleukin-2 and
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interleukin-1 production has been shown to be reduced 
(Joseph e_fc al. , 1985; Mendes e_t ad,, 1985) and it has been 
suggested that the T-cell deficiency is due to damage to 
thymic epithelium (Seddik e_t al. , 1979)* Iti addition many 
groups have identified specific donor Ts in mice with Gvhr 
(Lapp et_ al • , 1974; Pickel & Hoffman, 1977 5 Pollison &
Shearer, I98O; Gleichmann ejfc al. , 1984), while others have 
shown the generation of non-specific "natural suppressor" 
cells (Maier e_t ad., 1986). Interestingly, there is some 
evidence that the appearance of suppressor cell activity 
may be preceded by an early phase of enhanced immune 
responsiveness (Byfield e_t ad_. , 1973)? illustrating the 
complex abnormalities of immunoregulation which may occur 
in Gvhr.
Different patterns of pathology have also been reported 
in animal models although these rarely reproduce the clinical 
forms described above. Many workers have shown that the 
consequences of a Gvhr depend on several different factors, 
including the age of the host, its immune status and the 
donor—host combination as well as the dose and nature of 
the donor cells. One of the best characterised of these 
models is that using adult, unirradiated BDF^ mice, where 
it has been shown that BIO donor cells produce an acute, 
often lethal Gvhr which is associated with anaemia, hypoplasia 
of the lympho-hAsnopoietic system and hypogammaglobulinaemia 
(Gleichmann ejb ad., 1984). In contrast, DBA/2 cells produce 
a chronic proliferative disorder with hypergammaglobulinemia
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leading to the formation of autoantibodies characteristic 
°f SLE, immune complex glomerulonephritis and symptoms 
characteristic of other collagen vascular diseases (Gleichmann 
ot al., 1984). As will be discussed below, these forms of 
Gvhr appear to be due to different immune effector mechanisms, 
illustrating the potential usefulness of experimental Gvhr 
in studying immunopathology.
Cellular and genetic basis of Gvhr
The outcome of a Gvhr reflects a complex interaction 
between donor and host elements and depends on the donor 
cells used, the genetic differences involved and the nature 
of the host animal. T-lymphocytes have been shown to be 
essential for the induction of a Gvhr (Argyris, 1974;
Grebe & Streilin, 1976) and this has been confirmed by studies 
where depletion of T cells from the donor inoculum prevents 
the development of Gvhd in man (Prentice e_fc al. , 1984;
Waldmannet al., 1984) and mice (Cantor, 1972; Korngold & 
Sprent, 1978). T-cells are also required for the rejection 
of allografts, as animals made T-cell deficient by adult 
thymectomy, lethal irradiation and bone marrow reconstitution 
are unable to reject skin allografts (Loveland _et al. , 1981; 
Dallman e_t a_L_. , 1982).
Although T-lymphocytes are clearly required for the 
induction of Gvhr, the T cell system displays a broad spectrum 
of functions, including helper and suppressor T cell activity, 
cell mediated cytotoxicity and delayed type hypersensitivity 
(Sprent et al., 1986b). Therefore, considerable effort has 
been made to attempt to determine which of these activities
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is required for the induction of Gvhr. Particular attention
has centred on the relative roles of CTL and TTV_H_but these
DTH
studies should be interpreted carefully in the light of the 
fact that phenotype does not necessarily predict the function 
of a T-cell.
Early studies using Lyt 1 and Lyt 2 as markers of mouse
helper and cytotoxic T-cells showed that although both Lyt 1+
and Lyt 2+ T cells were required for the induction of Gvhd
(Kisielow et al. , 1973) only depletion of Lyt 1+ cells
prevented the induction of a lethal Gvhr. Later studies in
rats also showed that helper/indueer T cells appeared to be
essential for a lethal Gvhr (Mason, 1981), these cells were
also shown to be MRC OX 22+ (Spickett ejb al.,1983) and
together, these results were interpreted as support for the
role of DTH in Gvhr. However, further work suggested that 
+ +both Lyt 1 and Lyt 2 T-cells were required for the induction 
of anti-host DTH in Gvhr (Walters & Benner, 1981), as well 
as for the development of lethal Gvhr in unirradiated BDF^ 
mice (Rolink e_t al. , 1983; Rolink & Gleichmann,1983) .
Korngold & S p r e n t  (1982) also provided evidence in irradiated 
mice that Lyt 1+ 2+ cells were required to induce a lethal 
Gvhd across minor histocompatibility antigens.
In addition, further experiments in rats showed that 
radioresistant CD8+ cells were still present in the host 
animals in whom Gvhr appeared to be due entirely to helper/ 
inducer T-cells. Furthermore, the MRC OX 22+ T cells which 
were required to induce a local Gvhr in rats were found to 
assist the generation of CTL as well as mediating DTH 
(Spickett et aL., 1983; Arthur & Mason, 1986).
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The interpretation of* initial studies in mice was 
also complicated by the demonstration that Lyt 1 was expressed 
on both Tjj and CTL (Ledbetter et al. , 1980) and more recent 
work in mice has used L3T4 and Lyt 2 as non-overlapping 
markers on Class II restricted and Class I MHC restricted 
T cells (Dialynas e_fc al. , 1983; Sprent et al. , 1986b). These 
studies have shown that both L3T4+ and Lyt 2+ T cells alone 
can cause systemic Gvhr, providing they are stimulated by the 
appropriate MHC antigen (Cobbold e_t al. , 1986). In contrast 
it has been shown that the induction of Gvhr associated 
immune deficiency across a combined Class I and Class II 
MHC disparity is dependent upon both L3T4+ and Lyt 2+ cells 
whereas only L3T4+ cells are required to induce immune 
deficiency across an isolated Class II difference (Moser 
et al., 1985)* There is also some evidence that different 
T cell subsets may be responsible for different components 
of the Gvhr. Thus, while both Lyt 2+ and Lyt 2 cells are 
required for an acute lethal Gvhr in BDF.^  mice, Lyt 2 cells 
alone induce the chronic proliferative form of Gvhr. In 
contrast, Lyt 2+ cells alone could not induce any form of 
Gvhr (Rolink & G1eichmann,1983)•
The earliest studies showed that generation of a Gvhr 
requires genetic differences between the host and donor 
(Billingham, 1967). Subsequent work has found that these 
differences can be either MHC gene products (Elkins, 1976;
Klein & Chiang, 1976; Gleichmann e_fc al. , 1984) or minor 
histocompatibility differences (Hamilton et al., 1981;
Korngold and Sprent, 1982; Hamilton, 1984; Maier e_t al. , 1985).
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In mice, the H—2 complex is the most potent inducer of 
systemic Gvhr and, in congenic mice Class II MHC loci have 
been shown to be of most importance in the development of 
lethal Gvhr (Klein & Chiang, 1976; Elkins, 1976; Rolink _et al. , 
1983) 9 splenomegaly (Klein, 1977; Mowat e_t al. , 1986), and 
anti—host DTH (Wolters & Benner, 1979)* The 1—A region has 
also been shown to be the most important stimulus for 
intestinal damage in irradiated (Piguet, 1985) and unirradiated 
mice (Mowat e_t al • , 1986) with Gvhr. In contrast, isolated 
Class I MHC differences in congenic mice have little or no 
ability to induce systemic changes of Gvhr (Klein & Chiang,
1976) and do not cause intestinal Gvhr (Mowat e_fc al. , 1986). 
However, the development of a fully lethal Gvhr in unirradiated 
BDF^ mice has been shown to require both Class I and Class II 
MHC differences (Rolink et_ al. , 1983; Rolink & Gleichmann,1983) • 
Recent work using MHC mutant mice has shown that both 
Class I and Class II MHC differences can induce systemic 
Gvhr under appropriate circumstances (Sprent et al., 1986a). 
However, there is some evidence that these incompatibilities 
may cause different forms of Gvhr associated pathology 
(Rolink al. , 1983; Sprent et_ al. , 1986b). Together, these 
results suggest that both Class I and II restricted T cells 
can induce Gvhr in experimental animals and as these T cell 
subsets are both capable of CTL and DTH (Sprent & Webb, 1987), 
the functional nature of the inducer T cell remains unclear. 
However, it should be noted that most studies emphasise the 
role of Class II restricted T cells and therefore DTH mediated 
reactions may be of most importance. Nevertheless, different 
MHC classes may result in different pathology.
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Role of host factors in the outcome of Gvhr
Although Gvhd necessitates recognition of host allo- 
antigens by donor T-lymphocytes, the pathogenesis of Gvhd 
is greatly influenced by host factors, including the age, 
sex and microbiological and immune status of the host animal 
(Billingham, 1967; Bril & Benner, I985). The potential 
importance of host mechanisms is underlined by the severity 
of the Gvhr which occurs in hosts which have received 
chemotherapy, whole body irradiation or which are development- 
ally immature (Grebe & Streilin, 1976). The reasons for 
host dependent regulation are complex, but it has been shown 
that certain stxains of allogeneic and F^ hybrid mice can 
reject lymphocytes (Fox & Howard, 1963; Cudkowicz & Stimpfling, 
1964; Nakamura & Cudkowicz, 1979; Elkins & Quant, 1981) or 
bone marrow cells from fully or semi-allogeneic donors (Kiessling 
e t al. , 1977; Dennert _ejfc al. , 1985). F^ hybrid resistance in 
mice is controlled by MHC-linked haemopoietic histocompatibility 
loci (Cudkowicz & Nakamura, 1983) which appear to be non- 
codominantly expressed by homozygous, parental mice, but not 
by F^ animals (Daley & Nakamura, 1984). In many cases, host 
NK cells seem to indicate resistance to BM cells (Cudkowicz 
& Stimpfling, 1964; Elkins & Quant, 1981; Kiessling e_fc al. ,
1977; Murphy _et al_. , 1987) and this may involve ADCC (Warner 
& Dennert, 1985). However, recent studies suggest that 
Class I restricted CTL may also be required for resistance 
to fully allogeneic BM in mice (Harper e_fc al., 1987)* In 
addition, anti-idiotypic host T-lymphocytes with CTL activity 
against donor lymphoblasts can suppress a Gvhr mediated by 
parental lymphocytes in rats (Bellgrau & Wilson, 1978;
Kimura & Wilson, 1984; Kimura e_fc al., 1984).
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One particular host factor which has profound effects 
on the outcome of the Gvhr and which is important for many 
of the results described in this thesis, is the age of the 
host. Neonatal animals undergo a much more severe form of 
Gvhr than adults of the same strain given the same donor 
cells. Neonatal animals have a functionally immature immune 
system (Murgita & Wigzell, 1981). Although neonatal splenic 
T cells reach 75% of adult numbers within the first week 
(Murgita & Wigzell, 1981), there is evidence that neonatal 
T-cell function is reduced until about 4 weeks of age (Spear 
et al., 1973)* However, the evidence is conflicting as some 
T-cell functions have developed by 7-8 days of age (Spear 
& Edelman, 1974; Pilarski, 1977; Schwartz & Doherty, I98I). 
Furthermore, by 4-5 days old neonates will reject allogeneic 
transplants (Billingham & Brent, 1959)* NK cell activity 
is also defective in neonatal mice (Kiessling e_fc al. , 1975; 
Roder e_fc al. , I98I; Koo e_t al. , I982) and this may involve 
both a lack of precursors in very young mice, followed by 
functional immaturity of precursors which arise at later 
times (Roder et al., I98I; Koo et al., 1982). NK activity 
appears rapidly around the time of weaning, at 3 weeks 
(Kiessling ejt al. , 1975) reaching a peak at 6-8 weeks of 
age (Murgi ta & Wigzell, 1981).
In addition to these effector cell defects, neonatal 
mice have high levels of non-specific suppressor cell activity 
which may be due to Ts (Mosier & Johnson, 1975; Ptak & 
Skowron-Cendrzak, 1977; Argyris, 1978; 1984) or large granular 
lymphocytes with natural suppressor activity (strober, 1984; 
Maier e_fc al. , 1986). These suppressor cells may affect both
- 19 -
B and T cell functions (Mosier & Cohen, 1975, Ptak & Skowron- 
Cendrzak, 1977) and may also account for the poor 
production of IL-2 in the neonate (ishizaka & Stuttman,
1983; Argyris ejfc al. , 1985)* Finally, a lack of 
macrophages and dendritic cells (steinman e_t al. , 197 ;^
Steinman e_fc al^ . , 1979; Lu _et al. , 1979) may also contribute 
to the defective immunity in neonates (Snyder e_fc al^ , , 1982). 
Studies in neonatal rats have also shown the absence of 
Class II expression in the gut epithelium (Mayrhofer e_t al. ,
1983).
Effector mechanisms in Gvhr
The effector mechanisms responsible for tissue damage in 
Gvhr are controversial and their complex nature can be 
imagined from the preceding discussion of the induction phase. 
For many years it was assumed that specific CTL activity was 
responsible for the tissue damage which occurs during allograft 
rejection and Gvhr (Cerrottini e_t a_L. , 1971; Cantor & Asofsky, 
1972; Elkins, 1978). In support of this, specific anti-host 
CTL activity was described in early studies of experimental 
Gvhr in irradiated hosts (Elkins, 1978) as well as in patients 
with clinical Gvhr (Tsoi, 1982). In addition, immuno- 
histochemical studies show that a large proportion of 
lymphocytes infiltrating the skin, gut and liver lesions of 
acute Gvhr have the suppressor/cytotoxic phenotype (janossy 
et al., 1982). Although these findings support those from 
studies of allograft rejection they do not prove that CTL 
are the pathogenic effector cells. As noted above, Class II 
MHC restricted T-cells seem to be of most importance in the
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induction of Gvhr and recent work has indicated that the 
presence of anti-host CTL activity did not correlate with 
the development of acute Gvhd in irradiated mice* across 
either full MHC differences (jadus & Peck, 1983) or minor 
histocompatibility differences (Hamilton, 1984).
Furthermore, specific anti-host CTL activity frequently 
cannot be detected in unirradiated mice with Gvhr (Borland 
et al., 1983) and does not predict the outcome of the Gvhr 
when it does occur (Van Elven ejb al_. , 1981; Kubota ejfc al. ,
1983)* In parallel, the signs of acute Gvhd in irradiated 
mice are preceded by a specific anti-host DTH response 
(Benner _et al. , 1983)*
There are also several reports that non-specific effector 
mechanisms are activated during a Gvhr (Singh _et al_. , 1971; 
1972). Early studies showed that macrophages were activated 
during a Gvhr in unirradiated mice (Ptak e_t aJL. , 1975; Fung & 
Sabbadini, 1976) and macrophages from mice with Gvhr had 
enhanced microbicidal activity (Blanden, 1969; Rhodes e_fc al., 
1979; Zinkernagel, 1980; Anthony e_t al. , 1984) and antigen 
presenting cell activity (strobel _et al. , 1985)* There is 
also evidence for the recruitment of mast cells in Gvhr 
(Mowat & Ferguson, 1982; Schrader et al., 1983)* while many 
workers have shown that there is a generalised increase in 
NK activity during a Gvhr in unirradiated F^ rats (Clancy,
1984) and mice (Roy et al., 1982; Borland et al., 1983;
Kubota _et al. , 1983; Mowat _et al. , 1985; Varkila & Hurme,1985)* 
This enhanced NK cell activity develops in parallel with the 
evolution of other proliferative features of the Gvhr
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(Borland ejfc al • , 1983 ) involves both donor and host NK cells 
and is preceded by the anti-host DTH response (Ghayur e_fc al., 
1985; Mowat et al., 1985)* These findings suggest that 
NK cells may be one component of the effector mechanisms 
responsible for the tissue damage in Gvhr (Mowat e_fc al_. , 1983) 
as has been suggested in allograft rejection (Mason & Morris,
1986). Alternatively, host derived NK cells could be 
responsible for a form of F^ resistance against the parental 
lymphoid cells, as described earlier.
Suppressor T cells have already been discussed with
respect to the disordered immunoregulation found in Gvhr.
However, G1eichmannand colleagues have suggested that
allospecific Ts may also account for the anaemia, lymphoid
atrophy and weight loss which occurs in unirradiated BDF^
mice given BIO spleen cells (Gleichmann et al.,1984). This
acute Gvhr does not appear to correlate with anti-host CTL
activity but is associated with the appearance of donor-
derived Ts which inhibit the function of F^ lymphoid cells
(Van Elven e_t al_. , I98I). Activation of allospecific Ts
occurs subsequent to proliferation of donor anti-host T
and requires both Class I and Class II MHC incompatibilities
(Rolink _et al. , 1983; Rolink & G1 ei chmann, 1983 ) • In contrast,
Gleichmannhas also presented evidence that the chronic
proliferative SLE-like Gvhr in BDF^ hosts given DBA/2 cells
is due to continued activation of Class II MHC restricted
allospecific T^,.. These findings suggest that abnormalities H
in immunoregulation may contribute to organ damage in Gvhr 
and highlight the possibility that manipulating the immune
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response in Gvhr may produce predictable changes in tissue 
pathology.
Intestinal Gvhr
Intestinal damage was noted in the earliest studies of 
Gvhr in mice (Gorer & Boyse> 1959) and severe enteropathy 
was first detailed in work on newborn BDF.^  mice (Reilly & 
Kirsner, 1965)* With the development of runt disease* the 
intestinal pathology in these mice was most pronounced in 
the ileum and was characterised by clubbing of the villi* 
with enlargement and hyperplasia of the crypts (Wall _et al. * 
197l)« In parallel there was a decreased number of goblet 
cells (Reilly & Kirsner* 1965). The same authors showed that 
more severe intestinal damage was observed if the neonates 
had been irradiated* indicating that the Gvhr and the 
irradiation might act synergistically.
Later studies on 10 day old mice with runt disease* 
confirmed the histological changes noted above and showed 
they were associated with a deficiency of brush border 
disaccharidases (Hedberg e_fc ad.* 1968)* malabsorption (Palmer 
& Reilly* 1971) and protein losing enteropathy (Cornelius, 
1970). Degeneration and necrosis of the mucosa* flattening 
of the villi and infiltration of the mucosa by lymphocytes 
and other mononuclear cells is also a prominent feature of 
Gvhr after clinical BMT and is a frequent cause of morbidity 
and death in these patients (Slavin & Santos, 1973J 
Glucksberg et al. * 197^ -* Woodruff et al. * 1976). Although 
some workers have shown that bacterial antigens may influence
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the severity of the intestinal lesions during Gvhr 
(Van Bekkum & Knaan, 1977)» similar mucosal alterations 
occur in sterile antigen free intestine implanted under 
the kidney capsule of mice with Gvhr (Ferguson & Parrott*
1971; 1972). Therefore, it seems unlikely that the lesions 
are due to direct infection of the mucosa (Elson et al•*
1977* Mowat & Ferguson* 1981b), although a role for bacterial 
products from the host intestinal flora cannot be excluded 
(Van Bekkum & Knaan, 1977)*
As in other work on Gvhr, the villus atrophy and crypt 
necrosis were originally assumed to be due to specific CTL. 
However, the studies by MacDonald and Ferguson (1977) in 
5 day old (CBA x BALB/c)F^ mice showed that the villus 
atrophy was preceded by an increased crypt cell production 
rate and crypt hypertrophy (MacDonald & Ferguson, 1977)* 
Therefore* it was suggested that the primary cause of the 
enteropathy was the production of stimulatory lymphokines 
during a local DTH response (MacDonald & Ferguson* 1977)* 
Further experiments in adult or one week old, unirradiated 
F^ hybrid mice supported these conclusions, by showing that 
the principal mucosal alterations were increased in IEL,
CCPR and crypt depth (Mowat & Ferguson, I98I, 1982). These 
features appeared within 2k hours of cell transfer and 
evolved in parallel with the proliferative phase of the 
Gvhr, as measured by splenomegaly (Mowat & Ferguson, 1981; 
1982). There was no evidence of specific CTL in the gut or 
elsewhere (Borland _et aA., 1983), and the mucosal changes 
also occurred as a bystander effect in grafts of foetal gut
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which were syngeneic to the donor cells (Elson ejt al. , 1977 )• 
More recent work in semi—allogeneic unirradiated mice shows 
that the intestinal Gvhr was due principally to Lyt-2 T cells 
recognising Class II alloantigens present on bone marrow 
derived cells (Piguet, 1985; Mowat, 1986; Mowat e_t al. , 1986). 
Together, these results suggest strongly that the mucosal 
alterations in this model of Gvhr occur as a result of a 
DTH reaction. This idea is supported by the findings that 
the intestinal Gvhr is associated with recruitment of mucosal 
mast cells (Mowat & Ferguson, 1982) and enhancement of NK 
cell activity by IEL (Borland e_fc al_. , 1983; Mowat £jfc al. ,
1985)* Thus activation of IEL NK cell activity parallels 
the other changes in the gut, as well as the development of 
splenomegaly, and was preceded by an anti-host DTH response 
(Borland jet al. , 1983; Mowat _et al. , 1983)*
The crypt hyperplasia and increased numbers of IEL 
and MMC found during a Gvhr in unirradiated mice are similar 
to those seen in clinical FSE. Therefore, the features 
discussed above are consistent with the hypothesis that a 
local DTH reaction is the principal mechanism responsible 
for this pattern of pathology in FSE. However a major defect 
in these earlier studies has been that the villus atrophy 
which characterises FSE, was never found (Mowat & Ferguson, 
1981; 1982). Thus it is possible that the development of 
villus atrophy may require effector mechanisms which differ 
from those which induce crypt hyperplasia.
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The principal aims of this thesis were therefore to 
develop models of acute Gvhr in mice which would produce 
villus atrophy and to elucidate the effector mechanisms 
which were responsible. In addition, I have attempted to 
define the conditions which influence the outcome of the 
Gvhr and have investigated the role of selected effector 
mechanisms in more detail.
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CHAPTER 2 
MATERIALS AND METHODS
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Animal s
CBA/Ca (H-2k ), BALB/C (H-2d ) C57B1/10 (H-2b ), DBA/2
d b
(H-2 ) and BALB/B (H-2 ) mice were obtained from departmental
stocks, unless stated otherwise. ATH (H-2b°), ATL (H-2^),
BIO.A (H-2d ), BIO.AQR (H-2yl), B10.AKM (H-2m ), B10.A3R (H-2l3)
and B10.A5R (H-21S) mice were purchased from Harlan Olac Ltd.
(Bicester, Oxon.). (A list of these mice and their haplotypes
\6 found in Table l). (CBA x BALB/C)FX , (C57B1/10 x  DBA/2)F1,
(ATH x A T L ^ ,  (BALB/B x DBA/2)F1 , (BIO. A x B10. AQR) F± ,
(BIO.A x B10.AJKM)F1 and (B10.A3R x B10.A5R)F1 hybrid mice
were bred in the Department from the appropriate parental
strains, the maternal strain being the first named of each
pair. Adult mice were first used at 6-10 weeks of age, except
when 12-16 week old mice were used for irradiation experiments.
In experiments using neonatal mice, age-matched neonates
from individual mothers were mixed immediately after birth
to obtain larger groups and were then maintained with their
mothers throughout the course of the experiment. Male and
female (CBA x BALB/c)F^ nu/nu mice were obtained from
Mrs S. Jenks, National Institute for Medical Research, Mill
Hill, London. Control mice in these experiments were age
and sex-matched euthymic (CBA x BALB/C)F-^ mice. Athymic
mice were kept for 3 weeks before use to enable stabilization
of their intestinal flora, and all animals were maintained
under standard conditions.
All animals were maintained on a standard rodent diet 
(Labsure Maintenance Diet) and had access to tap water ad 
libitum.
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Anaesthesia and sacrifice of animals
Procedures such as footpad or intravenous injection 
via the tail vein were carried out under light ether 
anaesthesia. Mice were sacrificed by ether inhalation 
followed by cervical dislocation.
Irradiation of mice
60Mice received 950 Rads irradiation from a cobalt 
source of ^ rays at a distance of 100 cm and a close rate 
of 250 Rad/min. This was performed by courtesy of the 
staff at Belvidere Hospital, Glasgow.
After irradiation, mice received 100 mg/l Neomycin 
(Neomycin Sulphate; Sigma) in their drinking water.
Measurement of haematocrit
The circulating packed red cell volume was assessed by 
measuring the haematocrit. Under ether anaesthesia, blood 
was collected from the heart, into heparinised capillary 
tubes (Hawksley, England). These were sealed, centrifuged 
at 3,OOOg for 10 mins and the haematocrit calculated by 
measuring the relative proportion of red blood cells and 
plasma in the total blood volume.
Body and organ weights
Mice were weighed using an Oertling JC 12 single pan 
balance (accurate to O.Olg), while individual organs were 
dissected free of surrounding tissues and weighed to the 
nearest mg on a fine twin pan balance (accurate to 0.2 mg)
(Gallenkamp)•
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Histology
Tissues were removed immediately after sacrifice 
and placed in fixative. For conventional histology, the 
jejunum and liver were fixed in 10% phosphate buffered 
formalin. Tissues were embedded in paraffin wax and 
sections k p,m thick cut for staining with Haematoxylin 
and Eosin.
All histological specimens were examined using a 
Leitz Ortholux II microscope and processing was carried out 
by Mr Hector Cairns and Mrs Margaret Hardie.
Intraepithelial lymphocyte counts
Intraepithelial lymphocytes were counted by the method 
of Ferguson and Murray (1971) on H & E stained sections of 
jejunum taken 10 cm from the pylorus. Specimens were 
examined under x kOO magnification and only sections with 
a single layer were counted. Differential cell counts were 
performed by counting epithelial and lymphoid cell nuclei 
lying above the basement membrane and ignoring goblet cells. 
A total of 600 epithelial cells was counted in each specimen 
and results were expressed as IEL/lOO epithelial cells.
Measurement of mucosal architecture by microdissection 
The method of Clarke (1970) was employed to assess 
mucosal architecture. Mice were injected with 7*5 mg/kg
Colchicine (Sigma) i.p. and sacrificed at intervals of
2
20-100 mins, thereafter 1 cm pieces of jejunum were removed 
10 cm from the pylorus, opened and placed villus surface
- 30 -
upwards on pieces of card for fixation in 75% Ethanol/23% 
acetic acid for 6-24 hours. Tissues were stored in 75%
Ethanol before staining in bulk by the modified Feulgen 
reaction as follows: the pieces of gut were first immersed
in 30% Ethanol for 10 mins, followed by 10 mins in tap water 
and 7 minutes in 1M HC1 at 60°C. After a further 10 minutes 
in tap water, the specimens were flushed x 3 with fresh 
tap water, stained with Schiff reagent (Difco Ltd.) for 
30-40 minutes at room temperature and kept in tap water 
before microdissection. Under the dissecting microscope, 
the muscularis mucosae was first stripped off, and thin 
slices of mucosa, one villus thick and each containing a 
few villi with their surrounding crypts, were then cut 
from the edge by dissection with a cataract knife (Weiss Ltd.). 
The fragments were then placed on a microscope slide in 43% 
acetic acid, covered with a coverslip and villus and crypt 
lengths measured by conventional microscopy, using a previously 
calibrated eyepiece micrometer. The pieces were then 
gently squashed under the coverslip and the number of 
metaphases per crypt counted. In each specimen, 10 villi 
and crypts were counted and the crypt cell production rate 
was obtained by correlating the mean number of metaphases/ 
crypt with the time after Colchicine. The pairs of results 
were plotted by linear regression analysis and having 
established linearity, the CCPR was calculated from the 
gradient of the line of best fit calculated by the method 
of least squares.
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2 1 Deoxyguanosine
2 1 Deoxyguanosine (Sigma, Poole, Dorset) was dissolved 
in warm distilled water at 5 mg/ml before use. Adult mice 
were injected with 1 mg in 0.2 ml daily by the intraperitoneal 
route, while neonatal mice received a weight adjusted dose 
of 50 pg/g in 0.05 nil daily i.p. This dose was increased 
every 3^d day according to the weight of the mice. Control 
mice received an appropriate amount of distilled water i.p.
Polyinosinic : polycytidylic acid
PolyI:C (Sigma) was dissolved in 0.01M NaOH for use.
Adult mice received 100 pg polylsC in 0.2 ml NaOH i.p., 
while neonatal mice received a weight related dose of 
5 V-s/S polylsC in 0.05 nil NaOH i.p. Control mice received 
the appropriate control volume of 0.01M NaOH.
Monoclonal antibodies
The GK1.5 hybridoma (a kind gift of Professor N.A.
Mitchison) was maintained in RPMI 1640 in 5% foetal calf 
serum, 5% newborn calf serum (Gibco), Penicillin (100 p/ml)/ 
Streptomycin (100 pg/ml) (Gibco) and 2 mM glutamine (Gibco), 
and the supernatant used as a source of anti-L3T4 antibody 
at a concentration of 1 :10.
In later experiments rat monoclonal anti-L3T4 ascites 
was obtained from Serotec Ltd. and used at a final dilution 
of 1 :500.
Monoclonal rat anti-Lyt2 ascites was obtained from 
Serotec Ltd. and used at 1:400.
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Treatment with anti-asialo Gw, anti-serum — —----------------------- - ------------------------------ ML ------------------------
Mice were injected intravenously with 0.2 ml rabbit 
anti-asialo G ^  antiserum (a kind gift from Dr N. Hanna 
SK & F Research, Philadelphia, PA) diluted 1:50 in saline,
3 days before the induction of Gvhr and at 3-4 day intervals 
thereafter (Charley et al., 1983). Control mice were injected 
with 1:50 normal rabbit serum.
Preparation of cell suspensions
Spleens, thymuses and lymph nodes were removed 
immediately after sacrifice. After washing in RPMI 1640, 
they were dissected free of surrounding material and sliced 
with scissors. The pieces were then gently passed through 
a fine gauge wire mesh using the plunger of 25 ml syringe 
(BD Ltd.) or teased apart using a scalpel. After repeated 
passage through a glass pasteur pipette to break up any 
clumps, the cells were allowed to stand for a few minutes at 
room temperature to allow debris to settle out, and washed 
three times at 400g in RPMI 1640. Cells which were to be 
injected intravenously were further passed through 1-2 ml 
glass wool (May & Baker), loosely packed into a 10 ml syringe, 
to remove any clumps, before being washed once more. After 
counting in a haemocytometer (Neubauer) the final cell 
pellet was made up to the required concentration in RPMI 1640 
for use. Cell viability was assessed by phase contrast 
microscopy and was normally greater than 90%.
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Purification of lymphocytes by nylon wool columns
The method of Julius e_t al_. (1973) was followed. 0 .6g 
nylon wool (Fennal Labs) which had been washed previously, 
in distilled water for one week at 37°C was packed loosely 
into a 10 ml syringe and the column washed through with 
RPMI 1640, supplemented with 5% FCS. The column was drained 
and incubated at 37°C for 1 hour before use. Spleen cell 
suspensions in RPMI 1640/5% FCS were passed over a glass 
wool column to remove debris and dead cells and, after 
washing in fresh medium, were allowed to pass into the 
nylon wool column which was then incubated for 45 minutes 
at 37°C. Non-adherent cells were then flushed out with 
warm RPMI 1640/5% FCS, washed once and resuspended for use.
Titration of monoclonal antibodies
100 pi of a suspension containing 10 spleen or popliteal 
lymph node cells were added to 100 pi aliquots of serial 
dilutions of anti-L3T4 or anti-Lyt2 in 96 well u-bottomed 
microtitre plates (Titertek Flow Labs) and incubated for 
40 minutes at 4°C. Fresh guinea pig serum,as a source of 
complement, was then added to each well to a final concentration 
of lslO, and the plate incubated for a further 30 mins 
at 37°C. Control wells contained cells in the presence 
of antibody or complement alone. The efficiency of the 
depletion was assessed by counting the proportion of dead 
cells by phase contrast microscopy.
Bulk depletion of T-cell subsets with monoclonal antibodies
7
10 Spleen cells/ml in RPMI 1640/5% NCS, were incubated 
with anti-L3T4 or anti Lyt2 for 40 minutes at 4°C. The 
cells were then centrifuged at 300g for 5 mins, the antibody 
containing supernatant removed and stored at 4°C. The cells 
were resuspended in the same volume RPMI 1640/5% NCS containing 
a final concentration of 1:10 guinea pig serum as a source 
of complement, for 30 mins at 37°C. The cells were then 
centrifuged and the complement containing supernatant 
removed and stored at 37°C. The cells were then resuspended 
in antibody and the depletion procedure repeated. Before 
use, the depleted cells were washed three times in RPMI 1640 
and resuspended at the required concentration, without 
correcting for the number of cells lost.
Induction of local Gvhr
The ability of spleen cells to induce a local Gvhr 
was assessed by the popliteal lymph node assay as described 
by Ford e_t al. (1970).
7
F1 mice were injected into the rear left footpad with 10 
parental spleen cells in a volume of 0.05 ml RPMI 1640.
One week later the mice were sacrificed, the draining 
popliteal lymph nodes removed and weighed. The intensity 
of the local Gvhr was assessed by comparing weights of the 
popliteal lymph nodes draining footpads injected with 
parental cells with the weights of the lymph nodes draining 
the opposite footpads which had been injected with medium 
alone.
- 35 -
Induction of systemic graft—versus—host reactions
1. Adult unirradiated mice
A graft-versus host reaction was induced in adult 
unirradiated (CBA x BALB/c) mice by injecting 6 x 10^ 
viable CBA spleen cells in 0.2 ml RPMI 1640 intraperitoneally, 
while (C57B1/10 x  DBA/2)F^ mice received 10^ BIO or DBA12 
spleen cells in 0.3 ml RPMI 1640 intravenously. In each 
case, age and sex-matched controls received medium alone.
2. Adult irradiated hosts
Within 24 hours of receiving 900 Rad -irradiation,
(CBA x BALB/c )f ^ mice received 1 - 4 x 10^ CBA spleen cells, 
i.v., in a volume of 0.2 ml or 0.3 ml RPMI 1640. Control 
mice received appropriate numbers of syngeneic spleen cells 
or were left unreconstituted.
3• Neonatal hosts
A Gvhr was induced in neonatal F^ hybrid mice of various
7ages, by injecting 10 spleen cells of maternal origin m  
0.05 ml RPMI 1640 i.p. All injections were performed through 
the musculature of the lower inguinal region with a 30G 
needle to prevent leakage and to minimize trauma.
Initially age and sex-matched littermate controls 
received 0.05 ml RPMI i.p., but a comparison of uninjected 
controls and medium injected controls proved it was unnecessary 
to inject control mice, and in most experiments, control 
littermates received no injection.
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Assessment of systemic graft-versus-host reaction
The development of an acute/lethal Gvhr was assessed 
by weighing all the mice at frequent intervals and noting 
the appearance of clinical disease, such as hunched posture, 
ruffled fur. In the case of neonatal mice, the late 
development of body hair or opening of the eyes was also 
noted. In addition the time of death of the mice was noted 
and mortality curves constructed.
The spleen weight assay of Simonsen (Simonsen, 1962) 
was used to assess the proliferative response during the 
Gvhr. On the day of sacrifice, mice were weighed, the 
spleens removed and weighed, and the relative spleen weight 
expressed as mg/lOg body weight.
The spleen index was then given as:
Relative spleen weight in individual mice with Gvhr 
Mean relative spleen weight in control mice.
Assessment of allospecific systemic delayed-type hypersensitivity
Mice were immunised into the rear left footpad with 
2 x 10^ allogeneic spleen cells and 5 days later, the 
systemic DTH response was assessed by measuring the increment 
in footpad thickness, 2k hours after intradermal injection 
of 10^ stimulator spleen cells into the opposite rear footpad, 
using a pair of skinfold calipers (Carobronze). Antigen 
specific DTH responses were calculated by subtracting the 
increment in footpad thickness after challenge of unimmunized 
mice.
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Anti-host DTH in mice with Gvhr
Spleens were pooled from 3-4 F^ mice with Gvhr and
710 viable cells injected into one rear footpad of recipients* 
which were syngeneic to the parent strain used to induce 
the Gvhr. The adoptive transfer of DTH was assessed by 
the increment in footpad thickness measured 24 hours after 
injection. The opposite footpads were injected with 
appropriate numbers of control F^ spleen cells* and the 
specific DTH activity of the Gvhr was obtained by subtracting 
the increment in control footpads from that in footpads 
injected with Gvhr cells.
Tumour cell lines
The following cell lines were originally purchased 
from Flow Labs, and used as target cells in cytotoxicity 
assays. YAC-1* a Moloney virus* induced T-cell leukaemia 
of A strain mice (H-2a ) was used as a natural killer cell 
sensitive target. P813 (H-2^) a methylcholanthrene induced 
mastocytoma of DBA/2 mice and EL-4 (H-2^)* a C57B1/6 
thymoma cell line were used in assays of specific CTL 
activity. These cell lines were maintained at 37°C in 5%
C02 in air* in RPMI 1640 supplemented with 10% FCS (YAC—l) 
or 3% FCS and 3% NCS (P813; EL-4); Penicillin/Streptomycin 
(Gibco); L-Glutamine and 1.23 pg/ml Fungizone (Gibco) in 
273 ml plastic tissue culture flasks (Costar). The cells 
were subcultured at 1:10 ratios every second day and* 
whenever possible* 24 hours before use.
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Preparation of lymphoblast target cells
Lymphoblasts for use in cytotoxicity assays were 
prepared by culturing 4 x 10^ spleen cells/ml with 2 mg/ml 
concanavalin A (Sigma) for 3 days or with 10 ]j.g/ml 
LPS for 2 days in RPMI 1640 supplemented with 10% FCS;
— C
Penicillin/Streptomycin, L-Glutamine and 5 x 10 M
2-mercaptoethanol (Sigma) in a total volume of 15-20 ml 
in a 50 ml plastic tissue culture flask (Lux) at 37°C in 
5% 00^ in air in a humidified incubator (Flow Labs. Digital 
CO^ incubator 220). After culture surviving lymphoblasts 
were washed x2 in RPMI 1640/5% NCS and counted before use 
in microcytotoxicity assays.
Measurement of specific and non-specific cell mediated 
cytotoxicity
The cytotoxic activity of lymphoid cell populations was 
measured in a microcytotoxicity assay as described by Davies 
and Parrott (1980).
5 x 10 tumour or lymphoblast target cells/ml were
er -i
labelled with 50 y,Ci Sodium Chromate (Amersham) for 45 min 
at 37°C and washed five times in RPMI 1640 with 57 NCS 
before being resuspended at 2 x 10 cells/ml immediately 
before use. 100 ml lymphoid effector cells at different 
concentrations were added to the wells of v-bottomed micro- 
titre plates (Flow Labs, Irvine) and 2 x 10^ target cells in 
100 ml added to give effector:target (E:T) ratios of 50:1, 
25:1 and 12.5 si*
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NK cell assays were incubated for k hours at 37°C 
in 5% while specific CTL assays were incubated
for 2 hours at 37°C in 5% C02 in air, followed by 1 hour 
at 45°C. After culture, 100^1 of supernatant were removed
51
carefully and the Cr-specific radioactivity assessed in 
a gamma counter (LKB Compugamma). The percentage lysis was 
determined as follows:- 
Natural cytotoxicity:-
n, „ , , . . . (release with effector cells - spontaneous% Cytotoxicity = ' ^ n x_________________________________________release)
(maximum release - spontaneous release)
x 100%
Specific cytotoxicity:-
(release with experimental cells - 
% Specific Cytotoxicity = _______ release with control cells)
(maximum release - control release)
x 100
In NK assays, appropriate numbers of NK.inactive thymocytes
were used to obtain spontaneous release, while control spleen
in c i l
cells were used to obtain spontaneous release „ In some 
experiments NK results are expressed as a ratio to controls, 
because of low and variable results in the controls.
Maximum release in all assays was obtained by incubating 
target cells with 10% Triton X. All assays were performed 
in quadruplicate and variability was normally <10%? between 
wells.
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Mix:ed lymphocyte reactions
Spleen cells to be used as stimulator cells were treated 
with 60 ]ig mitomycin C/lO cells/ml in RPMl/5% NCS for 30 mins 
at 37°C before being washed x 4 in RPMI 1640/5% NCS and 
resuspended at 2 x 101 cells/ml in RPMI 1640/5% NCS.
Responder cell populations were made up to a final 
concentration of 2 x 10^/cells/ml in RPMI 16^0 + 5% FCS, 
pen/strep, L-Glu and 2 ME and 100 ^1 aliquots added to the
wells of flat-bottomed microtitre plates (Linbro: Flow Labs).
5
2 x 10 Stimulator cells were then added in 10 aaI to give
a stimulator: responder ratio of 1:1 and the cells were
cultured in a total volume of 200 for 96 hours at 37°C
3
in 5% ^0 a -^r * Cultures were pulsed with 1 ^Ci H-
Thymidine (Amersham International) for the last 18 hours of 
culture and the cell bound radioactivity was harvested with 
water using a Skatron multi-well cell harvester. After 
drying? the filters were added to 2 ml scintillation fluid 
(Ecoscint) and counted on a Packard liquid scintillation 
counter.
In all cultures, control wells were included which 
contained either responder or stimulator cells alone and 
the viability of responder cells was confirmed by culturing 
one aliquot in the presence of 20 y,g/ml ConA. All assays 
were performed in quadruplicate and variability between 
wells was normally <15%. The stimulation index was given 
by the response of wells in the presence of stimulators 
divided by the mean value for the unstimulated responder 
cells.
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Proliferativo responses to Conca.Tia.va.iii A in vitro 
5
2 x 10 Spleen cells in RPMI 1640 supplemented with.
10% FCS, L—Glu; pen/strep and 2-ME were cultured in a final
volume 100 )il in flat—bottomed 96 well microtitre plates 
in the presence of 20 pg/ml ConA. Cultures were performed 
at 37°C in 3% C02/air in a humidified incubator for h days.
In assays using mixtures of responder and "suppressor" 
cells, the responder stimulator ratio was maintained at 
1:1 and different volumes of suppressor cells added to give
a final volume of 200 pi.
Statistics
Results are expressed as means ^ 1 standard deviation, 
unless otherwise stated. Student’s t-test was used to 
compare differences between groups in most cases. In 
experiments where non-parametric distributions were observed 
such as mortality assays, results were compared by Wilcoxon’s 
Rank Sum test.
Crypt cell production rates, calculated by linear
regression were compared by covariance analysis to detect
differences between the slopes. Calculations were performed 
on Casio PB-100 and 180P calculators.
Fixatives
Clarkes 1 litre
Ethanol 750 ml
Glacial
acetic acid 250 ml
10% Buffered formalin 1 litre
Formaldehyde 100 ml 
Distilled water 900 ml 
NaH2P02+. 2H20 ^ £
-  k2  -
Strain Haplo type K A E D
■"0lH
CBA k k k k k k
BALB/c d d d d d d
C57B1/10 b b b b b b
DBA/2 d d d d d d
ATH *2 s s s d s
ATL *1 s k k d k
BIO. A a k k k d k
B10.AKM m k k k q k
B10.AQR yl q k k d k
BIO.A3R 13
b b b d b
B10.A5R b b b d k
Table 1 H-2 haplotypes of mouse strains used in this thesis.
\
CHAPTER 3
INVESTIGATION OF THE MECHANISMS RESPONSIBLE FOR THE 
ENTEROPATHY IN IRRADIATED MICE WITH GRAFT-VERSUS-
HOST REACTION
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Introduction
The previous work which has been performed using 
intestinal Gvhr as a model of naturally occurring entero­
pathies has concentrated on the Gvhr in unirradiated adult 
or older neonatal mice. Under these circumstances? the 
principal intestinal features consist of crypt hyperplasia 
and increased I EL counts (Mowat & Ferguson, 198lb, 1982), 
both of which are found in clinical enteropathy (Mowat, 1984). 
Although these studies have indicated that a local DTH 
response is responsible for the intestinal features, this 
model of Gvhr is limited, as it does not reproduce the 
villus atrophy which is a major component of these clinical 
disorders. Therefore it is not clear whether the same 
immune mechanism causes villus atrophy.
It is well known that an acute lethal Gvhr in irradiated 
hosts does produce villus atrophy (Reilly & Kirsner, 1965), 
but the intestinal pathology in this model has not been 
investigated in detail. Furthermore, the immunological 
mechanisms responsible for the intestinal damage are unknown. 
Therefore the intestinal phase of Gvhr in irradiated mice 
was chosen as the first means of studying the immunopathology 
of an acute destructive enteropathy.
Experimental design
j\dult (CBA x BALB/c )F]L mice received 95^ Rads irradiation
7
and a Gvhr was induced by injection of 4 x 10 parental 
spleen cells i.v. At daily intervals, mice were sacrificed 
and the development of intestinal Gvhr was assessed by
measurements of mucosal architecture and I EL count. In 
parallel, anti—host CTL activity was assayed in the spleen 
as a measure of specific anti—host cell mediated effector 
activity using 51Cr labelled p8l5(H~2d) target cells.
Splenic NK activity against 51Cr labelled YAC-1 labelled 
target cells was also measured as an index of non-specific 
cell mediated functions which are recruited by anti-host 
DTH. In experiments examining cytotoxicity, control mice 
were either unreconstituted F± mice or irradiated CBA mice 
given CBA spleen cells to assess the normal behaviour of 
host and donor NK cells under these conditions.
Results
Progress of Gvhr in irradiated (CBA x BALB/c)F^ mice
Irradiated (CBA x BALB/c)F^ mice given 4 x 10^ CBA 
spleen cells developed clinical signs of Gvhr within 4-5 days 
of cell transfer, including ruffled fur, diarrhoea and runti.ng
and all animals died on days 6-7* Irradiated CBA or F~ mice
I
given 4 x 10^ syngeneic spleen cells as controls, survived 
indefinitely, while most irradiated F^ mice which were 
left unreconstituted died within 20 days of irradiation.
Specific and non-specific cytotoxicity iti irradiated (CBA x 
BALB/c)F1 mice with Gvhr
The splenic NK activity of F^ mice was virtually 
eliminated by the dose of irradiation used and remained 
very low throughout the 7 days of study (Fig. l)» Spleen 
NK activity was also absent in CBA hosts reconstituted with 
syngeneic CBA spleen cells, until 2-3 days after cell transfer, 
when a progressive recovery began. In contrast, significant
NK levels were directly apparent in Gvhr mice on day 1 
and rose to a peak on days 2-3 > when syngeneically reconstituted 
mice still had little or no NK activity. Thereafter, NK 
activity in Gvhr mice fell rapidly to zero after day 4.
Specific anti—host CTL activity did not appear in mice 
with Gvhr until day 3 and peaked on day 4, when NK activity 
was already markedly depressed (Fig. l). CTL activity then 
declined as the clinical condition of the mice deteriorated. 
Thus, enhanced NK activity occurs very soon after inducing 
a Gvhr in irradiated mice and a marked decrease in NK levels 
coincides with the development of specific CTL activity as 
well as the onset of overt clinical disease.
Intestinal phase of Gvhr
The jejunum of syngeneically reconstituted F^ mice 
showed few histological abnormalities after irradiation, 
other than the expected depletion of lymphoid cells. Mice 
with Gvhr had evidence of inflammatory cell infiltration by 
days 1-2 and after day 5, diffuse mucosal necrosis and 
complete villus atrophy precluded morphometric analysis in 
many specimens.
Intraepithelial lymphocyte counts
(CBA x BALB/c)F1 mice reconstituted with syngeneic 
spleen cells showed a gradual rise in IEL count throughout 
the course of the experiment, reflecting the recovery of the 
mucosal lymphocyte population after irradiation (Fig. 2).
F± mice with Gvhr had a significantly increased IEL count
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compared with these controls by day 1 (12.8 - 2.2 vs 7.9 - 2.0 
p < 0.01 and this rose to a maximum of 21.2 - 2.8 vs 9.61 ^ 
2.90 in controls p < 0.02). Thereafter, the IEL counts in 
mice with Gvhr fell and, at later times, became difficult 
to estimate due to the evolving mucosal damage.
Mucosal architecture
The cytostatic effect of the irradiation was evidenced 
by the very low CCPR seen in syngeneically reconstituted 
mice, one day after irradiation (Fig. 3 ) (l.02 - 0.2). 
Thereafter the CCPR in these mice recovered rapidly and this 
was paralleled by a progressive increase in crypt length 
(Fig. 4). Mice with Gvhr had a significantly increased CCPR 
on day 1 (Fig. 3) (5-8 - 0.5 p < O.OO5) and this rose to an 
extremely high level of 42.9 ~ 4.0 on day 3 (vs 14.7 - 3*3 
for F^ -+ F^ controls, p < 0.02). Thereafter, the deteriorating 
morphology made estimation of CCPR difficult in many samples. 
Nevertheless it could be shown that epithelial cell turnover 
ceased abruptly on day 4, when no normal metaphases were 
detectable at any time after colchicine. The Gvhr specimens 
suitable for analysis on day 5 also showed a very low CCPR 
which was significantly less than in control mice. In 
parallel with these changes in CCPR, mice with Gvhr had 
significant crypt lengthening on days 1 to 3 reaching a 
maximum of 207.8 - l6.0 pm on day 3 (Fig. 4) vs. 188.3 - 11.5 pm 
for F ^ F controls, but had significantly lower crypt 
lengths than controls by day 4 (108.2 1 10 inn vs 101.6 ± 4.5 inn, 
p < O.OOl). Villus lengths remained virtually constant in
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syngeneic ally reconstituted mice and in unrecons titut ed 
mice, while villus lengths in mice with Gvhr were similar 
io those in controls until day 5» when significant villus 
atrophy was observed (Fig. 5). Interestingly, this occurred 
after the sudden cessation of CCPR and no significant villus 
alterations were found before the initial increase in CCPR.
Therefore the intestinal phase of Gvhr in irradiated 
mice is characterised by an early, proliferative stage of 
crypt hyperplasia and increased numbers of IEL which precedes 
the fully developed picture of villus atrophy and mucosal 
destruction.
Active suppression of NK cell activity late in Gvhr
Earlier studies in unirradiated (CBA x BALB/c)F^ mice 
with Gvhr showed that the majority of NK cell activity was 
due to cells of host origin (Mowat et al. , 1985)* Therefore 
it was possible that the loss of NK activity at later times 
in Gvhr mice was due to direct killing of F^ NK cells by the 
coincidental appearance of anti—host CTL. Alternatively, the 
depressed NK activity could reflect an active, non-specific 
suppressor mechanism, as found in other models of Gvhr 
(Pickel & Hoffman, 1977; Hurtenbach & Shearer, 1983). I 
therefore performed a preliminary experiment to examine the 
ability of spleen cells from Gvhr mice to suppress NK cells
of both CBA and F^ origin.
Spleen cells from (CBA x BALB/c)F1 mice on day 5 of 
Gvhr were mixed 1:1 with normal F;L spleen cells and assayed
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against YAC-1 target cells at a total E:T ratio of 50:1.
As shown in Table 1, the NK activity of this mixture was 
considerably less than would be anticipated if the cytotoxicity 
obtained with either population alone at 25:1 had been 
added (7*8% vs. 18.4%). Suppression of normal NK activity 
was also found when Gvhr spleen cells were mixed with normal 
CBA spleen cells (8.5% vs. 13«4%). These results suggest 
that the depression of NK activity was not merely due to 
anti-Fj^ CTL activity, but was due to a non-specific 
suppressor mechanism.
Summary and conclusions
The results presented here show that a Gvhr in irradiated 
mice produces a biphasic enteropathy, with each stage being 
associated with different forms of cell mediated immune 
effector activity.
The mucosal alterations which occurred in the first 
2-3 days of Gvhr were characterised by increases in IEL and 
CCPR and were associated with enhanced splenic NK activity, 
but occurred in the absence of significant specific CTL 
activity. After the initial phase of crypt hyperplasia, 
a sudden inhibition of crypt cell production rate preceded 
the development of villus atrophy, which was paralleled by 
the appearance of specific anti—host CTL activity and by 
the clinical deterioration of the mice.
Therefore the induction of a Gvhr in irradiated hosts 
provides an experimental model of destructive enteropathy 
which is characterised by villus atrophy. The early stages 
of this enteropathy are similar to the changes found in
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unirradiated hosts, with Gvhr, suggesting that a similar 
pathogenic mechanism may be responsible. Nevertheless, 
the results also show that the appearance of villus atrophy 
is associated with the generation of CTL. Although this 
could indicate that villus atrophy is due to a distinct 
mechanism, irradiated hosts develop specific CTL activity 
particularly readily in Gvhr and irradiation itself can 
have significant effects on the gut (Wiernik, 1966; Bril 
& Benner, 1985). Therefore, it would be important to 
confirm these findings in other models of Gvhr, which 
produce villus atrophy.
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Cell source
% NK Activity 
50:1 25:1 % Suppression (a)
Gvhr 4.9 4.6
Control F^ H 00 • VO 13. 8
Gvhr + F.^
00• - 58%
Control CBA 15* 2 8.8
Gvhr + CBA 00 • - 37%
Table 1 Active suppression of NK cell activity in later
stages of Gvhr in irradiated (CBA x BALB/c) mice.
Spleen cells from mice with Gvhr were assayed alone 
against YAC + target cells on day 5 of Gvhr or mixed with 
spleen cells from normal > unirradiated CBA or (CBA x BALB/c)F-^ 
mice. Results shown were obtained from cells pooled from 
4-5 individual mice and are from one of three separate 
experiments with similar findings.
(a) Mixed populations contained each population at an effector: 
target cell ratio of 25 si and °fo suppression was calculated 
by comparing the lysis obtained from the mixed population 
with that which would have been expected by summing the 
activity of each population alone at 25 si E:T ratio.
% Cytotoxicity
•  CBA—►F, \
■----- ■ CBA—*  CBA |  NK
a------ a Irrad F, J2(H
x-------x Anti—host
CTL Activity
__ x
\
— *x
£3 5 62 7
Days After Induction of GvHR
Fig. 1 : Natural and specific cell mediated
cytotoxicity during a Gvhr in irradiated 
(CBA x BALB/c)F^ mice induced by k x 10 
CBA spleen cells. Spleen cells were pooled 
from 5”6 mice with Gvhr and assayed at 
50:1 Effector:Target cell ratios against 
YAC-1 (NK cells) or P815 (anti-H” CTL) 
target cells. In NK assays, control spleen 
cells were from 5-6 irradiated, un­
reconstituted F.. mice or syngeneically 
reconstituted CBA mice.
IEL/100 
Epithelial Cells
2 0 -
• -------•  CBA-+ F,
16-
p<0.01
• *
12-
(2 samples only)
3 6 72 5
Days After Induction of GvHR
Fig. 2 : Intestinal phase of Gvhr in irradiated
(CBA x BALB/c)F.. mice. Intraepithelial 
lymphocyte counts in the jejunum at 
intervals after transfer of b x 10 
CBA or F^ spleen cells. Results 
shown are mean IEL/lOO epithelial 
cells i 1 standard deviation for 
A-5 mice/group, unless otherwise 
stated.
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Crypt Cell 
Production Rate
( /c ryp t /h r )
3 0 -
* p < 0 .0 2
** p < 0 .0 0 5
20 -
10-
Undetectable;
765U3
Days After Induction of GvHR
F i g .  3 : Intestinal phase of Gvhr in irradiated
(CBA x BALB/c)F1 mice. Crypt cell 
production rates in the jejunum of 
mice with Gvhr and in syngeneically 
reconstituted F1 mice. Results shown 
are means - 1 standard deviation for
3-5 mice/group.
Crypt Length (pm)
• ------ •  CBA
■---■ F, —
2 0 0 -
160-
120 -
80-
* p<0.01 
** p<0.001
73 6U 52
Days After Induction of GvHR
Fig. h i Intestinal phase of* Gvhr in
irradiated (CBA x BALB/c )F^ mice. 
Crypt lengths in the jejunum of* F1 
mice with Gvhr and in syngeneically 
reconstituted F^ mice. Results shown 
are mean lengths - 1 standard 
deviation for 3-5 mice/group.
Villus Length (34m) * p<0.02
800-
.600 -
200 -
5 762 3
Days After Induction of GvHR
Fig. 5 i Intestinal phase of* Gvhr in
irradiated (CBA x BALB/c)F^ mice. 
Villus lengths in the jejunum of 
mice with Gvhr and in syngeneic ally- 
reconstituted F^ mice. Results shown 
are mean lengths - 1 standard 
deviation For 3-5 mice/group.
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CHAPTER 4
CORRELATION BETWEEN IMMUNE EFFECTOR MECHANISMS 
AND THE TYPE OF ENTEROPATHY DURING A GVHR IN
NEONATAL MICE OF DIFFERENT AGES
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Introduction
The results in the previous chapter showed that an 
acute* destructive Gvhr in lethally irradiated mice was 
associated with villus atrophy and the parallel development 
of specific CTL activity. However* in view of the effects 
irradiation has on the small intestine it was possible 
that the severe enteropathy was ah artefact of the use of 
irradiation. Furthermore, irradiated hosts do not provide 
a flexible model in which a spectrum of intestinal damage 
and immune effector responses can be produced.
Earlier reports have shown that a Gvhr in neonatal mice 
can produce an enteropathy which may or may not include villus 
atrophy* apparently depending on the age of the host animals 
(MacDonald & Ferguson, 1977; Mowat & Ferguson, 1982). However, 
the conditions which influence the type of enteropathy have 
not been defined and the cell mediated effector mechanisms 
have not been studied. Therefore, the aim of this chapter 
was to test the hypothesis that a Gvhr in neonatal mice of 
different ages would produce different forms of intestinal 
pathology in association with different types of CMI. In 
this way, it would be possible to generate varying severities 
of enteropathy in the same mouse strain and using the same 
donor cell inoculum.
Experimental design
A Gvhr was induced in neonatal (CBA x BALB/c)F^ mice 
within the first ^8 hours of life or at 5 or 7 days of age
- 59 -
7by injection with 10 CBA parental spleen cells. The 
development of1 systemic Gvhr was assessed by regular 
weighing* noting developmental changes, such as the appearance 
fur and eye-opening and by measuring the haematocrit as 
an assay for anaemia.
The immunological changes were assessed by measuring 
splenomegaly, as well as specific and non-specific cytotoxicity 
and measurement of immune responsiveness in Gvhr mice. In 
parallel, anti-host DTH and mucosal architecture was also 
studied.
Results
The relationship between intestinal pathology and immune 
effector mechanisms was examined by inducing a Gvhr in 
(CBA x BALB/c)F^ mice aged 48 hours or less, or on the 5th 
or 7th day of life. Up to four individual experiments were 
conducted on these 3 groups of neonatal mice with essentially 
identical findings within each group. Therefore, for 
simplicity, only the results of one typical experiment from 
each series are presented.
Progress of systemic Gvhr in neonatal (CBA x BALB/c)F^ mice
7
(CBA x BALB/c)F1 mice given 10' CBA spleen cells before 
48 hours of age developed an acute Gvhr, which was 
characterised by runting, diarrhoea and ruffled fur. These 
mice matured less rapidly than littermate controls with 
delayed appearance of body fur and later opening of the eyes. 
Gvhr mice began to lose weight rapidly after day 8 and in 
most experiments all died within 21 days of inducing the
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Gvhr (Fig. 1A). In contrast, littermate controls grew 
continuously throughout the study and deaths were rare.
These mice with Gvhr had significant splenomegaly from 
day 8 until day 18 (Fig. IB), and this was particularly 
notable in view of the marked weight loss which occurred 
at the later stages of the Gvhr. However, a frequent 
finding in some of the most severely runted mice was the 
development of an involuted, shrunken spleen immediately 
before death. This phenomenon is evidenced by the large 
variation in spleen index seen at later times in this 
experiment. In parallel, these mice became anaemic by 
day 12 (Table l) (haematocrits: 29*7 - 2.4 vs 36.2 - 4.7 
in controls p < 9.05) and this became more severe, as mice 
continued to runt.
Finally, most of these mice developed macroscopic 
evidence of liver damage and showed lymphocytic portal 
infiltrates followed by diffuse necrotic changes on 
histological examination.
In contrast to these findings, mice injected with 
parental spleen cells at 7 days of age did not develop a 
lethal Gvhr. There was no evidence of weight loss or 
runting and both control and Gvhr mice developed at the same 
rate (Fig. 2A) . However, these Gvhr mice developed intense 
splenomegaly which first appeared on day 9 with a maximum 
spleen index of 3*40 — 0.90 on day 13> falling to 1.34 — 0.67 
by 30 days (Fig. 2B ). No anaemia (Table l) or macroscopic 
evidence of liver necrosis was found in these mice, although 
histological sections showed occasional portal infiltrates.
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The Gvhr in 5 day old mice was a more variable disease, 
whose outcome was usually midway between the acute, lethal 
disease found in 1-2 day old mice and the entirely proliferative 
disease in 7 day old animals. Most 5 day old neonates with 
Gvhr developed normally until day 14 with little or no 
evidence of weight loss compared with controls (Fig. 3A ). 
Thereafter, some animals showed evidence of clinical runting, 
weight loss and diarrhoea and a small proportion of these 
mice died, usually between days 17 and 24 of the Gvhr. 
Nevertheless, other mice in the same group continued to 
grow normally with no evidence of runting. Five day old mice 
with Gvhr developed moderate splenomegaly which peaked around 
day 13 (Fig. 3B ). Interestingly, by day 18, mice which 
developed signs of runting had less splenomegaly than their 
non-runting littermates with Gvhr, although by day 24, the 
spleen index in both groups had fallen. As in 1 day old 
hosts, severely runted mice usually had splenic atrophy.
After day 18 in experiments using 5 day old hosts, 
samples from mice which lost weight were processed separately 
from those of non-runting littermates and the results are 
presented separately in subsequent sections.
Thus, there were clear differences between the systemic 
Gvhr which could be induced in neonatal mice during the first 
7 days of life and I next investigated whether these differences 
reflected different immune effector mechanisms.
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Development of* specific and non-specific cytotoxicity 
in neonatal hosts with Gvhr
In the experiment using 1-2 day old mice, control 
animals showed little or no splenic NK activity throughout 
the course of the study, confirming other studies of NK cell 
maturation (Murgita & Wig-zell, 1981; Koo _et al. , 1982).
In contrast, mice with Gvhr had a small but consistent peak 
of NK activity on day 5> which declined over the next few 
days, although detectable levels were present until day 11 
(Fig. IB ). Coinciding with this loss of NK activity, 
specific anti-host cytotoxicity appeared at 8-9 days and 
increased rapidly to a peak of 13*5% by day 11 (Fig. IB ). 
Thereafter, as the clinical condition of the Gvhr mice 
deteriorated in the third week, only very low levels of 
specific CTL activity were found.
In the studies of Gvhr induced in 7 day old mice, 
spleen NK activity appeared in controls by days 10-11 
(17-18 days of age) and continued to increase steadily 
thereafter (Fig. 2B ) . By day 5> mice with Gvhr already 
had detectable NK activity and had consistently higher NK 
activity than controls until day 18. By day 30 > adult 
levels of NK activity had developed in both the Gvhr and 
control mice. Little or no specific CTL activity could be 
detected at any time during the Gvhr in these mice (Fig. 2B ).
When 5 day old mice were used as hosts for Gvhr, NK 
activity appeared in controls around days 10—11, while in 
mice with Gvhr, some NK activity was detectable by day 5 
and was markedly increased compared with controls by day „
10 (12.2% vs. 5.4%). ( F i g .  3B ). Thereafter the pattern of
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NK activity in Gvhr mice depended on whether mice developed 
overt runting. Thus, NK activity in Gvhr mice which did 
not lose weight developed in parallel with that in controls 
while in mice which runted, NK activity became less than 
controls (day 18: 2.5% vs. 6.6%) and eventually disappeared 
completely. Interestingly, only a low level of specific 
CTL activity was present in either group of mice on day 10 
of the Gvhr and was never found thereafter (Fig. 3B).
Thus, the development of acute lethal Gvhr in 1-2 day 
old mice is associated with a transient enhancement of NK 
activity, followed by the development of marked specific 
CTL activity which parallels the onset of clinical disease.
In contrast, 7 day old mice with Gvhr have prolonged 
activation of NK cell activity, but no specific CTL are 
detectable. The intermediate form of Gvhr in 5 day old 
mice showed some features in common with both acute and 
proliferative Gvhr, although specific CTL activity was not 
a prominent feature.
Induction of anti-host DTH in adult and neonatal mice with Gvhr
These findings indicate that early neonatal mice suffer 
a much more severe systemic Gvhr than mice even a few days 
older. As this was also associated with marked differences 
in the development of cell mediated cytotoxicity in host 
mice, it was of interest to examine another form of anti—host 
immune response in these hosts.
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Anti—host DTH activity in Gvhr can be assayed by
measuring the increment in footpad thickness 2k hours
after local transfer of spleen cells from mice with Gvhr
into mice syngeneic with the donor of parental cells
(Mowat et al • , 1985)* Therefore? I used this approach to
assess the presence of anti-host DTH during a Gvhr in 1 day,
6 day and adult (CBA x BALB/c)F1 mice.
7
10 spleen cells taken from adult mice 1 day after
7
induction of a Gvhr with 6 x 101 CBA spleen cells, produced 
a significantly greater increase in footpad thickness, in 
CBA mice than that found after transfer of control F^ cells 
(Fig. k ) (specific increase: 0.25 - 0.08 mm vs. 0.07 - 0.04 
p <0.0l). A similar, but smaller anti-host DTH response 
was still present in the spleens of adult mice on day 7 of
the Gvhr (0.12 - 0.05 mm vs. 0.02 - .0 mm, p < 0.005)* In
contrast, spleen cells taken from 1 day old mice were
unable to transfer an anti-host DTH response on either day
1 or day 7 of Gvhr, with similar footpad swellings found 
in CBA mice after injection of Gvhr and control spleen 
cells (Fig. k ).
A separate experiment was performed to compare the 
DTH response during a Gvhr in 6 day old and adult F^ mice. 
Once again, adult cells taken on day 1 of Gvhr induced 
significantly greater increases in footpad thickness in CBA 
mice, compared with that found after transfer of control FJ_ 
cells (Fig. k ) (0.27 - 0.06 mm vs. 0.20 - 0.3 mm, p < 0.05).
Spleen cells from 6 day old mice with Gvhr also transferred
mm,
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a significant anti-host DTH response, although this was 
less than that found with adult cells (Fig. 4 ).
Thus 1 day old neonatal mice do not induce the anti- 
host DTH response found during a Gvhr in more mature hosts, 
despite the more aggressive disease which occurs in 1 day 
old hosts. Interestingly, the ability to induce an anti­
host DTH response seems to appear around 6 days, the time 
at which the nature of the Gvhr also altered.
Ability of Gvhr cells to proliferate in response to fully 
allogeneic spleen cells in vitro
Gleichmann has suggested that the development of an acute 
Gvhr is associated with the generation of Ts activity 
(Gleichmann _et al. , 1984). Therefore it was of interest to 
determine whether neonatal mice with Gvhr had reduced immune 
responses and if this was due to active suppression.
In this preliminary study, a Gvhr was induced in 1-2 day 
old (CBA x BALB/c)F1 hosts and spleen cells were taken from 
control and Gvhr neonatal mice on days 8 and 15 of the 
experiment and tested for their ability to proliferate in 
response to 3rd party allogeneic stimulator cells. At both 
times, Gvhr cells responded less well than control cells 
to mitomycin C treated C57B1/10 stimulator cells (Fig. 5).
In addition, if Gvhr and control cells were mixed (at a 
ratio of l:l), the response of the mixed cultures was less 
than that of control cells alone (Fig. -5 ) •
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These results are preliminary evidence that mice 
with an acute Gvhr induced at 1—2 days old have evidence 
of active immunosuppression. Unfortunately, lack of time 
prevented me confirming these studies or extending them 
to older mice with Gvhr.
Mucosal phase of Gvhr in neonatal hosts of different ages 
I next examined whether the differences in systemic 
disease and immune responsiveness during a Gvhr in neonatal 
mice of different ages would be reflected in different forms 
of intestinal Gvhr.
Intestinal Gvhr in 1-2 day old hosts
Villus atrophy was a consistent feature of the Gvhr 
in 1-2 day old neonates and was already present when the mice 
first began to runt on day 9 (Fig. lCtH^ ( 409*4 - 16 pm vs.
563*3 - 11 V-m for controls, p < 0.001).
This became even more marked by day 15» when all the 
mice with Gvhr were extremely ill and had significant CTL 
activity. At both times, mice with Gvhr had significantly 
longer crypts than controls (Fig. 1C ) (90.6 — 6 pm vs.
57.2 - 6 pm, p < 0.001 on day 9 and 162.5 - 35 P-m vs. 80.5 £ 6 pm 
p < 0.005 on day 15)* In parallel, mice with Gvhr had a 
moderate, but statistically insignificant increase in crypt 
cell mitotic activity at the earliest time examined (Table 2) 
(7.50 ± 1.15 vs. 4.2 ± 0.5 for controls), but thereafter,
Gvhr mice had levels of CCPR which were roughly half those 
in control mice.
Intestinal Gvhr in 7 day old hosts
No evidence of villus atrophy was found at any time 
during the Gvhr induced in 7 day old mice (Fig. 2C+IK>) However 
these mice had significant crypt lengthening compared with 
controls from day 9 (Fig. 2C ) (85.6 ± 11 pm vs. 44.8 - 3.8 pm 
for controls p < 0 .01) until day 30 (152.5 ^ 10 pm vs.
113*9 - 9 Pm For controls p < 0.02). In addition these 
animals had a significantly enhanced CCPR compared with 
controls during the same period (Table 2).
Intestinal Gvhr in 5 day old hosts
This group of mice developed a form of intestinal Gvhr 
which had features in common with both the proliferative 
and destructive enteropathies described above. On day 13> 
the fact that some Gvhr animals would runt was already 
reflected in a slight overall decrease in villus length 
compared with controls (Fig. 30 ) (400.6 - 27 pm v s * k66.6 - 
11.5 Pm , P < 0.05). Thereafter, runting mice developed 
progressive villus atrophy which became extremely marked by 
day 24 (346.3 - 10 pm vs. 625*4 i 44 pm for controls p < 0 .001) 
Mice which did not runt had no evidence of villus atrophy 
until day 24, when, although their villus lengths were 
significantly shorter than controls, these were still 
significantly greater than their runting littermates 
(453.0 ± 32 pm, p < 0.02). All Gvhr mice had crypt 
lengthening on day 13 <rnd this was maintained in non—runting 
mice until day 24 (Fig. 30 ) (153*2 — 50 Pm vs. 128.7 — 23 pm 
for controls). In contrast, on day 18, crypt lengths in •
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minting mice were no greater than those of controls and 
by day 2k , crypt lengths in runting mice were shorter than 
control values (93*6 i 5*5 p  vs. 128.68 ± 23 y.m for 
controls). In parallel, all mice with Gvhr had an increased 
CCPR on days 5 and 10 (Table 2) and> in non-runting mice? 
this became even more marked by day 2k (35.0 - 0 vs. 9.5 - 
1*73* P < 0.02). At this time crypt cell mitotic activity 
was absent in runting mice with Gvhr.
Intraepithelial lymphocyte counts in neonatal mice with Gvhr
Mice which had a Gvhr induced at one day old had slightly 
higher IEL counts than controls of a similar age on days 5 
and 11, and this was also present in the only surviving mouse 
examined on day 15 (Table 3) (6.1 vs. J.6 in controls).
It should be noted that at all times very few IEL were 
counted in these mice. In addition, these differences were 
not statistically significant and were small compared with 
previous reports (Mowat & Ferguson, 1982). Nevertheless, 
similar results were obtained in mice which received donor 
cells at 5 days of age where Gvhr mice had increased IEL 
counts on days 10 (Table 3) (3*8 - 0.3 vs. 2.0 - 0,kf 
p < 0.01) and 18 (4.1 - 0.2 vs. 3*7 - 0.3)* Mice with a 
Gvhr induced on day 7 also had increased IEL counts on days 
5, 13 and 17, although again the differences were small 
(Table 3).
Therefore the acute systemic Gvhr in very young neonatal 
mice was paralleled by severe intestinal damage which was 
characterised by both crypt hyperplasia and villus atrophy.
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In contrast, the 7 day old mice with Gvhr which did not 
die, developed only the proliferative enteropathy which 
has been described previously in adult mice, with crypt 
hyperplasia, but no villus atrophy. Interestingly, 3 day 
old mice developed a Gvhr with some of* the systemic and 
intestinal features of both the other groups of mice, and 
therefore seem to represent an intermediate group.
Effect of donor cell number on the outcome of Gvhr in
neonatal hosts
The experiments described above used an arbitrary number
of donor cells, which were not corrected for body weight.
Therefore one explanation for the more severe Gvhr in
one day old mice could be that these mice effectively
received a larger dose of donor cells. Therefore, I examined
whether the nature of the Gvhr in 1 day old mice would be
different if they received a lower number of donor cells.
At one day old, mice weighed about 1 • 5 S while 7 day
old mice weighed about 3 S* Therefore, to examine the
importance of donor cell numbers, I compared the Gvhr which
6 7
occurred in one day old mice given either 3 x 10 or 10 
donor cells.
Progress of systemic Gvhr
7 7One day old mice which received 0*3 x 10 or 10 donor 
spleen cells began to lose weight and develop clinical signs 
of Gvhr at a similar rate (Fig. 6a ) and there was no difference 
in their mortality rate. Both groups of mice with Gvhr had 
significant splenomegaly by day 11, with spleen indices of
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2.53 - 0.3^ and 2.75 - 0.50 in recipients of 1 x 10^ and 
70.5 x 10 cells respectively (Fig. 6b).
Specific cytotoxicity was found in all Gvhr mice on 
day H » although the CTL activity in recipients of 10^ donor 
cells was double that of mice given 0.5 x 10^ cells (Fig. 7A) .
A small amount of NK activity was also found in all Gvhr 
mice at this time, but this had disappeared by day 15 (Fig. 7A). 
Levels of specific cytotoxicity, although lower than on day 
11, were still found at the later time.
Mucosal phase of Gvhr
One group of these mice was killed on day 15 for 
assessment of intestinal Gvhr, when both Gvhr groups had 
significant crypt lengthening and villus atrophy compared 
with controls. Interestingly, despite the higher levels of
7CTL activity in recipients of 10 cells, there was no 
significant differences in the villus or crypt lengths in 
mice given 10^ or 0.5 x 10^ cells (Fig. 7B) .
Together these results show that halving the dose of 
donor cells does not alter substantially the consequences of 
Gvhr in neonatal mice and so indicate that the different 
forms of Gvhr in 1 or 7 day old hosts is not merely because 
one day old mice received a larger number of cells.
Therefore these differences in Gvhr must be a consequence 
of the relative maturity of neonatal mice of different ages.
The next experiments were undertaken to investigate some of 
the other differences in the neonatal immune system which 
could account for this maturational effect.
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Comparison of allospecific DTH responses induced by neonatal 
and adult spleen cells
The ability of neonatal mice to induce an anti-host 
DTH response appeared to correlate with the different outcome 
of Gvhr and suggested that one difference between mice of 
different ages might be their ability to activate certain 
types of donor effector cells. Therefore in the first 
experiments on the maturity of the neonatal immune system,
I examined the ability of neonatal and adult F][ cells to 
provoke an allospecific DTH response in CBA mice.
In the first experiment, CBA mice were primed intra-
dermally with either adult or neonatal (< 5 days) (CBA x
BABL/c)F^ spleen cells and 5 days later mice were challenged
7into opposite footpad with 10 adult or neonatal F^ spleen 
cells. Mice primed and challenged with adult F^ cells showed 
a specific - increase in footpad thickness of 0.47 - 0.10 mm 
(p < 0 .001) compared with that found after challenge of 
immunised mice (Fig. 8 ). In contrast, mice primed with 
neonatal spleen cells only showed a specific increase of 
0.22 - 0.10 mm after challenge with neonatal spleen cells 
(p < 0.02 vs. adults).
The second experiment was designed to establish whether 
neonatal cells were deficient at inducing either the afferent 
or efferent limb of the DTH response. This was particularly 
important in view of reports that the neonatal spleen 
contains a large number of non-specific suppressor cells 
which could potentially inhibit the recall phase of the DTH 
response when used as a challenge inoculum.
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Thus, mice were again primed with either adult or
neonatal spleen cells, but on this occasion, all mice were
challenged with adult spleen cells. Under these conditions,
the DTH response in mice primed with neonatal cells was
greater than that shown above, but was still significantly
reduced compared with that found in mice primed with adult
cells (Fig. 8 ) (O.35 - 0.10 mm vs. O .53 - 0.12 mm for
adults p < 0.05)» These results indicate that the poor
ability of newborn spleen cells to induce a DTH response is
primarily due to a failure to sensitise parental T ^  andDTH
are consistent with the poor anti-host DTH response found 
during a Gvhr in these mice.
Influence of age on the ability of donor spleen cells to 
induce a local Gvhr
The next series of experiments were performed to 
establish the degree of immunocompetence of neonatal mouse 
cells in vivo. This was addressed by inducing a local Gvhr
7in (CBA x BALB/c)F1 mice by footpad injection of 2 x 10 
spleen cells from either adult or neonatal CBA mice. The 
degree of local Gvhr was then measured by weighing the
draining PLN 8 days later.
Spleen cells from < 5 day old CBA mice induced only a 
small increase in popliteal lymph node weight compared with 
that found after injection of medium alone (Fig. 9 )
(7 ± 10 mg vs. 3 ± 1.4 mg). In contrast, adult CBA cells 
caused a very marked enlargement of PLN (46.9 _ 16 mg vs.
9.6 ± 3 mg, p < 0 .001) in a separate experiment spleen cells
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from 8 day old mice induced an increase in PLN weight 
that was similar to that found with adult spleen cells 
(46*8 — 11 mg and 46.4 — 13 mg respectively).
These results indicate that one day old mice have 
markedly deficient allospecific T-cell activity and as host 
T-cells have been reported to be one component of resistance 
against Gvhr, I performed a preliminary study to examine 
whether T-cell deficiency was responsible for the severe 
Gvhr in one day old neonates.
Effect of reconstituting one day old neonatal mice with
adult spleen cells
A Gvhr was induced in one day old (CBA x BALB/c)F^ mice 
7with 10 CBA spleen cells as before, but in this experiment,
7two groups of Gvhr mice were given either 10 unpurified 
or T cell enriched spleen cells from syngeneic F^ adults, 
at the time of inducing the Gvhr.
All the Gvhr mice began to lose weight after day 8 
of the Gvhr and although this was slower in the mice which 
had received adult T—cells enriched spleen cells, the 
differences were not significant (Fig. 10 ). By day 14 all 
of the mice with Gvhr had developed clinical signs of Gvhr 
and runting, and one mouse with Gvhr, which received no 
adult cells had died. By day 20 of the experiment, a similar 
proportion of the mice in all the groups of Gvhr mice had
died (Fig. 10 ) .
The results of this experiment do not show any clear 
difference in the severity of Gvhr in mice given adult 
syngeneic spleen cells.
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Summary
This chapter has shown that the systemic and intestinal 
consequences of a Gvhr in neonatal mice depend on the age 
the host used. Neonatal (CBA x BALB/c)F^ mice given 10^ 
CBA spleen cells at less than 48 hours old, developed an 
acute destructive Gvhr, typified by runting and severe 
intestinal damage, which included villus atrophy. These 
animals also developed marked specific anti-host CTL activity 
and invariably died. Preliminary studies indicated that 
these mice also had active suppression of immune responses.
In contrast, 7 day old F^ mice given the same number of donor 
cells developed a proliferative Gvhr, characterised by 
intense splenomegaly, prolonged NIC cell activation and crypt 
hyperplasia. These mice did not lose weight, had no villus 
atrophy or specific CTL activity and all recovered. A 
similar proliferative phase of splenomegaly, transient NK 
cell activation and crypt hyperplasia preceded the established 
destructive Gvhr in 1-2 day old hosts. Induction of a Gvhr 
in 5 day old hosts produced a disease which had some 
characteristics of both the proliferative and destructive 
forms of Gvhr. Thus, all mice had early proliferative 
features but some mice then lost weight and developed villus 
atrophy. In contrast, others did not lose weight or develop 
villus atrophy, but had prolonged crypt hyperplasia and NK 
cell activation. However, an important feature was that 
very little specific CTL activity was found in any of these 
animals, irrespective of whether they had a destructive 
Gvhr or not.
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The differences in the outcome of Gvhr were not due 
to an effect of relative donor cell numbers, as weight 
related adjustment of the donor cell inoculum only produced 
some increase in specific CTL activity, but had no significant 
effect on the systemic or intestinal consequences of the 
Gvhr.
Subsequent studies showed that, in comparison with adult 
cells, spleen cells from 1 day old F^ mice could not induce 
an efficient allospecific DTH response in vivo. Furthermore, 
an anti-host DTH response did not occur in one day old F^ 
mice after induction of a Gvhr with parental cells, whereas 
6 day old F^ mice were capable of inducing almost as much 
anti-host DTH as adult hosts. These results suggest that 
very young neonatal mice may activate different forms of 
effector T—cell than those induced in older hosts.
2-3 day old mice also had defective allospecific T-cell 
function as measured by the ability of their spleen cells to 
mediate a local Gvhr in F.^  hosts. In contrast, cells from 
8 day old mice induced a local Gvhr which was equal to 
that caused by adult cells. However, it proved impossible 
to prevent the severe Gvhr in very young neonatal mice by 
reconstituting with syngeneic adult spleen cells-
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Conclusions
This chapter confirms that a destructive enteropathy 
which includes villus atrophy can be reproduced by a Gvhr 
in neonatal F1 mice, providing the hosts are less than 
6-7 days of age. As in irradiated mice with Gvhr, specific 
CTL activity was frequently associated with the development 
of an acute intestinal Gvhr. However, villus atrophy occurred 
in the absence of CTL in 5 day old mice. These findings 
indicate that CTL may not be essential for the development 
of villus atrophy. It would be important to confirm these 
findings in a model of acute Gvhr which uses intact mature 
hosts. Finally, this study has highlighted the potential 
importance of host immunocompetence in modifying the Gvhr 
and this issue will be addressed further in Chapter 6.
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Age of host Day of Gvhr Haematocrit
( d a y s ) control Gvhr
8 41.8 -  1.3 41.9 ± 4.9
1 12 36.2 -  4.7 29.7 - 2.4*
16 37.8 -  3.7 25.8 - 0.5**
7 36.8 -  1.6 34.8 -  2.1
7
20 45.8 - 2,4 47.3 -  4,2
Table 1 : A ssessment of haematocrit in neonatal (CBA x BALB/c)F-^
mice with Gvhr aijid in littermate controls. Results 
shown are means - 1 standard deviation for 5 mice per 
group, in each experiment.
* p < 0.05; ** p <  0.005.
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Age of host Day of Gvhr Crypt Cell Production Rate
( d a y s ) Control Gvhr
5 4.12 - 0.50 7.50 -  1.15
1-2 7 5.80 ± 0.52 11.81 -  2.80*
9 8.80 t 4.10 4.38 i 1.32
15 12.73 ± 2.50 6.15 4.05*
5 0.69 - 0.43 5.25 -  0.64*
.5 10 3.30 - 1.12 7.81 i 1.78
24 15.10 ± 1.73 35.25 ± 0
9 3.24 -  1.0 8.65 - 0.99*
7 18 6.98 i 1.50 13.20 -  1.66*
1
1
24 11.80 -  0 18.22 -  2.08
Table 2: Crypt cell production rate in the jejunum of neonatal 
(CBA x BALB/c)F-, mice with Gvhr, an£ in littermate 
controls. Results shown are means - 1 standard 
deviation for four mice per group.
* p < 0.05; ** p < 0.02; *** P< 0.001.
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Age of host Day of Gvhr IEL/100 Epithelial Cells
( d a y s ) Control Gvhr
5 2.6 -  0.5 3.2 -  0.4
1-2 11 1.5 -  0.2 3.3 i 1.2
15 3.6 6.1
i
4 2.9 -  0.3
j
2.8 -  0.9
5
10
18
2.0 -  0.4 
3.7 -  0.3
3.8 ± 0.3***1 
4.1 - 0.2 1
i
24 8.4 7.6 |
5 2.5 -  0.5 3.8 ! 0.5 j
7
13
18
6.0 -  0.6 
5.6 ± 0.4
7.1 -  0.7
7.2 - 0.4**
30 8.6 - 0.8
i
6.7 i 0.3*
Table 3 : IEL counts in the jejunum of neonatal (CBA x BALB/c)F-^
mice with Gvhr, and in littermate controls. Results 
shown are means - 1 standard deviation for either 3 or 
4 mice per group.
* p < 0.05; p < 0.025; *** p < 0.01.
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later, with adult or neonatal F^ spleen cells, 
while in Experiment 2, hosts were primed with
F-^  spleen cells and challenged 
cells. Results shown are the
adult or neonatal
with adult F^ . _______ _____ __ __
mean increase in footpad thickness 2k hours 
after challenge of immunized or control mice - 1 s.d. 
for 6 mice/group.
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Fig. 9 : Influence of* age on the ability of parental
spleen cells to induce a local Gvhr in F^ 
hosts. Popliteal lymph node weights 7 days 
after Footpad transfer of 10^ spleen cells 
From adult> 8 day old or less than 5 day old 
CBA mice. Control Footpads were injected 
with medium. Results shown are means - 1 s.d, 
For 5 mice/group.
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Fig. 10: Effect of reconstituting one day old
neonatal (CBA x BALB/c)F^ mice with adult 
spleen cells on the systemic Gvhr induced by 
10' CBA spleen cells. Growth rate of neonatal 
mice with Gvhr given 2.5 x 10' syngeneic 
spleen cells or T-cell enriched spleen cells 
on day 1. Results shown are means - 1 s.d. 
for 4 mice/group.
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A) Microscopic 
appearance of a 
microdissected, 
section of jejunum 
from a 1 day old 
control (CBA x 
BALB/c)F-^ mouse. 
Note the short 
crypts and tall 
slender villi 
(Schiff x 400)
2
B) Microscopic appearance 
of the jejunum on day 11 
of Gvhr induced on day 1 
of life. There is marked 
crypt hypertrophy* as 
well as shortening and 
thickening of the villi 
(Schiff x 400)
Fig. 11: Effects of 
of neonatal
Gvhr
(CBA
on
x
mucosal architecture 
BALB/c)Fq mice.
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Legend as 
Fig. II B, but 
shows crypt 
hyp e r t ro phy 
in the absence 
of villus 
damage.
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CHAPTER 5 
INVESTIGATION OF THE MECHANISMS 
INVOLVED IN THE ENTEROPATHY CAUSED 
BY A GVHR IN BDF1 MICE
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Introduction
The previous chapters have shown that it is possible 
to modify the outcome of systemic and intestinal Gvhr by 
inducing different forms of immune response in different 
types of (CBA x BALB/c)F^ hosts. These studies showed that 
a destructive enteropathy involving villus atrophy* occurred 
when mice developed an acute lethal form of Gvhr. However, 
this was only found in hosts, whose immune systems had been 
altered by either immaturity or irradiation and it was 
possible that the pathology was an artefact of using these 
abnormal hosts. Furthermore, the low numbers of cells 
obtainable from the lymphoid tissues of irradiated or neonatal 
hosts made it difficult to examine immune effector mechanisms 
in detail. Therefore I decided it would be important to be 
able to confirm the findings by examining the immune 
mechanisms responsible for the different forms of pathology 
during a Gvhr in unmanipulated, preferably adult hosts.
One possible approach to this was suggested by the 
findings that adult BDF^ mice developed an acute lethal 
Gvhr after injection of C57B1/10 parental spleen cells, 
while a milder more chronic form of Gvhr induced by T—cells 
from the opposite parent (Gleichmann et al« , 1984). In 
parallel, mice given BIO cells developed anaemia and 
destruction of lymphoid tissues while hosts receiving DBA/2 
cells only showed late signs of autoimmune disease and 
lymphoid cell proliferation. Interestingly, it has also 
been shown that specific CTL only develop in BIO 
mice (Kubota et al. , 1983) and so this model might provide
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a fhz'bher means of assessing the effector mechanisms 
responsible for different forms of immunologically mediated 
enteropathy.
Experimental design
A Gvhr was induced in adult BDF1 mice by i.v. injection 
8
of 10 spleen cells from either BIO or DBA/2 parents while
7neonatal BDF^ mice were given 10 parental spleen cells i.p. 
at various times after birth. The progress of the Gvhr was 
assessed at intervals by the usual means of weighing mice, 
measurement of splenomegaly, splenic NK activity and specific 
anti-host CTL activity as well as by examining the ability 
of Gvhr spleen cells to suppress the mitogenic responses of 
normal lymphocytes. In parallel, the intestinal phase of 
Gvhr was also measured. (S€£. Rpp£*ocii<)
Results
Graft-versus-host reaction in adult (C57B1/10 x DBA/2)F^ mice 
The first experiments were designed to determine whether 
the different forms of systemic Gvhr which had been described 
in adult BDF^ mice would be reflected in the intestinal 
pathology.
Progress of systemic Gvhr
Ten days after the induction of Gvhr, mice receiving 
BIO parental spleen cells were already losing weight compared 
With control mice (Fig. 1A) and this continued until day 2k 
when the weights of the BIO— ►BDF^ mice had fallen to 
18.2g — 1. 6g compared with controls 25*9 "* 1.2g (p 0.001)
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and two of the Gvhr group had died (Fig. IB). Thereafter, 
the majority of these mice began to recover and the mean 
weight of the group increased gradually. However, two 
more mice died on days 64 and 70 of the Gvhr. In contrast, 
recipients of DBA/2 spleen cells showed no signs of clinical 
Gvhr throughout the study and none of these mice lost weight 
or died (Fig. 1A and B).
BDF1 mice given BIO parental spleen cells had significant 
splenomegaly by day 4 (Fig. 2 ) and by day 8 this had risen 
to give a spleen index of 4.8 - 0.5* This declined thereafter 
and had disappeared by day 20. Although mice given DBA/2 
spleen cells had much less intense splenomegaly, with a 
maximum spleen index of 2.04 i 0.15 on day 8, a similar 
level of splenomegaly was maintained until day 4l (Fig. 2) .
When specific anti-host CTL activity was measured in 
Gvhr mice, it was found that BIO— ► F^ mice developed 
consistently high levels of specific cytotoxicity against 
P815 cells, which reached a peak of 30.8/0 on day 8 before 
falling to ll/o by day 25 and being absent on day 4l (Fig. 3). 
In contrast, only very low levels of specific cytotoxicity 
against EL—4 were found in DBA/2-*F^ mice at any time 
during the Gvhr. Furthermore, in view of the enhanced NK 
activity in these mice (see below), it was not clear whether 
this cytotoxicity reflected true CTL activity, as, unlike 
P8I5, EL-4 cells are sensitive to NK lysis (Harmon e_t al. ,
1977).
- 96 -
Control mice had variable levels of NK activity during 
this experiment (Fig. 4a ) and to clarify the level of NK 
activity in Gvhr mice, this is also expressed as a ratio 
of that in appropriate controls (Fig. 4b )• Mice given 
BIO cells had normal levels of NK activity on day 3» after 
which NK activity fell rapidly and was undetectable after 
day 25. In contrast, mice given DBA/2 cells had increased 
NK activity compared with controls from day 3 onwards and 
this peaked on day 8 (24.4% vs. 6.1% in controls). Thereafter, 
NK activity in these mice fell but was never lower than 
that in controls.
Suppression of lymphocyte proliferation in BDF^ mic e with Gvhr 
The studies by Gleichmann e_t al. (1984) showed that 
the acute Gvhr in BDF^ mice given BIO spleen cells was 
accompanied by suppressor T cell activity and I attempted 
to confirm this phenomenon in my own model. In the first 
experiment, I examined the ability of Gvhr spleen cells to 
generate a MLR response against mitomycin C treated CBA (H-2 ) 
spleen cells on days, 3» 10 and 18 of the Gvhr. Throughout 
the experiment control BDF^ spleen cells showed a healthy 
proliferation to CBA spleen cells, while mice given BIO 
spleen cells always showed little or no MLR response and 
these were always markedly smaller than those of control
cells (Fig. 5)•
The proliferative response of DBA/2 . mice to
CBA spleen cells was also less than control levels on day 3 
and 10 (548.4 - 79 cpm and 677-05 - °Pm vs* 1672.5
535 cpm and 1882.5 1 163 <=pm in controls), but by day 18
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spleen cells from DBA/2-— ► Fx mice responded markedly 
better than control cells (2665.7 - 235 cpm vs. 1340.3 ±
^07 cpm in controls, p < 0.005). Furthermore, these Gvhr 
mice always had better MLR responses than those of BIO— ► F^ 
mic e.
The next experiments were designed to examine whether 
this defect in lymphocyte proliferation in Gvhr mice was 
associated with the presence of active suppression.Spleen 
cells were taken on days 3> 17 and 25 of the Gvhr and mixed 
at different ratios with control BDF1 spleen cells which 
were stimulated with ConA.
On day 3 spleen cells from both BIO—♦ BDF^ mice and 
DBA/2— BDF^ mice suppressed the ConA response of control 
cells, especially when mixed at high or very low ratios. 
However cells from DBA/2 F^ mice were generally less 
suppressive than those from BIO— ► BDF^ mice (Fig. 6 ).
On day 17, BIO— ^  BDF^ cells produced a similar pattern 
of suppression which was always < 30^ and became more marked 
at higher numbers of Gvhr cells. In contrast, cells from 
DBA/2— ► BDFX mice always exhibited less suppression than 
BIO— ► BDF1 cells and, at lower ratios, little or no 
suppression was seen with these cells. By day 25* neither 
Gvhr population suppressed control responses at low cell 
numbers, but addition of larger numbers of BIO ► F^ cells 
produced dose dependent suppression which was virtually 
complete at the highest cell numbers. In contrast, the 
same numbers of DBA/2— * BDF^ cells led to a dose-dependent 
enhancement of ConA responses. These results confirm those
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of Gleichmann et al. and are preliminary evidence that BIO 
donor cells are much more efficient than DBA/2 donor cells 
at inducing Gvhr mediated suppression.
Development of auto—antibodies in BDF-^  mice with Gvhr
A further index of systemic immunity which is reported 
to distinguish the Gvhr induced by BIO or DBA/2 parental 
cells in BDF^ mice is production of autoantibodies during 
the later stages of Gvhr in DBA/2— ► BDF^ mice (Rolink & 
Gleichmann, 1983). Therefore, I looked for the presence of 
serum antibodies to autologous red blood cells during the 
20th week of the Gvhr in both groups of Gvhr mice using a 
standard haemagglutination assay. However, despite the 
fact that DBA/2— m- F^ mice still had significant splenomegaly 
at this time (l.48 - O.52), anti-red cell autoantibodies 
were not detectable in any mice (Data not shown).
The results of this series of experiments confirm and 
extend those of other workers showing that BIO and DBA/2 
parental spleen cells induce markedly different forms of 
systemic Gvhr in unirradiated BDF^ mice. Furthermore, these 
models of Gvhr are accompanied by different forms of cell 
mediated effector and regulatory cell activity. In the 
next experiments I went on to investigate whether those 
differences were accompanied by different types of intestinal 
pathology.
Intestinal pathology during Gvhr in adult, unirradiated BDF1 mice 
The intestinal pathology was examined on days 4—128 
of Gvhr. Mice given BIO spleen cells had no evidence of 
villus damage until day 28, when significant villus atrophy
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was found (Fig. 7 ) (335-5 - 59-8 pm vs. 509-5 - 36 pm
in controls, p < 0.005). At this time th ese mice also
had significant weight loss. Some of these mice survived
until day 128 and there was still some evidence of villus
atrophy at that time, although this did not reach statistical
significance (530.9 - 122.6 pm vs 589-5 - 20.5 pm in controls).
In parallel, these Gvhr mice had significant crypt lengthening
by 8 of Gvhr (Fig. 7 ) (199-9 - 13-4 pm vs. 116.3 - 10.7 pm
in controls, p < 0 .001) and this was maintained until the
end of the experiment in surviving mice (day 128: I85.5 -
22.3 pm vs. 119.2 - 12.7 pm in controls, p < 0 .001).
This group also had increased crypt cell turnover which was
(FrfSft)
particularly marked on day 8 “(40.4 - 6.5 vs. 10.5 -in controls) 
and persisted until day 128 (26.5 - 8.6 vs. 9-1 - 0 .5> 
p < 0.02). Interestingly, BIO— ► BDF^ mice had significantly 
lower IEL counts than controls on day 3 (Fig. 8B ) (5-71 - 1-15 
vs. 9-67 - 1.84 in controls, p < 0.02) and although IEL 
cc. ants had recovered to normal levels by day 8, very low IEL 
counts were again found on days 17 and 28. Indeed, by day 
28, virtually no IEL were seen in the epithelium of Gvhr 
mice (1.42 i 1.09 vs. 11.38 - 1.46 in controls, p < O.OOl).
On day 128, surviving mice had normal levels of IEL.
Mice given DBA/2 spleen cells had surprisingly few 
intestinal changes, despite the presence of persistent 
splenomegaly and enhanced NK activity shown earlier. There 
was no villus atrophy at any time during the Gvhr and there 
were only small increases in crypt length and CCPR on days 
8 and 17 respectively (Fig.7 & 8a ).Similarly,no change 
in IEL numbers occurred at any time during the Gvhr in 
these mice (Fig. 8b ).
------------------------------------
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Graft-versus-host reaction in neonatal (C57B1/10 x DBA/2)F1 
mice
The results described above showed that although BIO 
and DBA/2 parental spleen cells induced markedly different 
forms of systemic Gvhr in adult hosts, only BIO cells caused 
significant intestinal pathology. Therefore, it proved 
impossible to correlate intestinal alterations with systemic 
immune responses. The results in Chapter 4 show that mature 
mice are more resistant to Gvhr than 1-2 day old mice. 
Therefore, it seemed possible that intestinal pathology 
might occur after injection of DBA/2 cells if neonatal BDF^ 
hosts were used and I carried out a series of experiments 
examining the Gvhr induced by BIO or DBA/2 cells in one 
day old neonatal BDF^ hosts. As a control this Gvhr was 
compared with that occurring in 5 day old hosts.
Progress of systemic Gvhr in neonatal BDF.^ mic e
One day old neonatal BDF^ mice which received either BIO 
or DBA/2 parental spleen cells developed normally until 
about day 8, when both groups began to lose weight. At 
the same time, Gvhr mice developed other clinical signs of 
runting, and deaths began to occur after day 18 (Fig. 9A) . 
Interestingly, recipients of DBA/2 spleen cells lost weight 
at a slightly slower rate than BIO— ** F^ Gvhr mice (Day 16: 
5.22 ± 0.8g, p < 0.05 and 3-72 ± 0.7g» p < 0.001 vs. 6.56 ± 
0.39 in controls). DBA/2— r BDF^ mice also had a slower 
mortality rate and the first mouse of this group had not 
died until day 23, while 60% of B10-* BDFX mice had died
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by day 19* However DBA/2 cells were undoubtedly capable 
oF causing an acute Gvhr in these neonatal hosts as the 
overall mortality and weight loss was similar to recipients 
of BIO cells.
BIO BDF^ mice had significant splenomegaly by day 8, 
(S.I. =1*52 - 0.3) and this rose to 1.53 - 0.32 on day 12, 
before falling rapidly to control levels thereafter. In 
contrast, recipients of DBA/2 cells had no splenomegaly 
on day 8, but then developed marked splenomegaly which 
reached a maximum of 2.35 - 0.3 on day 13 and was still 
present on day 18 (l.48 ^ 0.17) when none was present in 
BIO— w F^ mice.
Neonatal mice given BIO or DBA/2 parental spleen cells 
at 5 days old showed a markedly different pattern of systemic 
Gvhr. Mice given BIO spleen cells began to lose weight 
and developed the characteristic features of runting by 
about day 12 and all the mice died by day 24 (Fig. 12A).
In contrast, recipients of DBA/2 cells grew at the same 
rate as controls throughout the experiment and none of 
these animals died. In this experiment, mice given BIO 
spleen cells always had greater splenomegaly than DBA/2— F1 
mice, with a spleen index of around 2 throughout the course 
of the experiment (Fig.l^B ). In contrast, DBA/2 * F^ 
mice never had significant splenomegaly.
Development of cytotoxicity in neonatal BDF-^ mic e wi th Gvhr
Mice given BIO spleen cells on day 1 of life had a 
low level of specific CTL activity, which peaked on day 13
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and. had disappeared by day 18• One day old recipients of 
DBA/2 spleen cells also had some specific CTL activity on 
days 12 and 13 > but this was much less than in BIO— BDF^ 
mice (3% vs 13%) (Fig.lOA)* Five day old mice given BIO 
spleen cells also showed specific CTL activity? which was 
maximal on day 12 (Fig.l3A ) and fell thereafter. However, 
no significant specific CTL activity was found in mice 
given DBA/2 cells on day 3 of life.
When a Gvhr was induced in 1 day old mice, both groups 
of Gvhr mice had an early rise in splenic NK cell activity 
on day 8, but this was small and short-lived on day 12 
and thereafter, all Gvhr mice had NK levels less than 1%. 
Control mice in these experiments had no NK activity at all 
until day 18, when levels of 7% were reached (FigdOB )•
Both groups of 3 day old mice with Gvhr also had a small rise 
in NK activity on day 12, but this was more apparent in mice 
receiving BIO cells than in recipients of DBA/2 cells (Fig. 13B) 
(6.8% and 2.3% respectively). Thereafter, NK activity in 
BIO — r BDF^ mice declined to be undetectable by day 17> 
and was much less than in control mice in animals surviving • 
until day 2k (9.3% vs. 31%) • Although recipients of DBA/2 
cells had little evidence of NK cell activation on days 12 
and 17, these animals had NK cell activity which was equal 
to control levels on day 2k of the Gvhr.
These results are similar to those described earlier 
in neonatal (CBA x B A L B / c ^  hosts and confirm in a different 
strain that the outcome of a systemic Gvhr is dependent 
on the age of the host animal. Interestingly, although
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DBA/2 cells could not induce an acute, lethal Gvhr in 
5 day old BDFJL mice in the same way as BIO cells, the use 
of one day old neonates did allow DBA/2 cells to produce 
an acute Gvhr with similar features to that found using 
BIO cells. I next examined the intestinal phase of Gvhr 
induced by the two parental cells in neonatal hosts.
Intestinal pathology during a Gvhr in neonatal BDF1 mice
Mice given BIO parental spleen cells on day 1 of life 
had a significant increase in crypt depth on day 7 (Fig. 11 ) 
(62.4 - 6 pm vs. 35*1 - 6 pm in controls, p < 0.02) and 
this became more marked by day 14. Mice given DBA/2 cells 
also had some evidence of crypt lengthening at both times, 
but this was only significant on day 14, and was less 
than that found in BIO—► BDF^ mice (76.3 “ 9*9 pm vs.
98.4 i 4.6 pm, p <0.05). At this time, both groups had a 
significantly increased CCPR compared with controls which 
was slightly more apparent in recipients of DBA/2 cells 
(18.9 - 2.2 vs. 15.9 - 1.8 for BIO— ► BDF^ mice and 9.12 - 1.4 
for controls, both p <0.05). No villus atrophy was found 
in Gvhr mice on day 7> but on day 14, mice given BIO cells 
had significant villus shortening compared with controls.
Mice given DBA/2 cells also had shorter villi than controls 
on day 14, but this was not statistically significant.
Mic© given BIO spleen cells on day 5 ol* life had marked 
intestinal changes at all times examined. Clear villus 
atrophy and crypt lengthening were directly present on day 
12 in these mice, although the small number of animals in
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the group prevented statistical analysis (Fig. 14 ).Crypt 
hypertrophy became more marked in these mice on day 17 
(l4-5»2 - 44 pm vs. 74.5 i 14 pm in controls, p < 0 .03) 
but had disappeared on day 24. Severe villus atrophy was 
still present at these times and on day 24 Gvhr mice had 
villus lengths of 399• 4 ± 100 pm compared with 624 ± 59 pm 
for controls (p < 0.03). On day 17, BIO— ► BDF1 mice also 
had an increased CCPR compared with controls (17.1 - 7.3 
vs 4.63 i 0.9). In comparison 3 day old mice given DBA/2 
spleen cells exhibited little evidence of intestinal Gvhr, 
with the only alterations being a small but insignificant 
rise in CCPR on day 17 (9*9 - 1*13) and some crypt lengthening 
on day 24 (126.1 - 35 pm vs» 109*4 - 1.4 pm). No villus 
atrophy was found at any time.
Therefore, if one day old neonates are used as hosts 
for the Gvhr, DBA/2 spleen cells are capable of inducing a 
destructive enteropathy which has an identical pattern to 
that produced by BIO parental cells. However, as in adult 
BDF^ mice, this was slightly less severe, and DBA/2 cells 
could not induce an acute, intestinal Gvhr in 3 day old 
neonates, despite the fact that BIO cells caused an acute 
Gvhr in both types of neonate.
Ability of BIO and DBA/2 parental mice to mediate systemic
DTH to BDF1 cells
The most consistent finding from this Chapter was that j
DBA/2 cells failed to induce severe systemic or intestinal j
Gvhr in mature hosts. As intestinal Gvhr has been j
associated with the development of anti-host DTH> X was j
j
r
i:
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interested to determine if the differences in Gvhr generated 
by C57Bl/lO or DBA/2 spleen cells were reflected in the DTH 
response of the parental strains to F^ spleen cells. BIO 
and DBA/2 mice were immunized with 10^ BDF^ spleen cells 
and 5 days later, both parental strains exhibited virtually 
identical DTH responses, as measured by the specific 2k hour 
increase in footpad thickness after challenge with BDF^ 
cells (Fig. 15A) (0.28 ± 0.12 mm and 0.29 - 0.07 mm in B10 
and DBA/2 mice respectively). This experiment was repeated 
three times with essentially identical results. Therefore,
B10 and DBA/2 mice do not generate different levels of DTH 
to F^ alloantigens.
Proliferative response of BIO and DBA/2 spleen cells to 
adult or neonatal BDF^ cells
In view of the fact that B10 and DBA/2 mice made 
equivalent DTH responses to BDF^ cells, it was of interest 
to determine whether an MLR would reveal differences in the 
ability of B10 and DBA/2 cells to proliferate in response to 
BDF1 stimulators. This approach also allowed me to examine 
whether the different types of Gvhr which developed in neonatal 
mice under 5 days old and in adult mice reflected differences 
in the ability of adult or neonatal BDF^ cells to stimulate 
an MLR by either type of parental cells.
B10 and DBA/2 parental spleen cells both responded well 
to adult BDF1 stimulator cells in vitro, but B10 cells 
responded markedly better than DBA/2 cells (Fig.l^B) S.I.
27 vs 11). Therefore, these results are consistent with 
the more severe Gvhr induced by B10 cells in vitro .
- 106 -
Neonatal BDF^ cells also induced an MLR response by 
parental cells, but this was considerably less than that 
obtained with the same cells stimulated by adult BDF.^  cells 
(Fig. 15B). As before, BIO parental cells proliferated 
markedly better than DBA/2 responder cells (s.I. 8 vs 2). 
These results show that neonatal cells are poor stimulators 
of an MLR.
Summary and conclusion
The results in this Chapter confirm and extend earlier 
work showing that BIO and DBA/2 donor cells have markedly 
different capacities to induce Gvhr in BDF^ mice. Injection 
of adult BDF^ mice with BIO parental spleen cells produced 
an acute lethal Gvhr which was characterised by weight loss, 
runting and a mortality rate of up to 80%. These features 
were preceded by a marked splenomegaly and an early transient 
activation of NK cells, but the subsequent development of 
specific anti-host CTL activity was accompanied by a decline 
of NK cell activity to levels below those in controls. At 
the same time, these mice developed evidence of active 
immunosuppression. BDF^ mice given BIO cells also had 
evidence of a severe intestinal Gvhr, with an early and 
intense crypt hyperplasia which was maintained until several 
weeks after induction. In addition, villus atrophy became 
a major feature of this model of Gvhr. The evolution of 
mucosal pathology was accompanied by an early fall in IEL 
count, which recovered for a time* only to decline to very 
low levels later.
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In contrast to this severe Gvhr adult BDF^ mice given 
DBA/2 spleen cells showed no clinical signs of Gvhr, did 
not lose weight and no mice died. Furthermore, there was 
prolonged splenomegaly and enhancement of NK activity in 
this model of Gvhr, hut there was no evidence of significant 
specific CTL activity and immunosuppression was not marked.
BDF1 mice given DBA/2 cells also show ed few features of 
intestinal Gvhr, with only mild and transient crypt hyperplasia 
and no villus atrophy or alterations in IEL count. In 
contrast to previous work (Gleichmann e_fc al. , 1984), my 
preliminary studies found no evidence of autoantibody 
production in DBA/2— r BDF^ mice.
A similar pattern of Gvhr was observed in 5 day old 
BDF^ neonates, where BIO parental cells induced an acute, 
lethal Gvhr associated with intense splenomegaly, specific 
CTL activity and loss of NK cell activity as well as a 
severe enteropathy which included villus atrophy. In 
contrast, DBA/2 cells induced little splenomegaly or changes 
in villus and crypt measurements, and none of the mice lost 
weight or died. In parallel, there was some enhancement of 
NK activity but no CTL activity and no loss of NK cell function. 
However, an important finding from these studies was that 
it proved possible to induce an acute Gvhr by injecting 
one day old BDF^ mice with either BIO or DBA/2 spleen cells.
Under these circumstances both parental cells produced a 
similar type of disorder with weight loss, runting and death.
They also developed similar levels of NK activity and crypt 
hyperplasia. Although significant CTL activity was only
j
i
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found in recipients of BIO cells, both groups of Gvhr 
mice developed villus atrophy. However, DBA/2 cells were 
less efficient than BIO cells at causing all these lesions.
The different abilities of BIO and DBA/2 cells to 
induce a Gvhr in BDF^ mice was not reflected by differences 
in the ability of the parental strains to generate a DTH 
response to adult BDF^ cells in vivo. However, BIO cells 
responded much better to both adult and neonatal BDF^ 
stimulator cells in a MLR in vitro. The contrasting types 
of Gvhr found in adult or older neonatal BDF^ mice given 
BIO or DBA/2 parental cells is consistent with the results 
of Gleichmann, who suggested that these differences reflected 
the generation of different forms of anti-host immune 
response. Nevertheless, my finding that DBA/2 cells were 
able to induce a similar, if less severe form of Gvhr in one 
day old neonates suggests that DBA/2 cells are merely less 
efficient at inducing the same type of alloreactivity in vivo 
and that this can be revealed in an immunoincompetent host.
Together, these results in unmanipulated adult hosts 
support these from earlier chapters by confirming that the 
development of specific CTL activity and a severe enteropathy 
involving villus atrophy are features of a more severe 
progressive Gvhr and that these are preceded by proliferative 
alterations such as activation of NK cells and crypt hyper­
plasia. In addition, these results further support the 
temporal association between the development of villus atrophy 
and cytotoxic T-cells. This phenomenon will be investigated 
further in the following chapters.
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Fig. 2 : Induction of systemic Gvhr in adult unirradiated
BDF-. mice with 10° BIO or DBA/2 spleen cells. 
Development of splenomegaly in mice with Gvhr^ 
Results are expressed as mean spleen indices - 
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Fig. k : Induction of systemic. Gvhr in adult, unirradiated
BDF.. mice with 10 BIO or DBA/2 spleen cells.
A) H ain graph shows absolute levels of NK activity 
in Gvhr and control mice while the inset B) shows 
the NK activity in mice with Gvhr expressed as a 
ratio to control levels. Results shown are °fo 
cytotoxicity at 50:1 E:T using spleen cells pooled 
from 3 mice/group.
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Fig. 5: Mixed lymphocyte responses of BDF1 mice
with Gvhr induced by BIO or DBA/2 spleen 
cells. Spleen cells were pooled for 4/5 
mice/group on days 3> 10 and 18 of the Gvhr 
or from controls and were stimulated with 
mitomycin c treated CBA spleen cells for 
4 days. Results shown are mean cpm/well 
i 1 s.d. and stimulation induces (Si) for 
quadruplicate assays.
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Fig. 7 s Induction of intestinal Gvhr in adult,
unirradiated l®Fi mice with 10 BIO or DBA/2 
spleen cells. Villus and crypt lengths in the 
jejunum of mice with Gvhr and in controls. 
Results shown are means - 1 s.d. for 4-5 mice/ 
group•
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Fig. 8 : Induction of intestinal Gvhr ig adult,
unirradiated BDF., mice with 10 BIO or 
DBA/2 spleen cells. A) CCPR and B) IEL 
counts in the jejunum of mice with Gvhr 
and controls. Results shown are the CCPR 
or mean numbers of IEL/lOO epithelial 
cells - 1 s.d. for 4-5 mice/group.
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Fig. 9 . Induction of systemic Gvhr in one day old BDF1
mice with 10^ BIO or DBA/2 spleen cells.
A) Growth rates of neonates with Gvhr compared
with littermate controls. B) Development of 
splenomegaly in Gvhr. Results shown are means 
- 1 s.d. for 6-7 mice/group for growth rate 
and 3 mice/group for spleen index.
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Fjg . 12: Induction of systemic Gvhr in 5 day old BDF^
mice with 10? BIO or DBA/2 spleen cells.
A) Growth rates of neonates with Gvhr compared 
with littermate controls. B) Development of 
splenomegaly in Gvhr. Results shown are means 
i 1 s.d. for 3-4 mice/group.
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Fig> 13: Induction of systemic Gvhr in 5 day old BDF
mice with 10? BIO or DBA/2 spleen cells. ^
A) Specific CTL activity. B) NK cell activity. 
Results shown are °fo cytotoxicity at 50:1 E:T 
for spleen cells pooled from 3-4 mice/group.
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Fig. 14: Induction of intestinal Gvhr in 5 day old BDF
mice with 10? B10 or DBA/2 spleen cells. 
Villus and crypt lengths in the jejunum of 
mice with Glvhr and in controls. Results shown 
are means - 1 s.d. for 4-5 mice/group.
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Fig. 15; A) Ability of BIO and DBA/2 mice to generate
systemic DTH to BDF^ spleen cells. DTH responses 
7 days after immunization with 2 x 10' F^ spleen 
cells and in controls. Results shown are increases 
in„footpad thickness 2k hours after challenge with 
10 BDF, spleen cells, for 6 mice/group. B) Mixed 
lymphocyte responses of BIO and DBA/2 spleen cells 
to mitomycin c treated spleen cells from adult or 
neonatal BDF, mice. Stimulator and responder cells 
were mixed at a 1*1 ratio and results shown are mean 
incorporation of TdR (cpm/well) for triplicate 
assays•
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CHAPTER 6 
ROLE OF HOST MECHANISMS
IN THE ENTEROPATHY OF GVHR
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Introduction
The results in Chapters 3 and 4 showed that irradiated 
or very young (CBA x BALB/c)F1 mice developed much more 
severe systemic and intestinal Gvhr than that found in intact 
adults of the same strain. These findings underline the 
importance of host immunocompetence in determining the outcome 
of a Gvhr and the aim of the following experiments was to 
try and identify some of the host factors involved. Both NK 
cells (Kiessling et al. , 1977; Dennert _et al. , 1985) and T- 
lymphocytes (Bellgrau & Wilson, 1978; Kimura & Wilson, 1984) 
have been implicated in protecting F^ hybrid animals against 
parental lymphoid cells. As the function of both NK cells 
and T-cells is deficient in neonatal and irradiated mice,
I decided to examine the effect of depleting NK cells and 
T-cells, on a Gvhr in adult, unirradiated (CBA x BALB/c)F^ 
mice.
The importance of host T-cells was investigated by 
inducing a Gvhr in athymic (CBA x BALB/c)F^ mice, while NK 
cell^ were depleted from normal (CBA x B A L B / c ^  mice by 
in vivo treatment with anti—asialo antibody (Kasai et al. ,
1980; Habu et al. , 1981; Beck et_ aT. , 1982).
The possible role of NK cells in Gvhr was examined 
further by augmenting NK cell activity in neonatal F^ mice 
by treatment with polyinosinic:polycytidylic acid.
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Experimental design
The role of host NK cells was examined in adult 
(CBA x BALB/cjFj^ hosts by injecting 0.2 ml 1:50 rabbit 
anti —asialo antiserum, 3 days before inducing a
Gvhr with 6 x 107 CBA spleen cells and then at 3-4 day 
intervals thereafter. Control mice were injected with 1:50 
normal rabbit serum and all groups were examined for both 
systemic and intestinal Gvhr.
In studies of the role of NK cells was also examined 
in neonatal (CBA x BALB/c)F^ mice which had been given 107 
parental spleen cells at 2 days of age and were then treated 
with *5” pg/g poly I:C i.p. on days 7 and 10 of the experiment. 
These mice were examined for systemic and intestinal Gvhr 
on days 9 and 12.
The role of host T-cells was examined by inducing a 
Gvhr in athymic nude (CBA x BALB/c)F^ mice with 6 x 10 CBA 
spleen cells* and these mice were sacrificed on days 4, 11*
17 and 27. The Gvhr was then compared with that found in 
control hosts given the same inoculum of donor cells.
Results
Induction of a Gvhr in NK cell depleted adult (CBA x BALB/c )F  ^
mic e
Progress of systemic Gvhr
The effects of anti-asialo GM1 on Gvhr were studied m  
four separate experiments and none of the mice with Gvhr 
showed any clinical evidence of weight loss, skin disease 
or diarrhoea. In the experiment shown NRS-treated hosts
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with Gvhr had marked splenomegaly by day 4 and this rose to 
a peak of 2.84 - 0.6 on day 8 (Fig. 1A ) before declining 
thereafter. Although anti-asialo treated mice with Gvhr 
showed a similar pattern of splenomegaly, those animals had 
lower spleen indices throughout the Gvhr, with a maximum 
of 1.70 i 0.50 on day 8 (p < 0.05 vs intact Gvhr).
As in previous studies, normal hosts with Gvhr had 
enhanced spleen NK cell activity compared with appropriate 
controls (Fig. IB). The enhanced NK cell activity paralleled 
the development of splenomegaly and peaked on day 8 (50:1 :
48% vs 33% in controls). The efficacy of the anti-asialo 
G^i treatment was substantiated by the markedly reduced NK 
activity in control mice treated with the antibody, which 
was always less than that of normal controls. Induction of 
a Gvhr in these mice also produced an increase in NK activity 
which peaked on day 11. However, these levels were considerably 
less than in intact mice with Gvhr and did not even attain 
those found in normal control (CBA x BALB/c )F^ mice.
Specific anti-host CTL activity was never found in any 
Gvhr mouse. (Results not shown).
Intestinal phase of Gvhr in NK cell-depleted hosts
The intestinal phase of Gvhr was assessed on day 11 by 
counts of I EL and by measurements of mucosal architecture
in sections of jejunum.
As has been found previously in this model (Mowat & 
Ferguson, 1981b), NRS treated (CBA x BALB/c )Fjl mice with 
Gvhr had a significant increase in IEL count compared with
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controls (Fig. 2 ) (19.4 + 2.2 vs 13.5 1 1.7, p < 0.05).
Although control mice given anti-asialo G-.-. had a slight,
Ml
but significant, reduction in I EL counts compared with 
normal controls (10.2 ± 2.1 vs. 13.5 ± 1.7, p < 0.05), 
induction of a Gvhr in anti-asialo treated mice still led 
to an increase in IEL counts approaching that found in 
normal mice with Gvhr (18.0 - 2.8).
NRS-treated (CBA x BALB/c)F^ mice with Gvhr also had 
significant increases in both CCPR (Fig. 3 ) (22.9 ^ 4.5 
vs. 10.3 - 1«1> p < 0.025) and in crypt length (l4l.9 - 5*8 pm 
vs. 111.1 - 5.7 pm, p < 0.001) compared with controls. Villus 
atrophy was not found in these adult mice with Gvhr. In 
contrast to these findings, anti-asialo treated mice with 
Gvhr had CCPR and crypt lengths which were identical to 
those found in appropriate controls. Again no villus atrophy 
was found. It was also of interest to note that both groups 
of. mice which were treated with anti-asialo antibody had 
significantly longer crypts than normal controls (126.6 —
3.8 pm vs. 111.1 - 5.7 p < 0 .025) > as well as a slightly
increased CCPR.
Thus, treatment of mice with anti-asialo does not
prevent the increased infiltration by IEL which occurs 
during a Gvhr in unirradiated (CBA x BALB/c)F^ mice, but 
abolishes the crypt hyperplasia which usually characterises
the intestinal lesions.
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Effects of anti-asialo G^  on specific CTL and DTH activity
Although repeated injections of anti-asialo G,„ produced
Ml
clear depression of NK activity in vivo, it was also necessary
to exclude the possibility that the prevention of intestinal
and systemic Gvhr was due to effects on other aspects of
cellular immunity. In the first experiment, the effects of
anti-asialo on CTL activity was examined in CBA mice which
had been immunised with 3 x 10^ P815 (H-2d) cells i.p.
Eleven days after immunisation, normal CBA mice had significant
levels of splenic CTL activity, but this was much reduced
in mice which had been treated with anti-asialo G ^  antibody
(Fig. 4A ). Allospecific DTH activity was examined by
immunizing CBA mice with (CBA x BALB/c)F^ spleen cells into
one footpad. When these mice were challenged 3 days after
immunization, there was no difference between the DTH
responses generated in NRS or anti-asialo treated mice (Fig. 4b ).
Thus anti-asialo G,,. inhibits generation of CTL in vivo >Ml
but has no effect on DTH responses.
The results of these experiments show that depletion 
of NK cells decreases the severity of Gvhr. Together with 
the enhanced NK cell activity found in mice with Gvhr, 
these results suggest that NK cells may act as effector cells 
in the intestinal phase of a Gvhr, in unirradiated adult F± 
mice. However the anti-asialo GM1 treatment had a similar 
inhibitory effect on CTL activity and so it was important 
to study the potential role of NK cells in more detail. 
Therefore, I examined whether selectively boosting NK 
activity during a Gvhr would induce a more severe intestinal
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Gvhr. Poly I:C is a potent activator of NK cells in vivo, 
by virtue of its ability to induce interferon production 
(Djeu et al_. » 1979) and this was chosen as a means of 
examining further the role of NK cells in Gvhr.
Influence of poly I:C on a Gvhr in neonatal (CBA x BALB/c)F1
mice
Neonatal mice were chosen as hosts in these experiments, 
partly because of the small amount of poly 1:C available 
and partly because it was anticipated that they would be 
more sensitive to small changes in the effector cell function.
Preliminary experiments were first conducted in adult 
(CBA x BALB/c)F^ mice to establish the pattern of NK cell 
activation which occurred after injection of poly I:C. These 
studies showed that mice given 100 pg poly IsC had elevated 
levels of NK activity within 24 hours and these continued to 
increase at 48 and 72 hours before declining (Data not 
shown) • Therefore in the experiments examining a Gvhr in 
neonatal hosts? mice were treated with poly I:C 24 hours 
before inducing a Gvhr and then on days 7 and 10 of the
experiment around the time when the onset of a destructive
Gvhr was anticipated.
7
Two day old (CBA x BALB/c)F1 mice were injected with 10 
CBA spleen cells and both groups of mice with Gvhr developed 
weight loss and runting about day 9- Most of the mice with 
Gvhr died by day 18 and there was no difference m  the 
mortality rate (Fig. 5A) . Nevertheless, mice treated with
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polyljC had consistently more weight loss than untreated 
littermates at all times after day 8 of the Gvhr, although 
this did not reach statistical significance. There was 
no significant difference in weight between polyljC treated 
control mice and untreated controls, and no polyljC 
treated mice died. Both groups of Gvhr mice had significant 
splenomegaly on days 9 and 12 of the Gvhr and there was no 
significant difference between the spleen indices in the 
two groups of mice at either time (Fig. 5B).
Anti-host specific cytotoxicity was virtually undetectable 
on day 9 but by day 12 untreated mice with Gvhr had moderate 
levels of CTL activity, which was greater than that found in 
mice which had received polyljC (Fig. 6 ) (8.3% vs. 2.7%)«
As expected, virtually no NK activity was found in normal 
control mice at either time. However, some NK activity was 
detectable on day 9 I*1 control mice given poly I:C (Fig. 6) 
(2.8% vs. 0 .4% in controls) and similar levels were still 
present on day 12 (3.6% vs. 1.2% in controls). Gvhr mice 
treated with polyl. :C had markedly increased NK cell activity 
on day 9 (10.9%) and there was still some NK cell activation 
on day 12 (3 .6%). In comparison, although untreated mice 
with Gvhr had increased NK cell activity compared with 
appropriate controls, at both times these levels were less 
than those in polyljC treated Gvhr mice (l.4% and 3%) •
Thus poly IsC increased the NK cell activation found 
in Gvhr and there was some evidence that it also produced 
a more severe systemic disease. However, the generation 
of CTL activity in Gvhr was decreased by poly I:C.
- 132 -
°f Poly on the development of intestinal Gvhr
By day 9 of the experiment untreated mice with Gvhr 
had developed significant villus atrophy (493.4 ± 13 pm vs.
5^5»3 — 1 pm in controls, p < 0.001) and crypt hypertrophy 
(90.6 - 6 pm vs. 37.2 - 6 pm in controls, p < O.OOl) (Fig. 7). 
Similar features were found in Gvhr mice given poly I:C, but 
these mice had more severe intestinal damage with significantly 
shorter villi and longer crypts than untreated mice with Gvhr 
(384.9 — 11 p < 0.001 and 137*0 — 16 pm, respectively,
p < 0.001). Furthermore, whereas untreated Gvhr mice had a 
lower CCPR than controls at this time (Fig. 7 ) (4.6l - 0.30 
vs. 8.8 i 4.1). Poly I:C treated mice with Gvhr had a very 
marked increase in CCPR (26.4 - 3*02 vs. 4.75 - 1*63> 
p < 0.001). Poly I:C itself had no marked effects on mucosal 
architecture, although poly I:C treated controls appeared to 
have slightly shorter villi and longer crypts than untreated 
controls. A similar pattern of results was found on day 12, 
with more severe villus atrophy and crypt hypertrophy in 
poly I r C treated mice with Gvhr (Fig. 7 )• Insufficient 
mice remained at this stage of the experiment to examine CCPR.
Effects of activated adult NK cells on syngeneic neonatal ..mice 
These results suggested that poly IsC exacerbated the 
intestinal phase of Gvhr in neonatal (CBA x BALB/c)F1 mice 
and this was not accompanied by an increase in specific CTL 
activity. Therefore, the most likely interpretation was that 
non-specific activation of NK cells was responsible for the 
intestinal damage. If this were the case, it might be anticipated
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that poly IsC activated NK cells themselves might produce 
some intestinal pathology. Although this idea was supported 
by the alterations in mucosal architecture found in some 
poly I : C treated control neonates, these were minor and 
inconsistent and so I examined the possible role of activated 
NK cells in more detail by examining the intestine of adult 
(CBA x BALB/c)F1 mice in whom poly IsC had induced a large 
rise in NK activity. In addition, I investigated whether 
spleen cells from poly IsC treated mice would cause intestinal 
changes in syngeneic neonatal recipients.
Adult (CBA x BALB/c)F^ mice were given two daily doses 
of 100 pg poly IjC i.p. and sacrificed 48 hours after the 
second dose. At this time, the splenic NK activity of these 
mice was 58.4% compared with 9*2% in untreated controls (Fig. 8a) . 
Although these mice had minor villus shortening (Fig. 8b)
(579*0 - 4.0 pm vs. 616.5 i 21 pm) and longer crypts 
(IO6.3 i 13 pm vs. 84.7 - 9 pm) compared with control mice, 
these differences were not significant and poly I:C had no 
effect on the CCPR.
The effect of poly IsC treated donor cells was then
<7
examined by transferring 2.5 x 10 spleen cells from these 
adult donors into syngeneic 2 day old mice. When these hosts 
were sacrificed 48 hours later, they showed a small increase 
in CCPR compared with that in mice given normal adult spleen 
cells (Fig. 8C). However, the CCPR was very low in all 
groups and this difference was not significant. No other 
changes in mucosal architecture were noted and together, 
these experiments provided little conclusive evidence that 
NK cells, themselves, could induce intestinal pathology.
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Induction of Gvhr in athymic (CBA x r a t .b /c Ip  m l c e  
Progress of systemic Gvhr
Two separate experiments were performed to compare the 
Gvhr in normal and athymic hosts. All the mice remained 
w d l  throughout, with no evidence of runting or diarrhoea. 
The progress of systemic Gvhr was assessed in the first 
experiment and the results are shown in Figure 9 • The 
Gvhr in euthymic hosts followed a prolonged course with 
moderately intense splenomegaly from days 4-27 and, at each 
time after day 4, athymic mice with Gvhr had more severe 
splenomegaly than the corresponding euthymic hosts. The 
small number of athymic mice available, normally precluded 
statistical analysis, but in the groups studied on day 11, 
athymic mice had significantly greater splenomegaly than 
intact hosts (2.55 - 0.45 vs. 1.30 - 0.47 in controls,
p < 0 .0 2 ).
Splenic NK and CTL activity was measured throughout 
the Gvhr. As in other experiments using this model, an 
elevated level of NK activity was found during the first two 
weeks of Gvhr in euthymic (CBA x BALB/c)F^ mice and this 
peaked on day 11 of the experiment before returning to 
control levels thereafter (Fig.lOA). Compared with normal 
(CBA x BALB/c)F1 mice control nude mice had extremely high 
levels of spleen NK activity, confirming earlier studies 
(Mowat et al., 1983). However, in contrast with enhanced 
NK activity found in euthymic hosts, nude mice with Gvhr 
had lower levels of NK activity than athymic controls at all 
times of the Gvhr. This suppression was most marked on day 
15 (Fig.lOA! 12.8% vs. 53?» in nude controls). In parallel,
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nude mice with Gvhr, had low, but consistent levels of 
specific anti-host CTL on days 11-27> while intact mice 
with Gvhr never showed significant CTL activity (Fig. 10B).
CTL activity in nude mice with Gvhr reached a peak of 7.5% 
on day 11 and as found in previous chapters this seemed to 
be associated with the marked loss of NK activity in these 
mice.
Intestinal phase of Gvhr in athymic (CBA x BALB/c)F-l mice 
In the second experiment, intestinal pathology was 
examined in euthymic and athymic (CBA x BALB/c)F^ mice on 
day 11 of the Gvhr, as this was around the time of maximal 
systemic Gvhr in the nude mice used in experiment 1.
At this time, intact mice with Gvhr had an increased 
IEL count compared with controls (Fig. 11 ) (21.3 - 1*2 vs.
16.8 i 2.0, p < 0.02). As reported previously (Ferguson & 
Parrott, 1972), control nude mice had very low IEL counts 
compared with intact controls (5*0 ~ 0«7> p < 0.005) but 
a Gvhr led to a significantly increased IEL count in athymic mice 
with Gvhr (9.8 ± 1.4, p < 0.001 vs. nude controls). However, 
the IEL count in these mice did not even approach the levels
found in control euthymic mice.
In this experiment, fixation difficulties prevented 
measurement of the CCPR in euthymic F1 mice, but intact Gvhr 
mice had a significant increase in crypt length compared
with controls (Fig. 12 ) (141-5 1 5-5 vs. 123-3 ± 8 . 8  pm,
p < 0 .005) and previous studies indicate that there would 
also be an increase in CCPR under these conditions. As usual 
there was no evidence of villus atrophy in this model of
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Gvhr. In contrast, athymic F1 mice with Gvhr not only had 
very large increases in both CCPR (27.1 ± 0.7, p < 0.001) 
and crypt length (18O .9 - 9.8 pm, p < 0 .001) compared with 
athymic controls (7.6 ± 0.6 and 101.7 ± 1.8 pm respectively) 
but they also had significant villus atrophy (659.4 - 75.0 pm 
vs. 804.3 - 10.2 pm, p < 0.001). It was also interesting 
to note that athymic control mice had significantly reduced 
crypt lengths compared with normal controls (p < 0 .005).
Thus athymic mice not only develop more severe spleno­
megaly and proliferative intestinal pathology during a Gvhr 
but also have evidence of a more destructive disease as 
shown by the development of villus atrophy and CTL activity 
and suppression of NK cell activity. Interestingly, the 
acute Gvhr in adult, athymic mice had the same features of 
the destructive disease described in earlier chapters.
Summary and conclusions
These results confirm that the systemic and intestinal 
consequences of Gvhr can be altered by manipulating the 
immunocompetence of host mice.
Treatment of adult (CBA x BALB/c )F^ mice with anti-
asialo reduced their NK activity and inhibited the
Ml
development of the splenomegaly and NK cell activation found 
in normal F1 mice with Gvhr. Furthermore, anti-asialo-treated 
mice had slightly lower IEL counts than controls and although 
these rose during Gvhrs, anti—asialo—treat ed mice did not 
develop any of the alterations in intestinal architecture 
normally associated with Gvhr. Control experiments also 
showed that treatment of CBA mice with anti-asialo Gm  antibody
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reduced the generation of allospecific CTL, but had no 
effect on the generation of DTH responses to F^ cells.
These findings show clearly that NK cells do not protect 
the host from Gvhr induced intestinal lesions, but rather 
may play a pathogenic role in the Gvhr.
Compl mentary studies in neonatal (CBA x BALB/cjFj^ 
provided some support for this idea by showing that 
augmentation of NK activity with poly IsC produced more 
severe intestinal damage in mice with Gvhr as well as a 
slightly more severe systemic disease. This effect of poly IsC 
was paralleled by a greater enhancement of NK activity than 
that found in untreated Gvhr mice, but poly IsC reduced the 
generation of anti-host CTL activity.
Some evidence was also obtained that poly IsC itself 
produced minor degrees of villus atrophy and crypt hyperplasia 
in normal adult and neonatal mice. However, it proved 
impossible to induce intestinal damage by transferring 
activated NK cells from poly IsC treated mice and the 
pathogenic role of NK cells requires further confirmation.
The effect of host T-lymphocyte depletion was investigated 
using athymic adult (CBA x BALB/c)F^ mice. In comparison 
with intact (CBA x BALB/cjF^ hosts athymic mice developed 
a much more severe Gvhr, with more intense splenomegaly and 
crypt hyperplasia. In addition, nude mice with Gvhr had 
suppressed NK cell activity, which contrasted with the NK 
cell activation found in normal hosts. In parallel, only 
athymic hosts developed specific CTL activity as well as 
villus atrophy in Gvhr. These features are therefore similar
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to those found during an acute Gvhr in early neonatal 
(CBA x BALB/c)F^ mice and suggest that host T cells normally 
protect intact adults from the most severe consequences of 
a Gvhr.
In conclusion, the results in this chapter suggest that 
host T-cells protect recipient mice against Gvhr, while the 
non-specific activation of host NK cells plays a pathogenic 
rather than a protective role.
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Fig. 1 : Effect of anti-asialo GM1 on NK cell
activity during a Gvhr m  adult unirradiated 
(CBA x BALB/c)F^ mice. A) Assessment of 
spleen index in anti-As G ^  and intact 
Gvhr mice. B) NK Activity m  anti-AsGM1 
and intact Gvhr mice? compared with 
appropriate controls. Results shown are 
means - 1 s.d. for 3 mice/group. Cytotoxicity 
results are 50:1 E:T for spleen cells 
pooled from 3 mice/group.
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Fig. 2: Effect of anti-asialo GM1 on the intestinal
phase of Gvhr in unirradiated adult (CBA x 
BALB/c)F1 mice. IEL counts in the jejunum 
of NRS - or anti-AsGM1 treated mice on day 11 
of the Gvhr and in appropriate controls. 
Results shown are the mean numbers of IEL/lOO 
epithelial cells - 1 s.d. for 4-5 mice/group.
- 141 -
control
Gvhr
Anti-AsG, cont
8001
Anti-AsGM1 Gvhr
600
Day 11200-
Fig, 3: Effect of anti-asialo GM1 on the intestinal
phase of Gvhr in unirradiated adult (CBA x BALB/cjF^^ 
mice. Mucosal architecture in the jejunum of NRS 
or anti-AsGM1 treated mice on day 11 of the Gvhr, 
and in appropriate controls. Bars represent mean 
villus and crypt lengths - 1 s.d., and arrows 
show CCPR for 4-3 mice/group.
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CTL and DTH responses. AJ Specific anti- 
H-2d CTL activity in spleens of NRS or anti- 
AsGM1 treated mice, 11 days after immunization 
with 10^ P8l5 (H-2d) tumour cells i.p.
Results are the percentage lysis of P815 
targets at different E:T ratios, using spleen 
cells pooled from 3 mice/group. B) Anti-H-2d 
specific DTH responses in NRS or anti As G  ^
treated CBA mice, measured 7 days after 
immunization with (CBA x BALB/c)F^ spleen cells 
Results shown are mean specific increments in 
footpad thickness - 1 standard deviation, 24 hr 
after intradermal challenge with 10 F1 spleen 
cells for 6 mice/group.
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Fig. 5: Effect of § V-s/S poly IsC on systemic Gvhr
in 1-2 day old neonatal (CBA x BALB/c)F mice.
A) Growth rates of Gvhr mice which had been 
treated with poly IsC or NaOH on days 7 and 10, 
and of appropriate controls. B) Development of 
splenomegaly in poly 1:0 and NaOH treated mice 
with Gvhr. Results shown are means - 1 s.d. 
for 3 mice/group for body weight and 3 mice/group 
for spleen index.
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rj-g- T
TCffects of poly IsC on the intestinal phase 
of Gvhr in 1-2 day old neonatal (CBA x BALB/c)F1 
mice. Mucosal architecture in the jejunum of 
polv I:C or NaOH treated mice on days 9 and 12 
o? the Gvhr, and in appropriate controls. Bars 
represent mean villus and crypt lengths - 1 s.d. 
and arrows show CCPR for k mice/group.
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Fig. 8 Effects of poly I:C activated adult NK cells 
on mucosal architecture in syngeneic neonatal 
mice. A) NK activity in adult (CBA x BALB/c)f 
mice, which were sacrificed 48 hours after the 
second daily dose of poly I:C, and in appropriate 
controls. B) Mucosal architecture in adult (CBA x 
BALB/c)F^ mice as 8A). C) Mucosal architecture 
in the jejunum of 2 day old neonatal (CBA x BALB/c) 
F, mice given control or poly I:C treated syngeneic 
adult NK cells, and in appropriate controls. Bars 
represent mean villus and crypt lengths - 1 s.d., 
and arrows show CCPR for 4-5 mice/group. Cyto­
toxicity results are shown at different E:T ratios 
using spleen cells pooled from 5 mice/group.
C
C
P
R
Sp
le
en
 
i
n
d
e
x
-  147 -
2 -
1 '
•--- •* Gvhr
 ----   nu-Gvhr
o'
I .
T
\
"'A*
X p<0.005
12
- W  k -  
16 27
Day of Gvhr
Progress of systemic Gvhr in athymic (nu/nu) 
and intact (CBA x BALB/c)F1 mice. Results shown 
are mean spleen index for two mice/group at intervals 
after transfer of 6 x 10^ CBA spleen cells i.p. 
(intact Gvhr, 6 mice/group).
% 
c
y
t
o
t
o
x
i
c
i
t
y
U •
-  148 -
x x cont
•—  Gvhr 
a * nu-cont
a— _ -o nu-Gvhr
activity
•HO•HKO4-)O
u
20
8 76
Day of Gvhr 
CTL
Gvhr 
-o nu-Gvhr
/ V
/
/ x
/ N
/
/
/
/
8
Day of Gvhr
72 76
A ?  b 
~ ll~21
Fig. 10: Specific , anc} npn-specific cytotoxicity ,ip.
a thymic (nu/nu) and intact (CBA x BALB/c)F
mice with Gvhr. A) NK activity and B) CTL
activity against YAC-1 and P815 target cells
respectively. Cytotoxicity results are
50:1 E:T for spleen cells pooled from 3 mice/
group•
IE
L/
10
0 
E
p
i
t
h
e
l
i
a
l
 
c
e
l
l
s
-  149 -
20
cont Gvhr nunu
4  p<0.02
*  *  p<0.001
cont Gvhr
Fig. 11: Intestinal phase of Gvhr in athymic (nu/nu)
and intact (CBA x BALB/c)F, mice. IEL 
counts in jejunum on day IX of Gvhr, expressed 
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for 4-5 mice/group.
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CHAPTER 7 
GENETIC AND CELLULAR BASIS
OF INTESTINAL GVHR
- 152 -
Introduction
The results in the preceding chapters have shown 
that there are two forms of intestinal Gvhr, and these may 
be associated with different effector mechanisms. One 
possible means of investigating these mechanisms further 
would be to study the phenotype of the donor T cells 
responsible for inducing the intestinal Gvhr and to examine
its genetic basis. This concept is supported by the work of
G1 eichmann et al. on systemic Gvhr which showed that an SLE- 
like proliferative Gvhr is mediated by Lyt l+2~-T-cells and 
is stimulated by class II MHC antigens, whereas an acute, 
lethal Gvhr required activation of both Lyt l+2+ and Lyt l+2~
T cells by a combination of class I and class II alloantigens.
(Rolink & Gleichmann, 1983)* Although these workers did not 
examine the intestine,earlier studies in our own laboratory 
showed that a proliferative enteropathy in unirradiated mice 
is due mainly to Lyt l+2“ T-cells and was entirely class II 
MHC restricted (Mowat et al • , 1986).
However, these latter studies did not investigate a 
Gvhr which involved villus atrophy. Furthermore it is now 
known that the Lyt 1 antigen is expressed on virtually all 
mouse T— lymphocytes (Ledbetter et al. , I9S0 ), and is therefore 
not a reliable marker of functionally distinct subsets.
This difficulty can be overcome using antibodies to the L3T4 
antigen, which is expressed only on class II restricted T- 
cells and defines a population of T-cells which does not 
overlap with that carrying the Lyt 2 antigen (Dialynas et al. ,
1983).
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Thus, the experiments in this chapter used anti-Lyt 2 
L3T4 monoclonal antibodies and MHC congenic mice to 
examine the cellular and genetic basis of proliferative 
and destructive intestinal Gvhr.
Experimental design
The ability of T-cell subpopulations to induce different 
forms of Gvhr was investigated by depleting donor spleen 
cells of L3T4+ or Lyt 2 + T-cells using monoclonal antibodies 
and complement. These cells were then used to induce a Gvhr 
in irradiated or unirradiated adult (CBA x BALB/c)F^ mice, 
or in neonatal (CBA x BALB/c)F^ mice of different ages. As 
usual the development of systemic and intestinal Gvhr was 
then followed by measurements of splenomegaly, NK and CTL 
activity and of mucosal architecture.
In the second part of this Chapter, the genetic basis 
of acute intestinal Gvhr was studied in 1 day old neonatal 
F^ mice which had been bred from parents which differed at 
selected regions of the MHC.
Results
Induction of systemic Gvhr in adult unirradiated (CBA x BALB/c)F.^ 
mice with T-cell sub-populations
In the first experiments using different T-cell sub­
populations a proliferative Gvhr was induced in adult, 
unirradiated (CBA x BALB/c)F1 mice with 6 x 10^ CBA spleen 
cells. Before transfer, the donor spleen cells were treated 
with either anti-Lyt 2 or anti-L3T^ (GK1.5) antibodies plus 
complement, or were left untreated.
- 15^ -
Progress of systemic Gvhr
Mice were sacrificed on days 5 and 10 of Gvhr, when 
recipients of untreated spleen cells had significant 
splenomegaly (Table l) (Spleen Indices: 1.46 - 0.13 and
1.31 - 0.15 on days 5 and 10 respectively). Recipients 
of L3T4 cells had greater splenomegaly than that in control 
Gvhr mice on day 5 (l.68 - 0.12), but by day 10, this had 
fallen to 1.10 - 0.09* Lyt 2 donor cells induced splenomegaly 
which was similar to that in recipients of untreated cells 
on day 5 (l«48 - 0.08), but by day 10, this was much less 
than in intact Gvhr mice.
As anticipated, recipients of untreated spleen cells 
had enhanced splenic NK activity compared with controls on 
day 5 (Fig. l) vs. 2 6 .1 % 50:1 E:T), but this had
fallen almost to control levels by day 10. Interestingly, 
recipients of either L3T4 or Lyt 2 donor cells had NK 
levels which were considerably higher than those in untreated 
Gvhr mice on both days 5 and 10. This was most marked in 
recipients of Lyt 2 cells, whose splenic NK activity was 
extremely high compared with all other groups at both times. 
None of the animals with Gvhr developed specific CTL 
activity during the Gvhr (data not shown).
Development of intestinal pathology
The intestinal phase of Gvhr was also examined in the
same groups of mice given untreated or T—cell depleted
spleen cells. Mice given untreated donor cells had
significantly longer crypts than controls on both day 5 
and day 10 of the Gvhr as well as marked increases in CCPR
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(Table 2). Although mice which received L3T4“ cells also 
had significantly longer crypts and a higher CCPR than 
controls on day 5> these changes were less than those found 
in recipients of untreated cells, and had returned to control 
values by day 10. Mice given Lyt 2” cells had only minor 
and insignificant increases in crypt lengths and CCPR, 
compared with controls on day 5« Nevertheless by day 10, 
these mice with Gvhr had increases in both crypt length and 
CCPR, which were similar to those in recipients of intact 
donor cells.
In parallel, recipients of intact donor cells had a 
moderate increase in IEL count on day 10 compared with controls 
(Table 3) (18.25 - 4.8 vs. 13*4 i 0). In contrast, mice 
receiving L3T4 or Lyt 2~ donor cells did not have a significant 
increase in IEL counts at this time of the Gvhr. None of the 
Gvhr mice had increased IEL counts on day 5 Gvhr.
The results obtained from these experiments indicate 
that both L3T4+ and Lyt 2+ cells are required to induce the 
intestinal changes normally seen in irradiated mice with 
Gvhr. However, both L3T4 and Lyt 2 populations induce 
some systemic changes during Gvhr, and both induced very 
high levels of NK cell activation.
Induction of Gvhr in irradiated (CBA x BALB/c)F1 mice with
T-cell subpopulations
In the next experiment, the ability of T-cell subsets 
to induce an acute destructive, Gvhr was studied by injecting 
irradiated (CBA x B A L B / c ^  mice with 2 x 107 untreated,
L3T4“ or Lyt 2~ CBA spleen cells.
Progress of systemic Gvhr
Mice which received untreated CBA spleen cells rapidly 
developed Gvhr and all died within 8 days after cell transfer 
(Fig. 2). Recipients of Lyt 2“ cells also lost weight and 
runted rapidly and the majority had died by day 10. Only 
a small proportion of this group survived indefinitely. In 
contrast, most mice receiving L3T4 cells showed few signs 
of acute Gvhr and 40°/o of these mice survived beyond day 36 
of the experiment. Thus, depletion of L3T4+ cells significantly 
reduced the capacity of donor spleen cells to induce a lethal 
Gvhr in irradiated F^ mice. Insufficient numbers of mice 
were available in this experiment to obtain enough cells to 
study the generation of cytotoxic effector cells.
Development of intestinal pathology
Small intestinal changes were examined on day 6 of 
Gvhr, before recipients of untreated donor cells showed 
overt signs of clinical Gvhd. In this way, it was hoped 
to be able to examine the intestinal Gvhr when components 
of both proliferative and destructive enteropathy would be 
apparent.
At this time, mice which received untreated donor cells 
had significant villus atrophy (Fig. 3) (316*9 - 58.7 V<m vs*
664.1 ± 60.1 pm in controls, p < O.OOl) and crypt lengthening 
(142.8 ± 13.1 pm vs. 111.0 ± 6.56 pm in controls, p < 0.05). 
However, as was found at later stages of the Gvhr in irradiated 
mice in Chapter 3> "lice with Gvhr in the present experiments 
had a CCPR which was slightly less than control values. In
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contrast, no significant change in villus height was found 
in mice which received either L3T4" or Lyt 2“ spleen cells, 
but both these had significant crypt lengthening compared 
with controls (14-3.8 ± 8.7, p < 0.005 and 154.0 - 28.1 
p < 0 . 0 5  respectively). Recipients of both L3T4~ and Lyt 2~ 
cells did not have suppressed CCPR, but actually had crypt 
cell mitotic activity which was similar to, or greater than 
that found in controls.
These results suggest that both L3T4 and Lyt 2 cells 
are required to induce destructive intestinal pathology 
during a Gvhr across a full MHC incompatibility in irradiated 
mic e.
Induction of Gvhr in neonatal mice of different ages with 
T-cell subpopulations
The findings described above indicate that both L3T4+ 
and Lyt 2+ T-cells are required to induce an intestinal Gvhr 
which involves villus atrophy. However, the mortality due 
to Gvhr appeared to be predominantly due to L3T4 cells and 
so I thought it was important to confirm these results in 
another model. Furthermore, it would be of interest to 
examine whether depleted populations of donor T cells induced 
different forms of cell mediated effector functions. Therefore 
the experiments described below investigated the role of T— 
cell subpopulations in inducing systemic and intestinal Gvhr 
in neonatal mice of different ages. This approach allowed me 
to compare directly the cellular basis of proliferative 
and destructive Gvhr in the same model.
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Progress of systemic Gvhr in one day old (CBA x BALB/c)F1 hosts
As described in previous chapters, (CBA x BALB/c)F mice 
7given 10 untreated CBA spleen cells on day 1 of life began 
to runt by day 8 (Fig. 4a) and by day ^ two of the mice had 
died. In this experiment, 4 mice from each group were 
sacrificed on day 11, and therefore very few mice could be 
followed in later stages of the Gvhr. However, the one 
remaining mouse in the group given untreated spleen cells 
died on day 15» Mice receiving L3T4” cells also lost weight 
and had a similar runting syndrome to that found in recipients 
of untreated cells. This was particularly noticeable in the 
remaining mouse which remained in this group after day 11.
In contrast, recipients of Lyt 2 spleen cells grew and 
developed at an identical rate to control mice and showed 
no evidence of runting disease.
Mice from all these groups were assessed for splenomegaly 
on day 11 of Gvhr, when recipients of untreated spleen cells 
had a spleen index of I .38 - 0.27. Although recipients of 
L3T4 cells also had splenomegaly at this time (S.I. 1.30 - 
0.14) recipients of Lyt 2 cells had no splenomegaly compared 
with controls (S.I. 0.90 — 0.10). Thus, Lyt 2 cells appear 
to be essential for systemic Gvhr in 1 day old neonates.
As before, neonatal hosts of this age given untreated 
spleen cells, developed low, but consistent CTL activity on 
day 11 of the Gvhr (4.2%). Depletion of either L3T4 or 
Lyt 2+ T cells abolished the ability of donor spleen cells 
to induce CTL activity in Gvhr mice (Data not shown). Thus 
both Lyt 2+ and L3T4 + cells were required to induce anti-host
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CTL, despite the fact that only Lyt 2 cells were required 
for systemic disease.
When NK activity was examined in these mice on day 11 
very low levels were found in control mice as usual.
Increased levels of NK activity were found in mice given 
untreated donor cells (Fig. 4b ) (4.8% vs. 0.6% at 50:1 E:T).
As seen in adult unirradiated mice, very high levels of NK 
activity were found in mice given either L3T4~ or Lyt 2- 
cells (l6.6% and 15*3°f° respectively at 50:1 E:T).
Development of intestinal pathology in one day old mice with Gvhr
As anticipated, the mice given untreated spleen cells 
had markedly longer crypts and shorter villi than controls 
on day 11 of Gvhr (Fig. 5) (13^*9 ~ 23*0 pm and 325*0 - 14.1 pm 
respectively vs. 47*5 “ 8 pm and 622.4 - 36.0 pm in controls).
In contrast, no significant changes in villus or crypt lengths 
were found in recipients of L3T4 or Lyt 2 donor cells, 
although there was some evidence of a minor degree of crypt 
lengthening in both groups, as well as villus atrophy in 
mice given L3T4 cells (Fig. 5)* Insufficient mice were 
available for estimation of CCPR in these groups.
Only very low numbers of IEL were found in the very 
young mice used in this experiment and none of the group 
with Gvhr had a significant increase in IEL count on day 11 
of the Gvhr (Table 3)*
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Induction of Gvhr in 5 day old (CBA x BAI.B/r^ mice with 
T-cell subpopulations 
Progress of systemic Gvhr
Neonatal mice given parental cells at 5 days of age 
showed no significant differences in growth rate compared 
with control mice, irrespective of the nature of the donor 
cell population (Fig. 6a ) • However, as found in previous 
experiments, recipients of untreated spleen cells showed a 
minor degree of weight loss by the time the experiment was 
ended on day 11.
Recipients of untreated spleen cells had marked 
splenomegaly on day 11 with a spleen index of 2.78 - 0.50. 
This was significantly greater than that found in mice given 
either L3T4” (1.45 ± 0.51, p < 0.02) or Lyt 2" cells (1.36 ±
0 . 3 3 ,  p  <  0 . 0 1 ) .
Although none of the Gvhr mice had marked CTL activity 
some was detectable in untreated recipients with Gvhr (2.4% 
50:1 E:T) while recipients of L3T4 or Lyt 2 cells had none 
at all. In this experiment control mice also had low levels 
of NK activity by day 11, and this was slightly increased 
in mice given intact spleen cells (Fig* 6b ) (7*2% vs. 5*3% 
in controls 50:1 EsT). Once again, much higher levels of 
NK activity were found in recipients of either L3T4 or Lyt 2 
donor cells (l4.6% and 17-6% respectively). Therefore, both 
L3T4+ and Lyt 2+ T cells were required for splenomegaly and 
CTL activity in 5 day old mice with Gvhr.
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Development of intestinal pathology
Mucosal architecture was examined on day 11 of Gvhr 
and the results were similar to those in one day old hosts. 
Mice receiving untreated donor cells had significantly longer 
crypts than controls (Fig. 7) (196.6 - 26.0 p.m vs. 74.0 ±
11.6 p,m, p < 0 .001) as well as significant villus shortening 
(373*6 — 45 p.rn vs. 480.3 — 50.2 p.m, p < 0.05). These Gvhr 
mice also had a significantly increased CCPR compared with 
controls (19*8 - 0.05 vs. 8.6 - 0.04, p < 0.001). In 
contrast, mice which received L3T4” or Lyt 2~ donor spleen 
cells showed no significant changes in mucosal architecture 
compared with littermate controls.
Once again, control mice in these experiments had very 
low numbers of IEL, but in this case, recipients of untreated 
donor cells had significantly higher IEL counts than controls 
(Table 3) (3.8 i 0.3 vs. 2.0 - 0.4, p < O.Ol). In contrast, 
mice receiving L3T4 or Lyt 2 donor cells had IEL counts 
which were the same, or even less than control levels.
These results show that both L3T4 and Lyt 2 cells are 
required for proliferative and destructive enteropathy in 
1 or 5 day old mice.
Genetic basis of intestinal Gvhr in neonatal mice
The second group of experiments in this Chapter examined 
the genetic requirements for the induction of systemic and 
intestinal Gvhr in F± mice, using 1 day old neonates bred 
from parents differing at defined regions of the MHC.
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Induction of Gvhr across a class II MHC difference in 
neonatal (ATH x  ATL)^  mice 
Progress of systemic Gvhr
A Gvhr was induced across a class II MHC difference in 
one day old (ATH x ATL)F1 mice with 107 ATH spleen cells.
Mice with Gvhr developed normally until day 16 (Fig. 8A) , 
when weight loss and other symptoms of clinical Gvhr began. 
These features were most marked on day 24, but were never as 
severe as those found in previous studies using a full MHC 
incompatibility. Furthermore, mortalities did not occur 
until the fourth week of the Gvhr. On day 14, mice with 
Gvhr had marked splenomegaly, with a spleen index of 2.42 - 
0.21 and, although this fell sharply thereafter, some residual 
splenomegaly remained until at least day 21 (Fig. 8b ) .
Specific CTL activity was measured using LPS induced 
lymphoblasts from ATL mice, but no specific cytotoxicity was 
found at any time during the Gvhr (data not shown) • In 
addition no significant NK activity was found in either Gvhr 
or control mice. Thus, there is no activation of either 
specific or non-specific cytotoxicity in a Gvhr induced by 
a class II MHC difference, despite the fact that an acute 
systemic Gvhr is present.
Development of intestinal pathology in neonatal— (ATH x ATL^F^
mice with a Gvhr
There was no evidence of significant villus atrophy 
throughout the course of the Gvhr. Although the fall in 
villus height which occurred in all mice, on day 21,
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appeared, to be somewhat greater in mice with Gvhr, the 
small number of control samples at this time precluded 
statistical analysis# Mice with Gvhr had longer crypts 
than controls on day 14 (Fig. ^) (78.3 - 18 p,m vs. 52.5 ±
40 p,m, p < 0.03) but, thereafter, crypt lengths in Gvhr 
animals were similar to control values throughout the course 
of the experiment. In parallel, an increased CCPR was 
found in Gvhr mice on day 14 (8.81 ± 2.36 vs. 4.09 - 0.66) 
although this was not statistically significant and had 
disappeared by day 26 (11.4 ± 2.7 vs. 9.8 t 1.13 in controls).
Thus induction of a Gvhr across a class II MHC 
incompatibility in 1 day old mice produces many of the 
systemic and intestinal features of an acute Gvhr, but these 
are generally milder than those found using a full MHC 
incompatibility.
Induction of Gvhr across an isolated class I MHC incompatibility 
at H-2k
In this experiment a Gvhr was induced across an isolated
H-2 disparity by injecting newborn (B10.A x  B10.AQR)F^
7mice with 10 BIO.A spleen cells.
Progress of systemic Gvhr
Gvhr mice gained weight at the same rate as control mice 
throughout the experiment and no clinical signs of Gvhr 
were evident at any stage. Mice with Gvhr never had marked 
splenomegaly although a maximum spleen index of 1*38 — 0.40 
was found on day 22 of the Gvhr (Fig. 10A). Virtually no 
specific anti-host cytotoxicity was found against ConA
- 164 -
lymphoblasts from B10.AQR mice at any time during the Gvhr, 
but a low level was found on day 22 (Fig. 10B) (2.4%). 
Interestingly, mice with Gvhr did have a minor and transient 
enhancement of NK activity on day 11 (Fig. 10B) (3 .3% vs. 0.6%
at 30:1 E:T in controls).. NK activity in Gvhr mice then fell 
to control levels. Therefore an isolated class I difference 
produced little evidence of systemic Gvhr.
Development of intestinal pathology in neonatal (BIO.A x 
B10« AQR)F „ mice wi th Gvhr
Mice with Gvhr across H-2Kq had few intestinal changes. 
Although Gvhr mice had significantly larger crypts than 
controls, on day 17 (Fig. 11) (76.71 - 14 pm vs. 49»l6 - 4.82 pm 
p < 0.03)? no significant changes in crypt length were found 
at any other time and there was never any villus atrophy. 
Indeed, the crypt lengthening on day 17 was accompanied by 
a significant increase in villus length (3^5*^3 “ 11*2 pm 
vs. 430.10 - 26.31 P.m for controls, p < 0.03)* Mice with 
Gvhr also had a small increase in CCPR on day 9 (3*06 - 1.49 
vs. 1.16 - 0.43), but this was minor in comparison with that 
found in other models of Gvhr and was not significant.
Induction of a Gvhr across an isolated class I MHC 
incompatibility at H-2D
In view of the fact that the changes which occurred during 
3- Gvhr across an isolated H—2K mcompatioility we. e mj.no- and 
inconsistent, I thought it important to examine & Gvh^ induced 
by another class I incompatibility. Therefore, .^n th^~ 
experiment, I induced a Gvhr across H-2Dq by injecting 1 da>
°ld (BIO. A x B10.AKM)F1 with 10' BIO. A spleen cells.
- 165 -
Progress of systemic Gvhr
As in the Gvhr across H-2Kq, mice with a Gvhr across 
H-2Dq developed at the same rate as their littermate controls 
and showed no signs of clinical Gvhr (Fig. 12). Furthermore, 
these mice never developed marked splenomegaly with a maximum 
spleen index reaching 1.30 i 0.07 on day 11, before dis­
appearing by day 24 (Data not shown).
No specific cytotoxicity was found against ConA lympho­
blasts of B10.AKM origin in Gvhr mice and both control and 
Gvhr mice had identical, virtually undetectable levels of 
NK activity at all times (Data not shown).
Development of intestinal pathology in neonatal (BIO.A x 
B10.AKM)F^ mice with Gvhr
No evidence of intestinal damage was found in this model 
of Gvhr, with identical crypt lengths being found in mice 
with Gvhr and in controls, both at the peak of splenomegaly 
on day 11 and at the later time of day 24 (Fig. 12B).
There were no alterations in villus or crypt length.
Thus the transient increases in villus and crypt length 
seen in the previous experiment using a Gvhr across H—2K 
could not be confirmed using an H-2Dq incompatibility. Together, 
these findings indicate that an isolated class I incompatibility 
produces only minor systemic and intestinal Gvhr and these 
alterations are transient and inconsistent.
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Summary and conclusions
The first series of experiments in this Chapter 
examined the T cell subsets responsible for inducing systemic 
and intestinal Gvhr in a variety of models.
When unirradiated adult (CBA x BALB/cjF^ mice were 
used as hosts, Lyt 2+ or L3T4+ T cells were both required 
for the development of full splenomegaly. However, both 
Lyt 2+ and L3T4 + cells were alone capable of inducing some 
splenomegaly. Only recipients of untreated donor cells 
developed consistent and marked intestinal pathology but 
a transient, early increase in CCPR was seen in recipients 
of L3Tk~ cells and some crypt hyperplasia also occurred at 
later times in recipients of Lyt 2 T-cells. However, the 
changes due to depleted donor cells were generally minor 
and only mice given untreated donor cells had increased IEL 
counts. No Gvhr mice had villus atrophy or specific CTL 
activity.
The development of a destructive enteropathy in 
irradiated (CBA x BALB/cjF.^ mice also required both Lyt 2+ 
and L3T4+ T cells and, although both subpopulations alone 
did produce some crypt hypertrophy, this did not progress 
to villus atrophy. However, Lyt 2 donor cells were capable 
of inducing a lethal Gvhr in irradiated mice, whereas 
depletion of L3T^+ cells resulted in milder systemic disease, 
in which only a few delayed deaths occurred.
In contrast to these findings in irradiated adults,
L3T4~ cells were alone able to induce an acute lethal Gvhr 
in 1 day old (CBA x B A L B / c ^  hosts and also produced 
significant splenomegaly as well as some evidence of both
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crypt hyperplasia and villus damage. However, all these 
features were less severe than those found in recipients 
of untreated donor cells. In contrast, Lyt 2 donor cells 
produced no clinical Gvhr, no splenomegaly and very little 
evidence of mucosal pathology. Interestingly, only mice 
given untreated donor spleen cells had any specific anti- 
host CTL activity, despite the fact that L3T4“ T cells 
could induce some systemic and intestinal consequences 
of acute Gvhr.
As had been found previously, the Gvhr in five day old 
(CBA x BALB/c)Fx mice had some of the features both of the 
disease found in 1 day old neonates and of that in adult 
hosts, with some mice developing weight loss and villus 
atrophy, despite the absence of significant CTL activity* 
However, in these 3 day old mice, neither L3T% nor Lyt 2 
donor cells alone induced any clinical Gvhr and produced 
none of the alterations in crypt length, villus length or 
XML counts, which were normally present in Gvhr mice*
An interesting feature of these experiments was the 
effect of depleting T—cell subpopulations on the activation 
of MK cells during the Gvhr* As anticipated, MK cell 
activation was a characteristic feature of a Gvhr in intact 
hosts, tout this was always much more marked in mice given 
donor cells which had been depleted of either L3T4+ or Lyt 2+ 
cells* This feature seemed more apparent using Lyt 2 cells 
and was in marked contrast to the absence of clinical and 
intestinal Gvhd in recipients of L3T4" or Lyt 2' cells-
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Together, these results indicate that both L3T4+ and 
Lyt 2 T cells are required to induce the Tull systemic 
and intestinal consequences of Gvhr. However, a potential 
pathogenic role for the individual subsets was revealed in 
immunoincompetent hosts, with L3T4"*" cells being capable of 
inducing a lethal Gvhr in irradiated hosts and Lyt 2+ cells 
causing mortality in 1 day old neonates. Furthermore, Lyt 2"*" 
cells seemed to be able to induce a mild, intestinal Gvhr 
in both these hosts. These results highlight the complexity 
of the cells involved in the induction of acute Gvhr and 
also suggest that the intestinal and systemic consequences 
of a Gvhr may not be due to the same mechanisms.
The second part of this Chapter showed that a class II 
MHC incompatibility was sufficient to produce an acute, 
lethal Gvhr in 1 day old neonatal mice. This was associated 
with many of the clinical signs found during the acute Gvhr 
described in earlier chapters, as well as prolonged spleno­
megaly and some evidence of crypt hyperplasia and villus 
atrophy. However, the onset of severe, lethal disease 
occurred about one week later than was found across a full 
MHC incompatibility in mice of the same age. Furthermore, 
only about half of the (ATH x  ATL)F^ mice with Gvhr died, 
whereas a full MHC incompatibility would normally produce 
100% mortality. In parallel, no CTL or enhanced NK activity 
were found in the class II MHC restricted Gvhr and the 
intestinal changes were somewhat less marked than was 
normally found in a Gvhr across a full MHC incompatibility.
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In contrast, a Gvhr induced across an isolated class I 
difference at either H—2 K or D did not produce an acute 
Gvhr associated with weight loss, death or CTL activity, 
although a minor degree of splenomegaly was found occasionally. 
In a Gvhr across H—2Kq, there was also some enhancement of 
NK cell activity and minor crypt lengthening. However, 
these changes were transient and were not present during a 
Gvhr induced by an incompatibility at H-2Dq. Villus atrophy 
was never found in a Gvhr induced across a class I MHC 
incompatibility.
Thus a class II MHC incompatibility is alone sufficient 
to induce many of the systemic and intestinal consequences 
of an acute Gvhr in neonatal mice, whereas isolated class I 
differences have little or no ability to induce these 
alterations. However, the class II MHC restricted Gvhr 
is delayed and milder than that found across a full MHC 
incompatibility. Together with the results obtained using 
T—cell subpopulations, those findings indicate that both 
class I and II MHC restricted T cells are required to induce 
all the systemic and intestinal consequences of Gvhr. 
Interestingly, this feature applies to both proliferative 
and destructive Gvhr, suggesting that these disorders have 
a common cellular basis.
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Day of 
Gvhr
Donor Cell Populations
Untreated L3T4 Lyt 2
5 1.46 - 0.13 1.68 - 0.12 1.48 - 0.08
10 1.31 - 0.15 1.10 - 0.09 1.09 - 0.11
Table 1 : Development of splenomegaly in adult unirradiated ~
(CBA x BALB/c)F, mice with Gvhr induced with 6 x 10 
untreated L3T4 or Lyt 2“ CBA spleen <£ells.
Results shown are mean spleen indices ° 1 s.d.- 
3 mice/group.
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Day of 
Gvhr
Donor Cell Populations
None Untreated L3T4 Lyt 2
villus 
1ength 
(tun)
5
10
Gkk.0 -1 7 . 0  
557.8±10.0
599•8^68.5 
587.9-12.0
609.5^67.0 
617.^-9.0
605.^-23.9 
619.8±35.0
crypt 
length 
( V-m )
5
10
103.9-10.0 
97.9- 3.0
135.2 - 9 .4*
■
147.3-23.0*
126.0-16.0
*101.6^5.8
111.5-7.0 
117.1*9-5**
Ii
! CCPR
'
5
10
7.7- 1.2 
11.7- 2.3
21.9-1.8** 
17-5*3-9
* 16.7*4.3 
8.4*0.7
12.2-1•9 |
i 1
17.1-1.5 i
Table 2: Intestinal pathology in adult unirradiated (CBA x
BALB/c)F1 mice with Gvhr induced with 6 x 10' 
untreated? L3T^+— or Lyt 2~ CBA spleen cells. Villus 
and crypt lengths and CCPR in jejunum of mice with 
Gvhr and in controls. Results shown are means - 1 s.d.
for h mice/group.
*  p  <  0 . 0 2 5
* *  p  <  0 . 0 2
*** p < 0.005 vs controls.
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Hos t Day of 
Gvhr
Donor Cell Population
None Untreated L3T4" Lyt 2
5 14.4±1.1 10.1±2.1 l4.3±2.1 13.5-0.2
Adult
10 13.4±0.4 18.3-4.8 13* 7-0.7 12.9-0.2
1-2 day 
old
neonat e 11 3 .8±1.1 4.10±0.9 2 . 9-0 • 8 1 .8±0.5
3 day 
old 
: neonate
j
10 2.0±0.4
.
3.8 ±0.3* 1 .2±0 .4 1.6±0 .4
Table 3 ? Intestinal pathology in unirradiated adult or
neonatal (CBA x BALB/c)F1 mice with Gvhr induced 
with untreated L3T4 or Lyt 2 CBA spleen 
cells. Intraepithelial lymphocyte counts in the 
jejunum of mice with Gvhr and in controls. Results 
shown are the mean IEL/lOO epithelial cells — 1 s.d. 
for 4 mice/group.
* p < 0.01 vs controls.
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NK Activity *----* control
•----  untreated
A AL3T*T } CBA-F
o o Lyt2~
201-
(E:T cell ratio) 50:125:1 12.5:1
Day 10Day 5
Fig' Induction of systemic Gvhr in adult unirradiated 
(CBA x BALB/c)F1 mice with 6 x 10^ untreated,
L3T4"~ or Lyt 2 CBA spleen cells. NK activity 
din mice with Gvhr and in controls measured against 
YAC-1 target cells. Results shown are % cytotoxicity 
at different E:T ratios using spleen cells pooled 
from 3 mice/group.
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n g .  3 j Induction of intestinal G v h r  in adult irradiated
 1 (CBA x BALB/c)Fn mice with 2 x 10? untreated L3T4
or Lyt 2“ CBA spleen cells. Mucosal architecture 
in the jejunum of Gvhr and control mice on day 6 
of Gvhr. Bars represent mean villus and cryp 
lengths ± 1 standard deviation and arrows show 
CCPR for A— 5 mice/group.
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control
* K untreated • — •
L3T^_
Lyt2”
10
8
6
•H
2dead 2dead2
* 100%mortality
20 2 
Day of Gvhr
1 6 -
NK Activity
•h 10
(E:T cell ratio)50: 1 25:1 12.5:1
Day 11
Fig. h i Development of systemic Gvhr in one day old
(CBA x BALB/c)F-. mice induced with 10' untreated,*
L3T^“ or Lyt 2“ CBA spleen cells. A) Growth rate 
of neonates with Gvhr compared with littermate 
controls 3“ -^ mice/group. B) NK cell activity against 
YAC-1 target cells on day 11 of Gvhr using spleen cells 
pooled from 3 —b mice/group.
- 177 -
control
600 ■
untreated
5  400 ■ p<0.05
p<0.02
200-
200 J
Fig;. 5s Induction of intestinal Gvhr in one day old 
(CBA x BALB/c)F mice, 10 ( untreated, L3T4 
or Lyt 2*" CBA spleen cells. Mucosal architecture 
in the jejunum of Gvhr and control mice on day 11 
of Gvhr. Bars represent mean villus and crypt 
lengths - 1 standard deviation for 3-4- mic e/group.
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6
2
I Day of Gvhr
NK Activity
16
1 2 -
 x c o n t r o l
m 0 u n t r e a te d
m— * L3T4'
O—~0 L y t2 ”
•H 1 0  -
1 2 .5 :1  (E :T  c e l l  r a t i o )2 5 :150:1
Day 11
Fig. 6: Development of systemic Gvhr in 5 day old ?
(CBA x BALB/c)F-| mice induced with 2.5 x 10 
untreated, L3T4 or Lyt 2~ CBA spleen cells.
A) Growth rate of neonates with Gvhr compared 
with littermate controls using 5 mice/group.
B) NK activity on day 11 of Gvhr against YAC-1 
target cells, using spleen cells pooled from
3 mice/group.
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600 n
control
untreated
^  p<0.05
p<0.001
200 ■ Day
Fig. 7 : Induction of intestinal Gvhr in 5^day old
(CBA x BALB/c)F jjnice by 2.5 x 10' untreated, 
L3T4“ or Lyt 2”^G§A^pleen cells. Mucosal 
architecture in the jejunum of Gvhr and control 
mice on day 11 of Gvhr. Bars represent mean 
villus and crypt lengths — 1 s.d. and arrows 
show CCPR for k mice/group.
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control
ATH-* (ATHxATL)F
▲
Spleen index
2
1
20
Fig. 8 j Development of^y^t emic Gvhr across a Class II 
MHC disparity in 1 day old (ATH x  ATL)F1 mice.
A) Growth rates of neonates with Gvhr compared 
with littermate controls^ B) Spleen index.
Results shown are means — 1 s.d. for 3 mice/group 
for spleen index and 5 mice/group for growth 
rate.
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500.
 *--- * control
 •--- • ATH-* ( ATHxATL ) F1100.
300 *
100
io 20
Day of Gvhr
Fig. 9: Development of intestinal Gvhr in 1 day
(ATH x ATL)F mice* Villus and crypt lengths 
in the jejunum of Gvhr and control mice. 
Results shown are the means - 1 s.d. for 
3-4 mice/group.
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10-
— -* control
"* B10.A-* 
(B10.Ax B10.AQR)F
*--- * spleen index
o o CTL
— x control 
• Gvhr
168 28204 12
Day of Gvhr
Fig. 10: Development of systemic Gvhr across an H-2K 
Class I MHC disparity in 1 day old (B10.A x 
B10.AQR)F1 mice. A) Growth rates of neonates 
with Gvhr compared with littermate controls.
B) Spleen index, NK activity and specific CTL 
activity, against YAC—1 and P815 targets 
respectively• Results shown are means - 1 s.d. 
for U mic e/group. Cytotoxicity is shown as the 
lysis at 50:1 E:T for spleen cells pooled from 
h mice/group.
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X ----X  c o n t r o l
•--- • B10.A-*
(B10.Ax B10.AQR^ f
P<0.05
100
208H 1612 24
Day of Gvhr
Fig. 11: Development of intestinal Gvhr across an H-2R
Class I MHC disparity in 1 day old (B10.A x  
B10.AQR)F1 mice villus and crypt lengths in 
the jejunum of Gvhr and control mice. Results 
shown are the means — 1 s.d. for 4 mice/group..
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8
control
B10.A-
(B10.AxB10.AKM)F
>»
2
6001
4JbQ
C0)
M U00'
60p
rHiH
>
300
B3
8 22 
Day of Gvhr
Fig. 12: Development of Gvhr across an H-2D Class I MHC
disparity in (B10.A x  B10.AKM)F mice.- -
A) Growth rates of neonates with Gvhr compared 
with littermate controls. B) Villus and crypt 
lengths in the jejunum of Gvhr and control mice. 
Results shown are the means - 1 s.d. for 4 mice/ 
group.
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CHAPTER 8
EFFECTS OF DEOXYGUANOSINE ON THE DEVELOPMENT 
OF SYSTEMIC AND INTESTINAL CHANGES IN ACUTE
GVHR
- 186 -
Introduction
This thesis has concentrated on models of Gvhr which 
produce a destructive enteropathy involving villus atrophy.
In many experiments the development of villus atrophy 
coincided with the appearance of specific anti-host CTL. 
Nevertheless? this was not always the case suggesting that 
another immune effector mechanism might be responsible for 
this type of intestinal damage. One of the models characterised 
by villus atrophy was the Gvhr which occurred in BDF1 mice 
given BIO parental cells? and others have suggested that 
allospecific Ts may be responsible for the pathological 
consequences of this Gvhr (Pals ejt al. ? 1984). In support 
of this idea? I obtained evidence that suppressor cells were 
present during a destructive Gvhr in both BDF^ and neonatal 
(CBA x BALB/c)F1 mice.
Therefore? in this chapter I examined the effect of 
modifying Ts activity in vivo on the development of an acute 
destructive Gvhr. My first approach to this was to treat 
host mice with the purine metabolite 2'deoxyguanosine using 
a regime that has been shown to prevent the generation of 
Ts in vivo? but which does not affect effector T—cell functions 
(Dosch et_ al. ? 1980; Bril et al. ? 1985)* addition, I
examined the effect of activating Ts in vivo? by inducing a 
Gvhr across an incompatibility at the I-J locus.
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Effects of 2*deoxyguanosine on acute Gvhr 
Experimental design
The models of acute Gvhr which were studied were those
Q
occurring in adult BDF1 mice given 10 BIO spleen cells and 
in one day old (CBA x BALB/c)F1 mice given 107 CBA spleen 
cells. Both these models had been examined in detail earlier 
and both provided evidence of a destructive enteropathy in 
association with the presence of active suppression. In 
each experiment, one group of Gvhr and control mice received 
daily injections of 40 jig/g dGuo intraperitoneally from 
day 5 onwards > while untreated mice received daily injections 
of saline. The development of systemic Gvhr was assessed 
by regular weighing and? at intervals mice were sacrificed 
for measurement of splenomegaly, cytotoxic cell activity and 
of mucosal architecture.
Effects of 2 1 deoxyguanosine on cell mediated immunity in vivo 
Although others have found that dGuo has a selective 
ability to eliminate Ts activity in vivo (Dosch et al. , 1980; 
Bril et al., 1984, 1985), I considered it important to ensure 
that the regime I used did not also alter cell mediated 
effector responses. Therefore the first studies examined 
the effect of treating mice with dGuo on the generation of 
DTH responses as well as specific and non-specific cytotoxicity 
in alloimmunized mice.
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Effect of dGuo on allospecific DTH responses
Allospecific DTH responses were generated by immunizing 
adult CBA mice with 2 x 107 (CBA x BALB/c)F1 spleen cells 
into the footpad and the effect of dGuo was examined by treating 
host mice with 1 mg/day dGuo for the 5 days between priming 
and footpad challenge with (CBA x BALB/c)F1 spleen cells.
As shown in Figure 1A, mice given dGuo mounted an allospecific
DTH response which was identical to that found in control
mice treated with saline daily (0.49 - 0.11 mm vs. 0.43 - 0.17 mm).
Effect of dGuo on the generation of CTL and NK cell activity 
in alioimmune mice
In the second experiment, CBA mice were immunized with
72 x 10 P815 tumour cells i.p. and were given 1 mg dGuo daily
before being sacrificed on days 8, 11 and 14 for assessment 
of specific CTL and NK cell activity in the spleen. Specific 
CTL activity was found at each time, with peak levels occurring 
on day 11. At all times, mice given dGuo had higher levels 
of specific CTL activity than saline treated mice (Fig. IB).
dGuo and saline treated mice also had similar degrees 
of NK cell activation after immunisation with P8I5, although 
this occurred earlier in dGuo treated mice (day 11: 21.1% vs.
12% for controls) than in saline treated mice (day 14: 27*5% 
vs. 14.5% in controls). dGuo had no significant effect on 
the NK cell activity of unimmunized controls.
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Thus, dGuo does not inhibit the generation of allo­
specific DTH or of natural and specific cytotoxicity in 
alloimmunized mice. These results indicate that dGuo should 
not interfere with cell mediated effector mechanisms during 
a Gvhr.
Effects of dGuo on the development of systemic Gvhr in 
adult BDF^ mic e
In the first experiment examining the effects of dGuo 
on Gvhr, an acute Gvhr was induced in adult BDF^ mice by 
injection of BIO spleen cells. As anticipated, saline 
treated mice with Gvhr lost weight rapidly from day 8, 
until day 21, by which time they were significantly lighter 
than controls (Fig. 2) (17*4 - 2.3 S vs. 27*9 — 1*7 g* 
p < O.OOl) and 4 of the 8 mice had died (Fig. 3). Thereafter, 
the remaining Gvhr mice gradually increased In weight although 
one further mouse died on day 49» and the last mouse died 
on day 54. (Two mice from this group of 8 had been sacrificed 
on day 21). Gvhr mice given dGuo also lost weight, although 
this was somewhat delayed in comparison with saline treated 
mice with Gvhr and the minimum weight did not occur until 
day 25 (18,2 - 2.1 vs. 26.4 ± 2.7? p < O.Ol). Furthermore, 
there were only 2 deaths in this group and most of these 
mice continued to full recovery (MST < 100 days vs* 19 days
for saline Gvhr, p < 0.001).
Additional mice from this experiment were sacrificed 
on days 8 and 21 of the Gvhr for assessment of splenomegaly.
- 190 -
As found in earlier studies in this strain combination, 
significant splenomegaly was found in Gvhr mice on day 8 
of the Gvhr and there was no difference between dGuo and 
saline treated mice (Fig. 4). By day 21, the splenomegaly 
had virtually disappeared in both groups.
Effects of dGuo on the development of cell mediated cytotoxicity 
in adult BDF^ mice with Gvhr
CTL and NK activity were examined on days 8 and 21 and, 
as found previously, specific anti-host cytotoxicity was 
present in Gvhr mice on day 8. This was greater in Gvhr 
mice given dGuo than in saline treated mice (Fig. 5A)
(34.7% vs. 25*7% 50 si E:T). By day 21, control Gvhr mice 
had no detectable CTL activity, but low levels remained in 
dGuo treated mice. On day 8, both groups of Gvhr mice had 
markedly lower NK activity than that of appropriate controls 
(Fig. 5B) , but there was more NK activity in Gvhr mice given 
dGuo than in control Gvhr mice (8.8% vs. 6.8% 50:1 E:T ratio).
On day 21, difficulties in labelling the target cells resulted 
in unusually low NK activity in all mice. However, the 
results showed that saline treated mice with Gvhr had no 
detectable NK activity, whereas dGuo treated mice with Gvhr 
had levels which were actually greater than those in dGuo 
treated controls (Fig. 5B)• Interestingly, at both times, 
dGuo treated control mice had slightly higher levels of NK 
activity than untreated controls.
Thus, treatment of mice with dGuo ameliorates the systemic 
consequences of an acute Gvhr in adult BDF^ mice, despite the 
fact that the cell mediated effector mechanisms are spared 
or even enhanced.
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Effects ol* dGuo on the intestinal phase of acute Gvhr 
in adult BDF^ mice
Pieces of jejunum were examined on days 8 and 21 for 
mucosal damage. By day 8 minor, but insignificant villus 
atrophy was found in mice with Gvhr (Fig. 6) (553.2 ± 2^7 pm
vs. 645*4 — 72*5 P-m ) t which increased in severity until 
day 21, when villus lengths were almost half those in control 
mice (314.9 - 59*2 pm vs. 635*6 ^ 67 pm in controls, p < O.OOl). 
Although dGuo treated mice with Gvhr had villus lengths 
identical to those of appropriate controls on day 8, by day 
21 these mice had evidence of severe villus atrophy, which 
was comparable to that seen in untreated mice with Gvhr 
(345^>1 - 65*1 pm vs 557*6 - 49*6 pm in dGuo controls, p <
0 .005) •
Saline treated mice with Gvhr had a small but insignificant 
increase in crypt length compared with controls on day 8 
(Fig. 6) (156.9 - 14.3 pm vs. 123*6 ^ 4.8 pm) but mice 
surviving until day 21 had marked crypt lengthening (290.2 pm 
i 28.7 vs. 126.3 - 6.8 pm, p < 0.001). At both times, Gvhr 
mice also had significant increases in CCPR compared with 
controls (Table l). Gvhr mice treated with dGuo already had 
crypt lengthening on day 8 which was significantly greater 
than that found in saline treated Gvhr mice (198.O - 23*1 pm 
p < 0.05) and had a very large increase in CCPR (49*8 - 3.8 
p < 0.001 versus saline Gvhr). However, by day 21 dGuo 
treated mice had the same degree of crypt lengthening as 
that found in saline treated Gvhr mice, and had a smaller 
increase in CCPR.dGuo itself had no effect on the mucosal 
architecture of control mice.
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Therefore, dGuo appeared to delay the development of 
a destructive enteropathy in Gvhr, producing a concomitant 
increase in the early proliferative changes. However, this 
effect was not as marked as found with systemic disease 
and was overcome at later stages.
Effect of dGuo on the development of suppression during a 
Gvhr in BDF^ mice
In view of the ability of dGuo to delay the Gvhr, I 
conducted a preliminary investigation of the effects of dGuo 
on the generation of suppressor cells during Gvhr.
A Gvhr was induced in a separate group of BDF^ mice 
and spleen cells taken on days 8 and 22 were examined for 
their ability to suppress the response of control BDF^ spleen 
cells to ConA. On day 8 of this experiment, addition of 
different concentrations of spleen cells from both saline and 
dGuo treated mice with Gvhr led to an enhanced response to 
ConA, except when the highest number of control Gvhr cells 
was used, when some suppression was detectable (Fig. 7)»
This suppression was not found using any concentration of 
dGuo treated Gvhr cells.
On day 22 of the Gvhr, the splenic atrophy present in 
saline treated mice prevented the use of a full range of 
concentrations of Gvhr cells and there was no consistent 
evidence of suppression using the low ratios of Gvhr cells 
which were possible. However the results from the experiment 
described in Chapter 5 would suggest that higher concentrations 
of Gvhr cells would produce active suppression at this time.
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In the present study the responses of cell mixes were 
always less when saline treated Gvhr cells were present 
than when dGuo treated Gvhr cells were used. Cells from 
Gvhr mice treated with dGuo did not suppress the ConA 
response of control cells at any ratio. These results 
provide preliminary evidence that dGuo may interfere with 
the development of suppressor cells during an acute Gvhr 
in BDF.^ mice.
Effect of dGuo on a Gvhr in one day old (CBA x BALB/c ^F-l mice
As dGuo had only a rather transient effect on the long 
term Gvhr in adult BDF^ mice, I thought it was of interest 
to confirm its ability to inhibit another model of acute 
Gvhr using one day old neonatal (CBA x BALB/c)F^ mice.
As usual, saline treated mice of this age, given CBA 
spleen cells, developed an acute Gvhr, with a markedly 
delayed growth rate compared with controls after day 7» 
Although dGuo had no significant effects on the development 
of systemic Gvhd, there was some evidence that dGuo did 
prevent the most severe consequences. This was shown by 
the fact that, although Gvhr mice given dGuo undoubtedly 
lost weight during the experiment, the difference in weight 
between this group and their dGuo treated controls, was 
always less than that found with saline treated Gvhr and 
control mice (Fig. 8A). In addition, 3 of. the b remaining 
mice in the dGuo Gvhr group appeared to be healthier and 
heavier than the remaining Gvhr mouse and three of the saline 
treated Gvhr mice had died at earlier times. Although dGpo
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treated control mice were always lighter than saline—treated 
controls, these mice developed at a similar rate throughout 
the study, suggesting that dGuo itself was not influencing 
the growth of neonatal mice.
All Gvhr mice developed significant splenomegaly which 
peaked on day 11 (Fig. 8B). At this time, saline treated 
mice had slightly greater splenomegaly than dGuo treated 
Gvhr mice (2.85 - 0.26 vs. 2.5I ± 0.1k), but virtually 
identical splenomegaly was found at all other times in the 
two groups (Fig. 8B).
Effects of dGuo on the development of cell mediated cytotoxicity 
in neonatal mice with Gvhr
Specific anti-host cytotoxicity appeared in both groups 
of Gvhr mice on day 9* when dGuo treated mice had slightly 
more CTL activity than saline treated mice. CTL activity 
peaked in both groups on day 11 (Fig. 9) (l5»6% and 10*5%
in saline and dGuo treated mice respectively) and had almost 
disappeared by day 18. Thus dGuo had no effect on the 
development of CTL.
As in previous experiments using one day old (CBA x 
BALB/c)F1 mice a transient and minor enhancement of NK activity 
appeared in saline treated mice with Gvhr on day 11, at a 
time when there was no NK activity in control mice (Fig. 9)»
By day 18, saline treated mice with Gvhr had no detectable 
NK activity, despite the appearance of some NK activity in 
controls. In contrast, dGuo treated mice with Gvhr had no 
activation of NK cells on day 11, but at the later time,
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these mice had. NK cell activity which was actually higher* 
than that of either control group. These results provide 
some evidence that dGuo has converted a destructive Gvhr 
into a more proliferative form.
Effect of dGuo on intestinal Gvhr in neonatal (CBA x BALB/c)F1 
mice
Significant villus atrophy was already present by day 9 
in saline treated mice with Gvhr (Fig. 10) (442.7 - 9»7 pm 
vs 473.5 - 12.5 pm in controls, p < 0.05). This became more 
severe by day 11 (364.0 - 2.6 pm vs. 546.2 - 36 pm in 
controls, p < O.Ol) and was still present in mice surviving 
until day 18. In contrast, dGuo treated mice with Gvhr 
never had villus atrophy and indeed had significantly longer 
villi than appropriate controls on both days 9 an.d 18. Both 
groups of Gvhr mice had significantly longer crypts than 
appropriate controls at all times of the Gvhr with maximum 
values being attained on day 11. As in adult mice, dGuo 
itself had no significant effects on mucosal architecture.
Thus, dGuo prevents the development of a destructive 
enteropathy as typified by villus atrophy in neonatal mice 
with Gvhr, but does not inhibit the associated crypt hyperplasia
These findings provide some evidence that dGuo—sensitive 
suppressor cells may play a role in the pathogenesis of acute 
Gvhr. I decided to investigate this further by examining 
a model of Gvhr which has been shown to activate Ts, selectively 
namely, the Gvhr induced across an I-J incompatibility in 
(B10.A3R x B10.A5R)F1 mice.
Induction of a Gvhr across an I-J incompatibility
A Gvhr across an I-J alloantigen difference has been 
shown to induce suppressor T-cells (Liew, 198l) and has been 
reported to suppress some of the indices of mucosal Gvhr 
in adult mice (Movat e_t al. , 1986). Therefore, it was of 
interest to examine whether the changes which develop during 
a Gvhr induced across an I-J incompatibility would produce 
any of the features of an acute systemic and intestinal Gvhr 
in neonatal mice. This was investigated by inducing a Gvhr 
in 1 day old (B10.A3R x B10.A5R)F^ mice with B10A3R spleen 
c ells.
Progress of systemic Gvhr
No evidence of clinical Gvhr was found in this model of 
Gvhr, with Gvhr mice gaining weight at the same rate as 
controls throughout the period examined (Fig. 11A)• Furthermore, 
none of these mice developed any splenomegaly during the course 
of the Gvhr (Fig. 11B). Mice with a Gvhr across I-J never 
showed any CTL activity against LPS induced lymphoblasts 
of B10.A5R origin and no NK activity was detectable in 
either control or Gvhr mice until day 26, when identical levels 
appeared in both groups (Data not shown).
Development of intestinal pathology during a Gvhr in neonatal
(B10.A3R x B10.A5R)F1mice
Despite the absence of features associated with systemic 
Gvhr (B10.A3R x B10.A5R)F1 mice given B10.A3R spleen cells 
had villus atrophy on both days 11 (Fig. 12) (506.4 40.1 pm
vs. 584.7 i 31.2 pm in controls, p < 0 .05) and 16 of the
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Gvhr (498.4 1 47.1 pm vs. 540.8 pm in controls). By day 24 
villus lengths in Gvhr mice had returned to normal. 
Interestingly, the shorter villi found in Gvhr mice on days 
11 and 16 were thin and lacked an inflammatory cell infiltrate, 
and so were completely unlike the inflamed, stunted villi 
which characterised the enteropathy found in other models of 
destructive Gvhr. Furthermore, these alterations in villus 
length were not associated with crypt lengthening. Indeed, 
crypt lengths in Gvhr mice were consistently shorter than 
control crypts, although this was only significant on day 16 
(40.5 ± 3.7 pm vs. 48.7 - 0.4 pm in controls, p < 0 .05)•
Interestingly, crypt lengths began to recover after 
this time and, on day 24, Gvhr mice had a moderate but 
statistically insignificant increase in CCPR compared with 
controls (11.3 - 1*72 vs. 6.48 ^ 2.77)* This perhaps 
reflected a homeostatic response to the earlier mucosal 
atrophy.
Thus the induction of a Gvhr across an I-J incompatibility 
had no effects on systemic immunity and produces no clinical 
disease, but was associated with some evidence of an atrophic 
enteropathy.
Summary and conclusions
The experiments in this Chapter show that daily 
administration of 2'deoxyguanosine substantially reduced 
the mortality due to an acute lethal Gvhr in adult BDF^ mice 
and delayed the associated weight loss. In parallel, dGuo 
appeared to delay slightly the onset of villus atrophy m  
Gvhr and prevented the loss of NK cell activity which normally 
characterises the later stages of Gvhr m  these mice. dGuo 
treated mice with Gvhr also had more intense crypt cell
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proliferation during the early stages of the Gvhr.
Although dGuo had less effects on the systemic 
consequence of acute Gvhd in one day old neonatal (CBA x 
BALB/c)F1 mice, there was some evidence that dGuo treated 
mice with Gvhr had less severe weight loss and eventually 
showed some signs of recovery at later times. In addition 
dGuo treated mice did not have the early enhancement of NK 
cell activity found in control Gvhr mice and dGuo prevented 
the usual loss of NK activity at later times. dGuo had 
profound effects on the intestinal Gvhr in neonatal mice, 
no villus atrophy being found in dGuo treated mice with Gvhr.
In parallel, these mice appeared to have a higher level of 
crypt proliferation than untreated Gvhr animals. dGuo had 
no effect on the development of splenomegaly or anti-host 
CTL activity in either model of Gvhr and also did not 
influence either the growth or mucosal architecture of control 
mice. Furthermore, control experiments showed that dGuo 
did not affect the generation of DTH, CTL or NK cell activation 
in alloimmunized mice. However, experiments in adult BDF^ 
mice with Gvhr provided some preliminary evidence that dGuo 
interfered with the suppressor cell activity found in this
model of acute Gvhr.
The possible involvement of I-J restricted Ts in Gvhr 
was examined by inducing a Gvhr in (B10.A3R x B10.A5R)F^ mice. 
No clinical Gvhr occurred in these mice and there was no 
splenomegaly, anti-host CTL or increase in NK cell activity.
Despite these findings, a Gvhr across I-J did produce villus
1 • i _ j-v, o-p mod el s of des t rue t iv e Gvhr,atrophy. However, unlike otner moaexo
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this villus atrophy was accompanied by crypt shortening 
rather than hyperplasia and there was no mucosal inflammation. 
Interestingly, some evidence was obtained to suggest that 
the mucosa was attempting to recover from the atrophy at 
later times of this Gvhr.
These results indicate that dGuo may reduce the 
destructive consequences of an acute Gvhr, and together 
with the findings in mice with a Gvhr induced across an 
I-J difference, provide some support for a role for suppressor 
T cells in the pathogenesis of Gvhr.
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'
Day of 
Gvhr Control Gvhr
dGuo
control dGuo Gvhr
8 8 .88±^.58 31.16^2.79^ 15.60±1.80 49.81±3 .89**
21 15.40-1.91 50.62^11.94 11.22±1.72 23. 6l±7 . 61
Table 1 : Effects of dGuo on intestinal Gvhr in adult BDF^
mice given 10^ BIO spleen cells. CCPR in the 
jejunum of mice with Gvhr which had been treated 
with saline or dGuo daily from day 5 and in 
appropriate controls. The results shown are means 
- 1 s.d. for 4 mice/group.
*  p <  0 . 0 1
** p < 0.001 vs. appropriate controls.
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Fig. 1 ; Effects of 1 mg/day dGuo on the generation of
allospecific DTH and cytotoxicity in mice treated 
with dGuo (ip) daily. A) DTH responses in adult 
CBA mice immunized with 2 x 10 (CBA x BALB/c)F^ 
spleen cells and in controls. Results shown are 
increases in footpad thickness 2k hours after 
challenge with 10 F^ spleen cells in 6 mice/group.
B) Specific CTL and NK activity in CBA mice 
immunized with 2 x 107 P815 tumour cells and in 
controls. Results shown are Jo cytotoxicity vs 
P815 and YAC-1 at 50:1 E:T in 3 mice/group.
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Fig. 2 : Effects of dGuo on systemic Gvhr in adult BDF^
mice given 10 BIO spleen cells. Body weights 
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Fig* 5: Effects of dGuo on systemic Gvhr in adult BDF.. mice.
Development of A) specific CTL and B) NK activity in 
dGuo and saline treated mice with Gvhr on days 8 and 
21 in appropriate controls. Results shown are % cyto­
toxicity at different E:T ratios using spleen cells 
pooled from 3 mice/group.
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Fig. 6 : Effects of dGuo on intestinal Gvhr in adult
BDF^ mice. Villus and crypt lengths in dGuo 
and saline treated mice with Gvhr, and in 
appropriate controls. Results shown are the 
means - 1 s.d. for 5 mice/group.
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Fig. 7 : Effects of dGuo on the development of
suppression during Gvhr in adult BDF^ mice. 
Spleen cells from dGuo and saline treated 
mice with Gvhr were mixed with control BDF^ 
spleen cells at different ratios and cultured - 
with ConA for 3 days. Results shown are 
mean incorporation of 3h  TdR (cpm/well) for 
triplicate assays.
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B) Development of splenomegaly in dGuo and 
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Results shown are °fo cytotoxicity using spleen 
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Fig. 10: Effects of dGuo on intestinal Gvhr in 1 day old
(CBA x BALB/c)F1 mice. Villus and crypt lengths 
in dGuo and saline treated mice with Gvhr, and 
in appropriate controls. Results shown are the 
means ^ 1 s.d. for 4 mice/group.
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Fig. 12: As for Figure 11. Villus and crypt lengths
in the jejunum of mice with Gvhr and in 
controls. Results shown are means - 1 s.d. 
for 3 mice/group.
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CHAPTER 9 
GENERAL
DISCUSSION
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The principal aim of this thesis was to extend previous 
work on intestinal Gvhr in unirradiated mice, by establishing- 
models of Gvhr which were associated with villus atrophy in 
the small intestine* My intention was then to investigate 
the effector mechanisms responsible for this type of intestinal 
damage*
In Chapters 3> ^ and 5 I have shown that am acute 'Gvhr 
developed in irradiated adult (CBA x BALB/c)F^ mice, in 
neonatal (CBA x BALB/c)F^ mice and in both adult and neonatal 
BDF^ mice given BIO parental cells* All these models of 
acute Gvhr were characterised by destructive intestinal lesions# 
including villus atrophy* It was then possible to compare 
the mucosal pathology and iimaine effector mechanisms found 
in those mod els» with the features described earlier during 
a non—lethal, proliferative Gvhr. The results from these 
experiments on acute Gvhr will be discussed first before 
going on to the studies which attempted to alter the Imteatlmal 
Gvhr by modifying either the host or the "donor cell populati'Ofn*
Models of acute Gvhr
-The development of acute "Gvhr was studied in three 
’different models and the results of "these -will the disfcussed 
separately before assessing the overall :siigrltfic:affljfce of 'the 
results •
'The first model "Chosen was the Gvhr Whicfti oeiCiiMnred in 
heavily irradiated (CBA x BAhB/e|F^ mice given '©BA sqjAoam 
cells, as earlier studies had identified villus atrophy and 
mucosal necrosis in this form of Gvhr (Reilly & Kirsner, 1965?
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Hedberg et al», 1968). However, the intestinal changes had 
not been quantified previously and had not been correlated 
with immune effector mechanisms. All the mice in my experiments 
developed a rapidly lethal disease, but there was also an 
initial, proliferative phase of intestinal Gvhr which was 
associated with a marked enhancement of splenic non-specific 
cytotoxicity. The onset of overt clinical disease was then 
accompanied by the appearance of specific anti-host CTL and 
by villus atrophy in the small intestine. Little attention 
has been given, previously, to the proliferative alterations 
which I found to precede the established phase of acute 
Gvhr in irradiated hosts. These comprised elevated NK activity, 
increased numbers of IEL as well as increases in CCPR and 
crypt length, and thus were identical to the features which 
characterise the entire Gvhr in unirradiated (CBA x BALB/c)F^ 
mice (Mowat & Ferguson, 1981b; 1982; Borland ejt al_., 1983)* 
However a major difference is that villus atrophy and anti­
host CTL only develop during a Gvhr in these hosts if they 
have been irradiated.
Interestingly, the appearance of these latter features 
was preceded by a sudden loss of NK cell activity and a 
parallel cessation of crypt cell mitotic activity. The 
reasons for this are unclear, but an obvious possibility 
is that host derived NK or crypt cells are being lysed by 
donor CTL. Although NK cell precursors are relatively 
radioresistant and increased NK activity occurred in irradiated
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mice with Gvhr (Charley et al. , 1983; Varkila & Hurme,
1985)> it is unclear whether this is due to cells of host 
or donor origin.
However, there is some evidence from studies of Gvhr 
in unirradiated mice that both host and donor NK cells may 
be recruited non-specifically during a Gvhr in unirradiated 
mice (Roy e_t al. , 1982; Borland et_ ad., 1983; Kubota e_t al. , 
1983; Mowat ejb al • , 1985; Ghayur e_fc ad., 1987)* Thus the 
loss of NK activity may be due to a direct attack on host 
cells by donor CTL. Alternatively, it has been suggested 
that NK cells can suppress CTL activity (Schaaf-Lafontaine 
et ad., 1984; Gilbertson e_fc al_., 1986) and therefore it is 
possibde that CTL appear as a result of the cessation of NK 
activity. Finally, the possibility that the abrupt dis­
appearance of NK cell function may not reflect the killing 
of host derived NK cells by developing CTL, is supported by 
the finding of an active suppressor mechanism which inhibits 
NK cells of both donor and host origin develops in irradiated 
mic e wi th Gvhr•
These studies showed that an acute Gvhr in irradiated 
hosts led to villus atrophy which was associated with, specific 
CTL activity. Although one feature of this study was the 
surprisingly minor effects which irradiation itself had on 
the intestine, irradiation did alter epithelial cell renewal 
markedly and others have shown that irradiation and Gvhr 
may synergise in the development of a destructive enteropathy 
in neonatal mice (Reilly & Kirsner, 1965)* Therefore, X 
thought it important to confirm the findings in irradiated 
mice, using a model which did not require radiation to
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produce an acute Gvhr. A different approach was also 
considered necessary as the progression of the Gvhr in 
irradiated host was too rapid to investigate fully the 
effector mechanisms responsible for the intestinal lesions.
The nature and intensity of systemic and intestinal Gvhr 
in neonatal (CBA x BALB/c )F^ mice depended on the age of the 
host. Thus, seven day old mice developed an entirely 
proliferative disease, characterised by intense splenomegaly,
NK cell activation and crypt hyperplasia, identical to that 
described previously in adult mice of this strain (Mowat & 
Ferguson, 1981b, 1982; Borland et al., 1983)* In contrast, 
one or two day old mice developed an acute lethal Gvhr, 
associated with weight loss, specific CTL activity and villus 
atrophy with only transient activation of NK cells. In all 
these experiments, weight loss began about day 8 and death 
normally occurred within 3 weeks. In parallel, the splenomegaly 
found in the early stages of Gvhr disappeared and severely 
runted mice had shrunken spleens, anaemia and liver necrosis. 
Finally, as described previously in acute Gvhr (Pickel &
Hoffman, 1977; Kubota et_ al. , 19^3; Pals e_t al. , 1984) 
there was also some evidence of active immunosuppression 
during the later stages of Gvhr.
As in irradiated mice, the development of acute destructive 
Gvhr in 1—2 day old neonates was preceded by an early 
proliferative phase of NK cell activation and crypt hyperplasia. 
Therefore this biphasic pattern of enteropathy was not merely 
an artefact induced by irradiation, but probably reflects a 
rapidly progressive immune response in immunologically
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deficient hosts. One difference between the models was 
that there was only a very small increase in NK activity 
during the early stages of Gvhr in 1—2 day old neonates. 
Although this probably reflects the absence of NK cell 
activity in mice of this age (Kiessling et_ al. ? 1975; Roder 
e~t al. ? 1981; Koo e_t al_. ? 1982)* rather than a difference in 
the mechanisms involved. It should also be noted that 
there was also no evidence of a reduction in CCPR or IEL 
numbers in neonates with Gvhr.
My findings confirm older observations that the incidence 
of runt disease in neonatal mice decreases with time after 
birth (Nisbet & Heslop? 1962). Together? these features 
provide an explanation for the fact that previous studies of 
Gvhr in neonatal (CBA x BALB/c)F^ mice found villus atrophy 
in 5 day old? but not 6-8 day old hosts and indicate these 
differences were due to inherent differences in the mice used 
rather than to experimental variation (MacDonald & Ferguson? 
1977; Mowat & Ferguson? 1982). Furthermore? an experiment 
using a weight related adjustment of donor cells did not 
alter the systemic or intestinal consequences of the Gvhr? 
therefore the differences I observed were not due to. a cell 
dose effect.
One other difference between the intestinal Gvhr I 
observed in neonatal mice and that described previously in 
adult hosts? was that an increased IEL count was not a 
prominent feature of the present studies. In addition? when 
an increased IEL count occurred? this tended to be found 
later than had been noted in other studies. However, this
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discrepancy is perhaps not surprising in view of the fact 
that mice of this age have very few IEL (Ferguson, 1977;
Strobel & Shields, 1987)* Performing IEL counts in these 
animals also presented considerable technical difficulties.
One constant feature of the acute Gvhr in irradiated and 
1 day old mice was the association between the appearance 
specific CTL and villus atrophy. However, this was not 
confirmed in experiments using 5 day old neonates. Those 
hosts developed an extremely varied form of Gvhr which ranged 
from an acute, lethal disorder to an entirely proliferative 
disease, and so was somewhere between that found in 1 and 
7 day old mice. All 5 day old mice had an early proliferative 
phase of Gvhr with crypt hyperplasia and NK cell activation, 
which was maintained in some mice, and these animals did not 
runt. In contrast, some 5 day old mice with Gvhr lost weight 
and eventually died. As in irradiated hosts, this was 
associated with villus atrophy, the disappearance of NK cell 
activity, decreased crypt cell turnover and crypt shortening. 
However the transition from proliferative to destructive Gvhr 
in 5 day old neonates was accompanied by very little of the 
specific CTL activity found in other models of acute Gvhr.
These findings suggest that CTL may not be essential for villus 
atrophy and systemic runting.
Thus, the acute Gvhr in neonatal or irradiated (CBA x BALB/c)] 
mice provided very similar findings. However, both these 
models used hosts which were inherently abnormal, either 
because of irradiation or immaturity. Therefore, it was 
possible that the ability to induce an acute intestinal disease
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was an artefact of using abnormal hosts* Furthermore, 
the nature of the host mice meant it was difficult to obtain 
sufficient lymphoid cells to perform a comprehensive range 
of functional assays during the Gvhr* Therefore, I was 
concerned to produce an acute, destructive Gvhr in unmanipulated 
adult ho s t s.
Although an acute systemic Gvhr had.been detailed in 
adult, unirradiated BDF1 mice given BIO spleen cells, the 
development of intestinal pathology had not been described 
previously. The results in Chapter 5 confirmed that an acute 
lethal Gvhr could be induced in adult, unirradiated BDF.^  mice
g
by transfer of 10 BIO parental spleen cells. As reported 
previously mice developed weight loss (Van Elven e_fc aT. , 1981; 
Pals e_t al • , 198^-) from around day 8, and a proportion of 
these mice died. In parallel, specific anti-host CTL activity 
appeared as mice began to runt and villus atrophy developed 
in the small intestine. Therefore, this Gvhr was very 
similar to the acute Gvhr in neonatal and irradiated mice.
This was emphasised further by the fact that the early stages 
of the acute Gvhr in BDF-^  hosts were also characterised by 
proliferative changes such as splenomegaly and crypt hyperplasia. 
Although, others have also reported enhanced NK cell activity 
in this model of Gvhr (Kubota et al. , 1983)> I did not find 
this feature, possibly because it occurred before I sacrificed 
the first group of mice on day 3* As in other models of 
acute Gvhr, the transition from the early proliferative phase 
to an acute, destructive disorder was accompanied by the loss 
of NK activity and reduced numbers of IEL, as well as 
declining splenomegaly*
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The consistent finding of specific CTL activity in 
BOF.^ mice with acute Gvhr contrasts with initial studies 
in BDF^ mice given BIO spleen cells which suggested that 
this model of Gvhr was not due to specific CTL activity. 
Nevertheless, this earlier work did not measure CTL activity 
directly in unirradiated BDF1 hosts (Van Elven et al., 1981) 
and others have confirmed the presence of CTL in BIO — * BDF^ 
mice (Kubota ejt al_. , 1983)* Interestingly, these workers 
also found that activation of NK cells preceded the development 
of CTL and that a sudden loss of NK activity paralleled 
the appearance of specific CTL. Suppressed NK activity has 
been noted in other studies of Gvhr in BDF1 mice given BIO 
donor cells (Pattengale e_fc al_. , 1983) and as discussed above, 
it seems possible that this may be due to elimination of 
host NK cells by CTL.
IEL are a further population of cells which declined 
during the most severe phase of acute intestinal Gvhr.
Indeed, IEL had virtually disappeared by day 28, of the Gvhr
in BIO ► BDF1 mice, although animals which survived to day
128 had normal levels of IEL. A similar reduction in IEL 
was seen in irradiated mice with acute Gvhr. The reasons 
for the disappearance of IEL at the peak of the acute phase 
of the Gvhr are unclear. Although the accompanying appearance 
of specific CTL could indicate that infiltrating IEL of host 
origin are being killed by donor CTL, recent work shows 
most IEL in irradiated mice with Gvhr are donor derived 
(Guy-Grand & Vassalli, 1986). Furthermore, a similar decrease 
in the absolute number of IEL has been reported in the
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enteropathy of coeliac disease (Marsh, 1987) and it seems 
unlikely that this could be due to classical CTL. Therefore, 
the decline in IEL may merely reflect severe mucosal damage 
or a generalised defect in immune regulation. It would be 
important to investigate the origin of infiltrating IEL 
during different models of Gvhr.
My findings in BDF^ mice given BIO spleen cells confirm 
that an acute intestinal Gvhr can be induced in intact 
adult animals. In addition, my results in this model are 
very similar to those described by Gleichmann e_t al. (1984) 
and indicate that an acute destructive enteropathy accompanies 
the systemic disease. However, Gleichmann’s experiments had 
also suggested that BDF^ mice given DBA/2 cells would develop 
a different form of systemic Gvhr. Therefore, I had been 
interested to examine whether this strain combination would 
produce an enteropathy which was associated with a different 
pattern of anti-host immune responsiveness. This proved 
not to be the case, as my studies in adult BDF^ recipients 
of DBA/2"cells showed virtually no evidence of the chronic, 
proliferative Gvhr described previously. Although these 
mice had persistent splenomegaly and elevated NK activity, 
there were few intestinal lesions with little evidence of 
crypt hyperplasia and no alterations in IEL counts, or villus 
atrophy. Furthermore, I was unable to detect autoantibodies 
against mouse red blood cells, despite previous work suggesting 
that this model of Gvhr was associated with a SLE-like pattern 
of auto-antibody production (Gleichmann _et al. , 1984).
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Although, these features might suggest that I had merely been 
unable to induce any Gvhr at all in this model, this possibility 
was ruled out by the consistent findings of splenomegaly and 
NK cell activation. The ability of DBA/2 cells to respond 
to BDF^ alloantigens in vivo was confirmed by the fact that 
DBA/2 and BIO donor cells produced a very similar pattern of 
Gvhr in one day old BDF^ neonates, although the disease 
induced by DBA/2 cells was milder, with a delayed onset of 
runting and less severe villus atrophy. Furthermore, as in 
one day old (CBA x B A L B / c ^  mice, both DBA/2 and BIO donor 
cells induced a small, transient peak of NK activity in 
neonatal BDF^ hosts, and this was followed by low levels of 
specific cytotoxicity, crypt hyperplasia and eventually villus 
atrophy. In contrast, 7 day old neonatal BDF^ mice given 
DBA/2 donor cells revealed the same pattern of defective Gvhr 
seen in adult mice, despite the ability of BIO cells to induce 
an acute, lethal Gvhr0 Mice of this age given DBA/2 cells 
had no splenomegaly or elevated NK activity, and the only 
sign of intestinal Gvhr was a small amount of crypt lengthening. 
Therefore DBA/2 cells seem to be capable of inducing most 
features of acute Gvhr, but this requires the use of immuno- 
incompetent hosts.
Together these results suggest that DBA/2 cells do not 
cause a qualitatively different form of Gvhr, but merely have 
a generalised defect in their ability to induce a Gvhr.
Although this is supported by the fact that BIO cells 
responded better than DBA/2 cells to BDF^ stimulator cells 
in an in vitro MLR, there is also evidence that the defect
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in DBA/2 cells may affect some immune functions more than 
others. Whereas I found that both donor cell types appeared 
to induce similar levels of anti-host DTH in Gvhr, anti-host 
CTL activity could be generated in BDF^ mice given BIO, but 
not DBA/2 donor cells. Recently, it has been shown that the 
failure of DBA/2 cells to induce a lethal Gvhr in adult BDF^ 
mice is due to an absolute reduction in Lyt 2+ cells in 
DBA/2 mice (Via j|t al. , 1987)* Furthermore, Sprent has not 
only confirmed that DBA/2 mice have fewer Lyt 2+ cells than 
BIO mice but has also shown that BIO cells make a much stronger 
proliferative response to Class I MHC alloantigens than DBA/2 
cells (Sprent, unpublished observations). These features 
suggest that the ability of donor cells to induce an acute 
Gvhr may depend on their response to Class I MHC, and this 
will be discussed in more detail below.
A final point of interest from my experiments in BDF^
mice was that BIO cells produced more severe Gvhr and
reconstitute BDF.^  hosts very efficiently, despite the
Idtheoretical problem that H-2 cells should be resisted by F1 
mice (Cudkowicz & Stimpfling, 19 64; Shearer & Polisson, I98O,
1981). These findings suggest that F± resistance may not be 
of major importance in the outcome of Gvhr.
In conclusion, these experiments in irradiated or neonatal 
(CBA x BALB/c)F1 mice and in adult, unirradiated BDF^ mice 
given BIO donor cells show that an acute enteropathy involving 
villus atrophy can occur in appropriate models of Gvhr. In 
each case, the destructive intestinal pathology was accompanied
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by a systemic runting disease and frequently by the appearance 
of anti-host CTL activity. These features appeared to 
reflect a severe Gvhr which was allowed to progress due to 
host immunoincompetence or because of particularly potent 
donor cells. The destructive phase was always preceded by 
a proliferative stage of Gvhr, which was characterised by 
increased NK activity, as well as crypt hyperplasia and 
occasionally by increased numbers of IEL. As these initial 
alterations are essentially identical to the features which 
constitute the entire Gvhr in adult, unirradiated mice, 
it seems reasonable to propose that similar mechanisms may 
be responsible. Nevertheless, the onset of runting and villus 
a-trophy "was associated with a sudden transition both in 
immune effector functions and pathology, with an abrupt loss 
of NK activity, disappearance of IEL and sometimes cessation 
of crypt cell mitotic activity.In parallel, there was a 
concomitant appearance of specific anti-host CTL and active 
immunosuppression suggesting that different effector mechanisms 
cause the two aspects of acute Gvhr. The next sections will 
address some of the factors which determine whether an acute 
rather than a proliferative Gvhr occurs and will then discuss 
the potential effector mechanisms in acute enteropathy.
Role of host factors in the outcome of Gvhr - Ability of 
hosts to resist Gvhr
The importance of the host in determining the consequences 
of Gvhr is highlighted by the fact that irradiated or 1-2 day 
old (CBA x BALB/c JFjj^ mice developed an acute, destructive,
Gvhr, whereas older, intact mice of this strain showed only a
proliferative disorder. These features suggested that 
intact animals possess active mechanisms which normally resist 
the progress of Gvhr and I examined the role of two particular 
mechanisms of this type. First, NK cells have been implicated 
in rejection of parental bone marrow and lymphoid cells by 
Fj_ mice (Kiessling et al. , 1977; Varner & Dennert, 1982;
Dennert et al., 1985; Waterfall et al., 1987). That NK cells 
may protect intact hosts from severe Gvhr is supported by the 
fact that prolonged enhancement of NK cell activity is 
associated with mild proliferative forms of Gvhr, whereas loss 
of NK cell activity is one of the first signs of the transition 
to an acute destructive disorder. Furthermore, resting NK 
cell activity is absent in both neonatal (Chapter 4; Kiessling 
et al. , 1975; Roder ejt aT. , 1981, Koo e_t al. , 1982) and 
irradiated mice (Cudkowicz & Hochman, 1979)> which proved 
highly susceptible to acute Gvhr. Nevertheless, certain 
features argue against an essential role for NK cells in 
protection against acute Gvhr. First, resting NK activity 
does not become apparent in neonatal mice until the third 
week of life (Chapter 4; Kiessling e_fc al. , 1975; Koo e_fc al. , 
1982) and this was long after the ability to resist the 
development of an acute Gvhr develops. The best evidence 
that NK cells do not protect mice from Gvhr was my demonstration 
that depletion of NK cells by anti—ASG^. antibody reduced, 
rather than enhanced the systemic and intestinal Gvhr in 
adult (CBA x B A L B / c ^  mice,
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The second, immune mechanism which may account for 
the ability of intact hosts to resist Gvhr is host T-cells. 
Anti—idiotypic host T—lymphocytes can suppress a Gvhr in 
both rats (Bellgrau & Wilson, 1978; Kimura & Wilson, 1984) 
and mice (Kosmatopoulous, 1987) and both neonatal and 
irradiated hosts are markedly defective in T—cell functions. 
The development of neonatal T-cell activity remains somewhat 
controversial, but I found some evidence that T—cells from 
neonatal mice under 5 days old were immunoincompetent, as 
measured by their ability to induce a local Gvhr in the 
popliteal lymph nodes of F^ hosts. This confirms earlier 
work showing that peripheral lymphocytes from mice less than 
3-4 days old have deficient allospecific T-cell activity 
(Adler e_t al_. , 1971; Goldstein e_t al. , 1971)* In addition, 
neonatal mice do not develop the ability to develop T-cell 
tolerance after feeding antigen until after 4 days of age 
(Hanson, I98I), while seeding of peripheral lymphoid tissues 
with thymic T-cells also occurs around this time (Joel et_ al. , 
1972). Time did not permit me to perform detailed studies 
of the ontogeny of T-cell function in neonatal mice, but I 
did attempt to reconstitute 1 day old neonatal mice with 
adult spleen cells prior to the induction of a Gvhr. Although, 
neonatal mice given T—cell enriched adult spleen cells lost 
weight slightly more slowly than normal mice with Gvhr^ ^his 
effect was minor and was not observed with unseparated 
adult cells. However, others have shown that syngeneic adult 
cells can prevent the induction of a Gvhr in neonatal mice 
(Billingham, 1967) and it would be important to identify the
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cell responsible for these protective effects.
Strong evidence that host T—cells can regulate Gvhr 
came from the experiments using athymic (CBA x BALB/cjFj^ mice 
as hosts. Compared with intact (CBA x BALB/cJFj^ mice, nude 
animals developed a more severe Gvhr, with more intense 
splenomegaly and crypt hyperplasia. In addition, only the 
athymic mice showed any evidence of villus atrophy or specific 
CTL activity and also had suppression rather than enhancement 
of NK cell activity. Therefore the absence of host T-cells 
converts a normally proliferative Gvhr into a disease with 
many of the features of the acute Gvhr which was found in 
neonatal or irradiated mice of the same strain. This work 
extends earlier studies which showed that athymic hosts 
developed an unusually severe systemic Gvhr (Piguet & Vassalli, 
1983; Klein et_ al. , 1984) and indicates that a Gvhr in intact 
unirradiated mice is normally limited by a T-cell mediated 
host resistance mechanism. More recently, work by Moser e_fc al. 
(1987) suggests that host Lyt 2+ cells may play a role in 
preventing the development of an acute Gvhr. However, it is 
unclear whether this is mediated by cytotoxic or suppressor 
T-cells.
Nature of the anti—host response induced by different types 
of host
These findings show that a lack of host resistance may 
be one factor which allows an acute Gvhr to develop in 
certain types of host. However one further possible explanation 
for the varying types of Gvhr in different hosts could be that 
distinct immune mechanisms are activated under those
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circumstances. Some evidence for this idea was provided 
by experiments which showed that one day old neonate 
(CBA x BALB/c )F^ mice were deficient in inducing the anti­
host DTH reaction normally found in this strain combination.
The inability of 1 day old neonatal mice to stimulate an 
effective anti-host DTH reaction during Gvhr was also reflected 
by the poor ability of their spleen cells to induce a systemic 
DTH response in semi-allogeneic adult mice. In contrast, 6 day 
old neonates, which developed less severe Gvhr induced an 
anti-host DTH reaction similar to that seen with adult spleen 
cells. Furthermore, compared with adult spleen cells, 1 day 
old neonatal BDF^ spleen cells stimulated a smaller MLR 
response by either DBA/2 or BIO parental cells.
Therefore, the development of a severe, acute Gvhr in 
neonatal mice appears to be associated with a maturational 
defect in the ability of host cells to stimulate an effective 
anti-host DTH response. This seems rather surprising in view 
of the evidence that a donor cell mediated anti—host DTH 
response is an important early event in a Gvhr in both 
irradiated and unirradiated mice (Wolters & Benner, 1978;
Mowat e_fc al. , 1985). Therefore, the acute Gvhr in 1 day old 
mice may be due to a different mechanism to the DTH response 
that is thought to cause a proliferative Gvhr in intact 
adults (Mowat & Ferguson, 1981b). One explanation for the 
poor induction of DTH and MLR by neonatal stimulator cells 
could be low expression of Class II MHC antigens by tissues 
of neonatal rodents (Mayrhofer et al. , 1983; Guy-Grand & 
Vassalli, 1986). As a result, the acute Gvhr in these animals
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could reflect a predominantly Class I MHC restricted reaction 
which, does not induce DTH.
As noted above, an acute Gvhr in adult BDF^ mice is 
dependent on the presence of Lyt 2+ donor cells and the 
general implications of these findings will be discussed below.
Influence of tissue susceptibility on the outcome of Gvhr
One final factor which could influence the nature of the 
Gvhr in different types of host may be the susceptibility of 
tissues to the pathogenic mechanisms of the Gvhr. Many of the 
characteristic target organs in Gvhr are those with a high 
rate of cell renewal, such as the lymphohaemopoietic tissues, 
skin and gut. Irradiation has profound effects on cell renewal 
while the neonatal small intestine has an immature pattern of 
epithelial cell turnover (O’Conner, 1966; Al-Nafussi & Wright,
1982). Therefore, it is possible that these factors combine 
with the direct consequences of Gvhr to produce an unusually 
severe Gvhr. However, it should be noted that the time course 
of maturation of the intestine does not correlate with the 
age—dependent changes in susceptibility to Gvhr which I found 
(O'Conner, 1966; Al-Nafussi & Wright, 1982). Furthermore, 
the fact that a similar pattern of acute Gvhr could be produced 
in intact, adult BDF^ mice argues against tissue susceptibility 
being more than a contributory factor to the outcome of the 
Gvhr.
Immunological effector mechanisms in acute and proliferative Gvhr 
Cellular and genetic basis of different models of Gvhr
Investigations of the immunological basis of allograft 
rejection and Gvhr have concentrated on determining whether 
CTL and/or DTH are responsible. Previous work suggested that 
the proliferative enteropathy found during a Gvhr in unirradiated 
adult (CBA x BALB/c )F^ mice was due to DTH (Mowat & Ferguson, 
1981b). Therefore, the experiments in Chapter 7 were designed 
to investigate whether the induction of destructive and 
proliferative forms of enteropathy in Gvhr required different 
subsets of donor T-cells or recognition of different MHC 
alloantigens. In this way it was hoped to identify some of 
the mechanisms involved. However, my results showed that 
both L3T^+ and Lyt 2+ T-cells were usually required to induce 
the systemic and intestinal alterations seen in a Gvhr in 
both irradiated and unirradiated adult mice, as well as in 
neonatal (CBA x BALB/c)F1 hosts. Nevertheless, there was 
some evidence that individual subsets could have some effects 
alone, under certain circumstances. Thus, both Lyt 2 and 
L3T^+ T-cells induced some splenomegaly in unirradiated adult 
(CBA x BALB/c)F1 recipients, while Lyt 2“ donor cells alone 
were capable of inducing a lethal Gvhr in irradiated mice.
In contrast, L3/f^ cells were able to induce a lethal Gvhr 
in 1 day old neonatal (CBA x BALB/c )F^ mice and this was 
accompanied by some splenomegaly and intestinal lesions.
The findings that both L3T4 and Lyt 2 donor cells 
were usually required to induce most of the lesions of Gvhr
contrast with, earlier studies in rats which, showed that 
W3/25 (CDA- ) T— cells are able to mediate both local and 
systemic Gvhr reactions (White et al., 1978; Mason, 1981).
In addition, previous work in this laboratory showed that 
Lyt 1 2 cells were almost entirely responsible for inducing 
the intestinal phase of* Gvhr in adult unirradiated (CBA x 
BALB/c)F^ mice (Mowat et al. , 1986). Nevertheless, this work 
also indicated a role for Lyt 2+ T-cells in the development 
of the full crypt alterations, while others have shown that 
both Lyt 2+ and Lyt 2 cells are required to induce mortality 
(Vallera e_t al. , 1982; Rolink & Gleichmann, 1983) and 
splenomegaly (Kisielow _et_ al. , 1973; Mage et_ al. , 198l) 
during a systemic Gvhr in unirradiated hosts. One possible 
reason for discrepancies between different studies is that 
earlier work in mice employed Lyt 1 as a marker for helper 
T-cells. As it is now clear that Lyt 1 may be expressed 
on all mouse T-cells (Ledbetter et_ al. , 1981), it is difficult 
to interpret work using Lyt 1-depleted T-cells and more 
recent studies now employ the Lyt 2 and L3T4 antigens as 
non—overlapping markers of Class I and Class II restricted 
T-cells in mice (Dialynas _et al. , 1983)*
Using this approach, more recent studies have shown 
that both L3T^+ and Lyt 2+ T-cells are required for systemic 
Gvhr across a fully allogeneic disparity (Cobbold et al.,
1986), while both T-cells subsets can mediate Gvhr across 
appropriate MHC loci or minor histocompatibility differences 
(Korngold & Sprent, 1983; 19^7; Sprent e_t al_. , 1986a,b).
There is only one other study on gut Gvhr using L3T4 and
Lyt 2 depleted T—cells. This showed that although both 
L3Tb and Lyt 2 cells can alone elicit lymphocytic
infiltration, crypt hyperplasia and villus damage in irradiated 
or unirradiated adult or neonatal (C3H x DBA/2)F1 mice (Guy- 
Grand & Vassalli, 1986), far fewer L3T4+ cells were required 
to induce the enteropathy. In contrast, I found that although 
L3T4 cells were able to induce a lethal Gvhr across a 
fully mis—matched MHC in one day old neonatal mice, these 
mice had only minor crypt and villus damage.
My studies did not support previous suggestions that 
isolated populations of L3T4+ and Lyt 2+ T-cells could cause 
distinct forms of Gvhr (Gleichmann jet al. , 198^; Moser _et al. ,
1987)* Nevertheless, a consistent observation was that both 
L3T4 and Lyt 2 T-cells induced a much greater enhancement
of NK cell activity in Gvhr than that found using unseparated 
donor cells. This was particularly noticeable using Lyt 2~
cells and has been noted previously in this laboratory
(unpublished observations). The reasons for this are unclear, 
but could reflect the that recruitment of host NK cells
is normally limited by an anti-host mechanism which requires 
both Lyt 2+ and L3T^+ donor cells.
The experiments using T—cell depleted populations of 
donor cells were complimented by examination of the genetic 
basis of the intestinal and systemic Gvhr in one day old 
neonatal mice. A Class II MHC difference in (ATH x  ATL)F^ 
mice produced an acute lethal Gvhr with marked splenomegaly 
and crypt lengthening, and some villus shortening but there 
was no activation of NK cells or CTL. In addition, the onset
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of clinical Gvhr was delayed by around 1 week compared 
with the Gvhr seen across a full MHC incompatibility in 
neonatal (CBA x BALB/c)F^ mice, perhaps reflecting the 
delayed appearance of la in mice of this age (Guy—Grand & 
Vassalli, 1986). Induction of a Gvhr across an isolated 
Class I disparity did not result in a lethal Gvhr and there 
was no weight loss or significant splenomegaly. Although the 
Gvhr across H-2Kq in neonatal (B10.A x  B I O . A Q R ^  mice did 
produce minor enhancement of NK activity and some crypt 
lengthening, these changes were minor and transient and were 
not confirmed in the H-2Dq disparate combination. Therefore 
Class I and II antigens do not induce different forms of Gvhr 
and indeed Class I alone has virtually no effect.
These findings support previous work in congenic mice, 
showing that Class II MHC differences are most important for 
several different aspects of systemic Gvhr (Klein & Chiang, 
1976; Klein, 1977; Zinkernagel, I98O; Rolink & Gleichmann,
1983). Furthermore, a Class II MHC incompatibility has been 
shown to be alone sufficient and necessary for intestinal Gvhr 
in both irradiated (Piguet, 1983) and unirradiated adult 
mice (Mowat e_fc al. , 1986). Therefore the intestinal phase of 
Gvhr in both acute and proliferative Gvhr is primarily Class 
IX restricted. Nevertheless, these results contrast with the 
fact that both Lyt 2+ and L3T4+ T-cells were required to 
induce intestinal Gvhr in (CBA x BALB/c)F^ mice. Indeed 
L3T4” cells alone induced a lethal Gvhr in one day old 
(CBA x BALB/c)F1 mice. This indication that Class I MHC 
alloantigens may provide the stimulus for Gvhr under certain
- 233 -
circumstances is supported by recent experiments in mice 
carrying mutations in specified MHC molecules.
These studies have shown that both Class I and Class II 
MHC restricted T—cells can cause MLR, allograft rejection 
and systemic Gvhr provided these are stimulated with an 
appropriate mutant MHC molecule (Sprent & Schaefer, 1983; 
Sprent e_fc al. , 1986a). Very recent studies in MHC mutant 
mice have shown that Class I and Class II MHC restricted T- 
cells can also cause intestinal Gvhr under appropriate 
circumstances, although Class II restricted T-cells were 
consistently more potent (Mowat & Sprent, manuscript in 
preparation). Therefore, both Class I and Class II MHC 
antigens may be inherently capable of inducing similar forms 
of Gvhr and as both Class I and II restricted T-cells can 
mediate CTL activity or DTH (Golding & Singer, 1983; Mizouchi 
e t al. , 1983; Rosenberg e_fc aJL. , 1986; Sprent & Webb, 1987) t 
it is probably impossible to define different pathogenic 
mechanisms purely on the basis of the phenotype or MHC 
restriction of the T-cells responsible.
Therefore, the remaining parts of the thesis were 
designed to investigate the role of different effector 
mechanisms which were present in animals underoing a Gvhr 
and to correlate these with the intestinal pathology.
Effector mechanisms in proliferative and destructive Gvhr
Previous studies had shown that anti—host CTL could 
never be detected during the early proliferative Gvhr in 
adult, unirradiated (CBA x BALB/c )F-^  mice, supporting the
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view that a DTH response was responsible for the resulting 
crypt hyperplasia (Borland et al. , 1983). However, my 
experiments have provided evidence that two distinct phases 
of enteropathy can be induced in certain models of Gvhr 
and these were associated with different cell mediated 
effector mechanisms. Specific CTL were not detectable during 
the entirely proliferative Gvhr which occurred in older 
neonates or during the early proliferative phase which 
characterised all models of acute Gvhr. However, CTL activity 
was present when an acute Gvhr developed in one day old or 
irradiated (CBA x BALB/c)F^ mice or in adult BDF^ mice given 
BIO donor cells. Therefore, the simplest interpretation of 
these findings is that while a DTH response may be responsible 
for proliferative alterations such as splenomegaly, crypt 
hyperplasia and NK cell activation, specific CTL are required 
to produce the more severe features of Gvhr, including villus 
atrophy. Nevertheless, others have shown that the presence 
of CTL does not necessarily correlate with the development 
of a lethal Gvhr (Van Elven et al. , 1981; Jadus & Peck,
1983; Hamilton, 1984), while I found that villus atrophy 
and runting occurred in 5 day old neonatal (CBA x BALB/c)F^ 
mice with Gvhr, despite the absence of CTL. Furthermore, 
as discussed below, the ability of both poly I jC and dGuo 
to modify the systemic and intestinal consequences of Gvhr 
did not correlate with their effects on CTL activity. Finally, 
it has been shown recently tha.t during a Gvhr in irradiated 
hosts, villus atrophy occurs in grafts of foetal small 
intestine which are syngeneic to the donor cells (Mowat e_t al. ,
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1988) indicate that specific anti—host CTL are not essential 
for the development of villus atrophy. Thus, although it 
is impossible to formally exclude some pathogenic role for 
CTL in intestinal Gvhr, other mechanisms must be considered.
Activation of NK cells was found in virtually all my
experiments and has been noted in many previous studies of
Gvhr (Dokhelar et al., 1981; Roy et al., 1982; Borland et al.,
1983; Kubota e_t al. , 1983; Varkila & Hurme, 1985). I
therefore examined the role of NK cells in Gvhr by depleting host
mice of NK cells by treatment in vivo with anti-asialo G.,_
—  ----  Ml
antibody. As shown by others, this protocol resulted in profound 
depletion of resting NK cell activity in control mice (Habu 
e t al. , 1981; Charley e_t al. , 1983; Stitz e_t al. , 1986).
Although a Gvhr produced some increase in NK activity in 
these mice, the NK levels did not even approach those found 
in control untreated mice. Furthermore, in comparison with 
normal (CBA x BALB/c)F^ mice, anti-asialo treated mice with 
Gvhr had consistently less splenomegaly and did not develop 
the crypt lengthening and increased CCPR that characterize 
the intestinal lesions of this model of Gvhr. These findings- 
confirm and extend other reports that anti-AsG^ treatment 
prevents the development of systemic, lethal Gvhr across 
minor and major histocompatibility differences in irradiated 
mice (Charley et al., 1983; Varkila, 1987). In addition, my 
results suggest that AsGM1+ cells are an essential component 
of the local immune response which causes the intestinal crypt 
hyperplasia in Gvhr. Interestingly, although a Gvhr in anti- 
asialo treated hosts still induced an increase in IEL counts,
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control mice given anti-AsGM1 had a small, but significant
reduction in IEL count, which was roughly proportional to
the small number of IEL which have been shown to be AsG , +
Ml
(FI exman et al. , 1983; Carman e t al. , 1986). It is tempting 
to speculate that AsG^^+ IEL are involved in inducing a 
proliferative enteropathy during Gvhr.
Those experiments were interpreted on the basis of
previous findings that anti-As G ^  antibody has a selective
effect on NK cells (Kasai e_fc al. , 1980) and I showed that
anti-AsGj^ treated mice generated normal allospecific DTH
responses. However, A s G ^  has also been found to be expressed
on other lymphoid cells including T-lymphocytes (stein ejfc al.,
1978; Nakano e_t al. , I98O; Akagawa e_t al. , 1981; Beck ejfc al. ,
1982; Suttles et_ al. , 1986) and the majority of Lyt 2+ CTL
clones (Ting ejt al. , 1986). Furthermore, my findings that
anti-AsG^ treatment prevented the generation of specific CTL
in alloimmunised mice have been confirmed both in virus-
infected mice (Stitz afc al., 1986) and during a Gvhr in
irradiated mice (Varkila, 1987)* Although it is unclear
whether effecter CTL themselves express AsGM 1 , it is difficult
to completely exclude the possibility that the ability of
anti AsG,,, to inhibit Gvhr may not be due to an effect on 
Ml
CTL activity. However, it should be noted that the model 
of Gvhr which I used was chosen because it does not involve 
CTL. Furthermore, exPresse<  ^ muc-^1 higher
concentrations on NK cells than on T-cells and this antibody 
eliminates NK cells more readily in vivo and in vitro 
(Kasai et al. , 1980; Suttles et al., 1986; Stitz et al. ,
1986).
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Although it would be important to confirm the effects 
of* treating mice with anti—AsGj^, using NK cell specific 
antibodies such as anti—NK.l, my studies using poly IsC 
supported the view that NK cells may be important effector 
cells in Gvhr. Because of its ability to induce production 
of IFN (Gresser et al. , 1978; Korngold et al. , 1983), poly IsC 
is a potent augmentor of NK activity (Field _et al. , 1967;
Oehler at al_. , 1978; Oehler & Herberman, 1978; Djeu e_t al. ,
1979)* This was confirmed by the fact that treatment of one 
day old neonatal (CBA x BALB/c)F1 mice with poly IsC induced 
the appearance of some NK activity which did not normally 
appear in these very young mice until much later. Furthermore, 
poly IjC led to more marked enhancement of NK cell activity 
in one day old mice with Gvhr and, compared with untreated 
mice with Gvhr, poly IsC treated animals developed more 
marked weight loss and more severe intestinal damage, which 
included both villus atrophy and crypt hyperplasia. In parallel, 
poly IsC treated mice actually generated lower levels of specific 
anti-host cytotoxicity during a Gvhr, confirming other work 
that poly IsC does not activate CTL dn vivo (Biron et al. , 1987).
Poly IsC had no significant effect on the growth of 
control mice, but some evidence was obtained that poly IsC 
could produce a degree of crypt lengthening and villus shortening. 
These findings are consistent with the idea that non-specific 
activation of NK cells can result in intestinal damage.
Although this could not be confirmed by transferring poly IsC 
activated adult spleen cells into syngeneic neonatal mice,
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this may have reflected the inability of NK cells to migrate 
to the small intestine (Rolstad et al., 1986). The possibility 
that poly IjC activated effector mechanisms may be important 
in the pathogenesis of Gvhr are supported by the findings 
that increased levels of serum a i n t e r f e r o n  correlate well 
with the development of lethal Gvhd in irradiated mice 
(Reyes & Kimpel, 1987). Nevertheless, it has been reported 
that poly IsC does not affect the outcome of a Gvhr in 
unirradiated (CBA x C37Bl/6)FJL mice (Varkila & Hurme, 1985) 
while others have found that poly IsC actually inhibited the 
development of immunosuppression and tissue damage during a 
Gvhr in (b6 x  A)F-^  mice (Peres et al. , 1986a). The discrepancies 
between this result and my own may reflect the fact that the 
other study used B6 donor cells, which are highly susceptible 
to F^ resistance (Fox & Howard, 1963; Shearer & Polisson, I98O., 
I98I ). Under these circumstances, activation of host NK 
cells might be expected to increase the ability of F^ hosts 
to resist the B6 donor cells (Peres ejt al. , 1986b). In 
contrast, (CBA x BALB/c)F-^ mice show no resistance to CBA 
cells (Mowat ejfc al_. , 1985) and so in my experiments, NK cell 
activation may only play an effector role. Nevertheless, 
those findings underline the need to confirm the effects 
of poly IsC on several different models of Gvhr. In addition, 
the exact effects of poly IsC and its mediators require 
extensive investigation, as it has been suggested that both 
poly I j C and oc/l^ interferon may affect other limbs of the 
immune system, including antibody production and DTH (Abruzzo 
& Rowley, 1983; Shah et al., 1983)*
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If confirmed, these results with anti AsG^^ and poly I:C
provide some evidence that NK cells may be involved as
effector cells in damage to the intestine and other tissues 
during a Gvhr. These findings are supported by the presence 
of NK cell infiltrates in rejecting allografts (Nemlander 
et al., 1986) and by the fact that depletion of NK cells 
inhibits the induction of autoimmune diabetes in rats 
(Like e_t al. , 1986).
The nature of the NK cell involved in intestinal Gvhr
and the mechanisms by which NK cells could damage the intestine
are unclear. Previous studies have shown that the activation 
of NK cells in unirradiated (CBA x BALB/cjF^ mice with Gvhr
is preceded by the anti-host DTH response (Borland e_t al. ,
1983; Mowat et al., 1985)* Under these circumstances, the
NK activity of intestinal IEL is also enhanced and this
parallels the other features of intestinal pathology. As 
noted above, the ability of anti-AsG^ to prevent intestinal 
Gvhr is associated with a small decrease in IEL count and 
together, these features suggest that activation of epithelial 
NK cells by a local DTH response might contribute to the 
intestinal pathology in Gvhr. The pathogenic role of NK 
cells could of course involve nonspecific cytotoxic damage 
to the intestine. Nevertheless, NK cells are capable of a 
wide range of other immunological functions, including 
production of lymphokines such as IL—2 and IFN and these 
activities could also contribute to the mucosal lesions of 
Gvhr (Handa et al., 1983; Kashara et al., 1983)*
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One point which argues against an essential role 
for NK cells in Gvhr? was my finding that although recipients 
of L3T4 or Lyt 2 cells had significantly elevated levels 
of NK activity? this occurred in the absence of significant 
intestinal pathology. Furthermore? the evidence linking 
NK cells to intestinal Gvhr mainly concerns the proliferative 
form of enteropathy? and my experiments showed clearly that 
the transition to a destructive disease was accompanied by 
a loss of NK cell activity. Therefore? it is necessary to 
consider the possibility that other mechanisms may be 
responsible for the more severe intestinal alterations such 
as villus atrophy.
Previous studies of the acute Gvhr found in BDF^ mice
given BIO cells concluded that specific CTL were not
responsible? but suggested that allospecific Tg caused the
pathological lesions in the lymphohaemopoetic system
(Gleichmann _et. al_. ? 1984). As this model of Gvhr was one
which produced villus atrophy? it was of interest to consider
a possible role for T in intestinal Gvhr. This idea wass
supported by the presence of active suppressor cell activity 
in the spleen of adult BDF^ and neonatal (CBA x BALB/c)F1 
mice with acute Gvhr. Furthermore? there was evidence of 
suppression of NK activity and CCPR in the transition from 
a proliferative to a destructive Gvhr. Although this phenomenon 
requires more detailed investigation and confirmation in more 
models of Gvhr? it provides circumstantial evidence that an 
acute Gvhr is associated with Tg•
-  2k3  -
This idea is also supported by experiments which 
examined the effects of dGuo on the outcome of an acute 
Gvhr. Previous studies have shown that treatment of mice 
with dGuo prevents the generation of specific Ts, without 
affecting effector or helper T-cell development (Dosch et al•, 
1980; Varey _et al. , 1983; Bril et al. , 1984, 1985). My own 
experiments also showed that dGuo did not alter the generation 
of allospecific effector functions such as CTL or DTH.
However, I obtained preliminary evidence that dGuo did prevent 
the activation of suppressor cells which normally occurred 
in BDF^ mice given BIO cells. In parallel, dGuo reduced the 
mortality and runting during an acute Gvhr in adult BDF^ mice. 
Although dGuo did not prevent the development of villus atrophy in 
this model, it did delay the onset of this feature. In 
contrast, dGuo had few effects on systemic Gvhr in one day 
old neonatal (CBA x BALB/c)F^ mice, but prevented the 
development of villus atrophy found in untreated littermates 
with Gvhr. In parallel, dGuo appeared to increase the 
proliferative changes of Gvhr, as measured by crypt hyperplasia. 
dGuo had no effects on the generation of either NK cell 
or CTL activity in Gvhr and did not itself produce any 
intestinal damage. Thus, although dGuo had somewhat different 
effects on these two models of Gvhr, each model gave some 
support to the idea that T g play a role in the development 
of acute systemic and intestinal Gvhr.
The reasons for the different effects of dGuo on the 
Gvhr in adult and neonatal mice are not clear, but it could 
be because T play different roles in these models of acute
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Gvhr. Alternatively, I may not have adjusted the dose of 
dGuo correctly for adult and neonatal mice, or there may be 
age—dependent differences in susceptibility to dGuo.
Therefore, the effects of dGuo on each of these models requires 
further examination and it would also be important to examine 
in more detail, the effects of dGuo on immune cells other 
than Tg. Nevertheless, in subsequent experiments, dGuo has 
always had clear effects on the development of acute Gvhr 
(personal observation) and dGuo has never been shown to 
interfere with immune effector cells in the doses used here.
Finally, the ability of Tg to affect the intestinal 
mucosa was supported by experiments in neonatal mice with a 
Gvhr induced across the I-J locus. Despite the current 
controversy over the nature of the I-J gene and its product 
(Murphy, 1987)> induction of a Gvhr across a difference 
at I-J, has been shown previously to activate Tg in vivo 
(Zinkernagel, 1980; Bromberg et_ al. , 1981). In my studies, 
neonatal (B10.A3R x B10.A3R)F1 mice given B10.A3R donor cells 
had no evidence of clinical Gvhr or splenomegaly, but these 
mice did develop some villus atrophy. These findings are 
supported by the suppressed IEL counts, crypt lengths and 
CCPR during a Gvhr across I-J in adult, unirradiated mice 
(Mowat et al. , 1986) and indicate the potential ability of T g 
to modulate epithelial cell renewal in vivo. However, it should 
be noted that the villus atrophy found in neonatal mice with 
I—j restricted Gvhr was associated with crypt atrophy 
and an absence of the inflammatory cell infiltrate normally 
found when villus atrophy is present in Gvhr. Therefore,
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this form of villus damage may be due to different mechanisms. 
Nevertheless, it is tempting to speculate that activation 
of T g during a severe, progressive Gvhr contributes to the 
inhibition of CCPR and NX cell activation seen during the 
transition from a proliferative Gvhr to a destructive 
disorder. Modulation of epithelial cell renewal in this 
way might then contribute to the villus damage.
Conclusions
The work in this thesis has used three separate models 
of acute Gvhr to try and define the mechanisms responsible 
for the development of villus atrophy. Previous work in 
unirradiated mice suggested that DTH is responsible for the 
crypt hyperplasia and NX cell activation (Mowat & Ferguson, 
1981b, 1982; Borland e_t al • , 1983) and the work here showed 
that similar features preceded the development of destructive 
enteropathy. This was found in models of Gvhr when immuno- 
incompetent hosts or very potent donor cells were used. 
Therefore it is possible that villus atrophy is the result of 
a more progressive form of DTH response, as has been suggested 
previously (MacDonald & Ferguson, 1977)* Furthermore? this 
is supported by the incomplete correlation of CTL activity 
with villus atrophy and recently, it has been shown that the 
development of mucosal damage in mice with acute Gvhd can 
be prevented by treatment with anti-tumour necrosis factor 
(Piguet et al. , 1987) and anti- £ interferon (Mowat, 
unpublished observations). Therefore villus atrophy could 
be due to the prolonged release of high levels of lymphokines,
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which, in smaller amounts cause crypt hyperplasia. This is 
supported by the fact that ^ -interferon may be stimulatory 
as well as inhibitory (Trinchieri & Perussia, 1985), 
Alternatively, this could be due to the cumulative effects 
of different lymphokines being produced at various stages 
of the Gvhr.
It is clear that much more work examining these problems 
is required and this may be pursued by measuring the production 
and level of lymphokines during Gvhr induced enteropathy or 
by the direct effects on the small intestine of in vivo 
treatment with lymphokines. Examination of the phenotype 
of T-cells responsible for the mucosal damage did not provide 
any conclusive information, but agents which are said to 
discriminate effector cell functions, for example leucyl- 
leucine methyl ester (Thiele e_t al_. , 1987)* may be more 
useful. Finally, the most direct approach may be to study 
the effects of purified lymphokines and, or effector cells 
on intestinal organ cultures or epithelial cells in vitro.
The clinical relevance of this work is that the villus 
atrophy, crypt hyperplasia and lymphocytic infiltration 
reproduces many of the mucosal alterations found during FSE. 
Therefore, it is important to pursue these in vivo studies 
of the evolution of enteropathy, although the relevance of 
Gvhr as a suitable model may require further examination.
This is highlighted by the apparent reduction in CCPR and loss 
of I EL seen during the destructive phase of Gvhr, which 
are not found in FSE. Nevertheless, it would be useful to 
be able to make use of some of the features of my work on 
Gvhr, to attempt to produce a similar, acute enteropathy in
animals fed protein antigens.
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Gvhr )
A p p e n d ix :
As th e  two m odels o f  a d u l t  u n ir r a d ia te d  m ice w h ich  deve loped  d i f f e r e n t  
fo rm s o f  G vh r, re c e iv e d  dono r s p le e n  c e l l s  by d i f f e r e n t  r o u te s ,  i t  was 
n e ce ssa ry  to  exam ine w h e the r t h i s  a lo n e  may c o n t r ib u te  to  th e  d if fe re n c e s  
o b s e rv e d .
A Gvhr was in d u c e d  i n  a d u l t  u n ir r a d ia te d  ( CBAxBALB/c) mice w ith  6x10^
CBA s p le e n  c e l l s ,  w h ich  were g iv e n  e i t h e r  in t ra v e n e o u s ly  o r  i n t r a p e r i t o n e a l l y . 
D if fe re n c e s  i n  m o r t a l i t y ,  sp lenom eg a ly  and c y t o t o x i c i t y  were measured a t  
i n t e r v a ls  t h e r e a f t e r .
R e s u lts
P ro g re ss  o f  s y s te m ic  Gvhr i n  a d u l t  (C B A xB A LB /c)^ m ice 
B o th  g roups  o f  (CBAxBALB/c)F/j m ice w ith  Gvhr were in s p e c te d  a t  r e g u la r  
i n t e r v a ls  and no c l i n i c a l  s ig n s  o f  Gvhr were seen a t  any tim e  and none 
o f  th e  m ice  d ie d .
M ice from  each group  were s a c r i f i c e d  on days 1 , 4 , 8 , 1 2  and 26 and a 
s i g n i f i c a n t  s p le e n  in d e x  was p re s e n t in  th e  Gvhr m ice w h ich  re c e iv e d  
d o n o r c e l l s  in t r a v e n e o u s ly , by day 4 (T a b le  1 APP), and by day 8 
s i g n i f i c a n t  sp le n o m e g a ly  had deve lo p e d  in  b o th  groups o f  m ice w ith  
Gvhr ( 1 .3 4 hD . 10 and 1 .6 3 + 0 .1 4  in  i p  and i v  Gvhr m ice r e s p e c t iv e ly ) .  
S ig n i f i c a n t  sp le n o m e g a ly  was found  i n  bo th  groups o f  m ice w ith  Gvhr 
u n t i l  day 26 b u t t h i s  was a lw ays  g re a te r  in  m ice g iv e n  donor c e l l s  i v .
D eve lopm ent o f  s p e c i f i c  and n o n - s p e c if ic  c y t o t o x ic i t y
O n ly  v e ry  low  le v e ls  o f  s p e c i f i c  c y t o t o x ic i t y  were ^ u n d  in  (CBAxBALB/c)F/j 
m ice  w ith  Gvhr a t  a l l  t im e s ,  and th e re  was no d i f fe r e n c e  between th e  two 
g roups (T a b le  1 APP). In  c o n t r a s t ,  in c re a s e d  le v e ls  o f  NK c e l l  a c t i v i t y  
were fou n d  in  m ice w ith  G vhr. These were r e la t i v e l y  modest i n  th e  ip  
in je c te d  g ro u p , b u t th e  in c re a s e ” appeared sooner and was n o t ic e a b ly  
g re a te r  i n  m ice g iv e n  dono r c e l l s  in t ra v e n e o u s ly .  N e v e rth e le s s , by 
day 12 NK c e l l  a c t i v i t y  i n  b o th  groups o f  Gvhr m ice were s im i la r  (31% 
and 32% in  ip  and i v  m ice  r e s p e c t iv e ly  vs 18% in  c o n t r o ls ) .
A lth o u g h  th e  in d u c t io n  o f  a Gvhr i n  (CBAxBALB/c)F/j m ice w ith  6x10^ CBA 
s p le e n  c e l l s  i v ,  p roduced  more se ve re  sys te m ic  p r o l i f e r a t i v e  changes 
th a n  ip  in je c te d  m ice , th e s e  d id  n o t c o r r e la te  w ith  th e  deve lopm ent o f  
an a c u te  le t h a l  G vhr. T h e re fo re  th e  d if fe re n c e  in  th e  ty p e  o f  Gvhr w h ich  
d e ve lo p e d  in  a d u l t  u n ir r a d ia te d  (CBAxBALB/c)F/j m ice and a d u lt  u n ir r a d ia te d  
BDF^ m ice  was n o t due to  th e  method o f  in o c u la t in g  c e l l s .
Day o f  Gvhr C o n tro l Gvhr
in t r a p e r i t o n e a l in tra v e n e o u s
1 - 1 .0 3 + 0 .0 6
I
1 .15 + 0 .1 3
4 - 1 .1 8 + 0 .0 8 1 .7 6 + 0 .3 6
S p leen
in d e x 8 - 1 .3 4 + 0 .1 0 1 .63 + 0 .1 4
12 - 1 .30 + 0 .0 2 2 .1 2 + 0 .5
26 - 1 .3 7 + 0 .3 1 .58+0 .1
1 - 0% 0%
4 - 4% 1.2%
CTL 8 - 4.2% 3.6%
12 - 0% 2.6%
26 - 0% 0%
1 32% 30% 51%
4 14% 20% 29%
NK 8 42.4% 44% 82%
12 ,18% 31% 32%
26 9.4% 16.7% 14%
T a b le  1 APP: Assessm ent o f  s y s te m ic  Gvhr in  a d u lt  (CBAxBALB/c)F,j m ice
g iv e n  6x107 CBA s p le e n  c e l l s ,  e i t h e r  ip  o r i v .  Development 
o f  sp le n o m e g a ly  and c y t o t o x ic i t y  in  m ice w ith  Gvhr and in  
c o n t r o ls .  R e s u lts  shown a re  means (+  1 s .d .  f o r  sp le e n  in d ic e s )  
f o r  3 m ic e /g ro u p .
